Document:

EX-10.2

 Exhibit 10.2 

PLEDGE AND SECURITY AGREEMENT 

THIS PLEDGE AND SECURITY AGREEMENT (as it may be amended, restated, supplemented or otherwise modified from time to time, this
“Security Agreement”) is entered into as of July 27, 2017 by and among Heska Corporation, a Delaware corporation, Diamond Animal Health, Inc., an Iowa corporation, Heska Imaging, LLC, a Delaware limited liability company, (each
a “Grantor”, and collectively, the “Grantors”), and JPMorgan Chase Bank, N.A., in its capacity as administrative agent (the “Administrative Agent”) for the lenders party to the Credit Agreement
referred to below. 
 PRELIMINARY STATEMENT 

The Grantors, the Administrative Agent, any other Loan Parties and the Lenders are entering into a Credit Agreement dated as of the date
hereof (as it may be amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”). Each Grantor is entering into this Security Agreement in order to induce the Lenders to enter into and extend
credit to the Grantor under the Credit Agreement. 
 ACCORDINGLY, the Grantors and the Administrative Agent, on behalf of the Secured
Parties, hereby agree as follows: 
 ARTICLE I 

DEFINITIONS 
 1.1. Terms
Defined in Credit Agreement. All capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Credit Agreement. 

1.2. Terms Defined in UCC. Terms defined in the UCC which are not otherwise defined in this Security Agreement are used herein as
defined in the UCC. 
 1.3. Definitions of Certain Terms Used Herein. As used in this Security Agreement, in addition to the terms
defined in the first paragraph hereof and in the Preliminary Statement, the following terms shall have the following meanings: 

“Accounts” shall have the meaning set forth in Article 9 of the UCC. 

“Article” means a numbered article of this Security Agreement, unless another document is specifically referenced. 

“Chattel Paper” shall have the meaning set forth in Article 9 of the UCC. 

“Closing Date” means the date of the Credit Agreement. 

“Collateral” shall have the meaning set forth in Article II. 

“Collateral Access Agreement” means any landlord waiver or other agreement, in form and substance satisfactory to the
Administrative Agent, between the Administrative Agent and any third party (including any bailee, consignee, customs broker, or other similar Person) in possession of any Collateral or any landlord of any real property where any Collateral is
located, as such landlord waiver or other agreement may be amended, restated, supplemented or otherwise modified from time to time. 

“Commercial Tort Claims” means the commercial tort claims as defined in Article 9 of the UCC, including each commercial tort
claim specifically described on Exhibit I. 

 “Control” shall have the meaning set forth in Article 8 or, if applicable, in Section 9-104, 9-105, 9-106 or 9-107 of Article 9 of the UCC. 

“Copyrights” means, with respect to any Person, all of such Person’s right, title, and interest in and to the following:
(a) all copyrights, rights and interests in copyrights, works protectable by copyright, copyright registrations, and copyright applications; (b) all renewals of any of the foregoing; (c) all income, royalties, damages, and payments
now or hereafter due and/or payable under any of the foregoing, including, without limitation, damages or payments for past or future infringements for any of the foregoing; (d) the right to sue for past, present, and future infringements of
any of the foregoing; and (e) all rights corresponding to any of the foregoing throughout the world. 
 “Default”
means any event or condition which constitutes an Event of Default or which upon notice, lapse of time or both would, unless cured or waived, become an Event of Default. 

“Deposit Account Control Agreement” means an agreement, in form and substance satisfactory to the Administrative Agent, among
any Loan Party, a banking institution holding such Loan Party’s funds, and the Administrative Agent with respect to collection and control of all deposits and balances held in a deposit account maintained by such Loan Party with such banking
institution. 
 “Deposit Accounts” shall have the meaning set forth in Article 9 of the UCC. 

“Documents” shall have the meaning set forth in Article 9 of the UCC. 

“Equipment” shall have the meaning set forth in Article 9 of the UCC. 

“Event of Default” means an event described in Section 5.1. 

“Excluded Collateral” means, collectively, (a) any rights or interest in any contract, lease, permit, license, or
license agreement covering real or personal property if under the terms of such contract, lease, permit, license, or license agreement, or applicable law with respect thereto, the grant of a security interest or lien therein is prohibited or
restricted as a matter of law or under the terms of such contract, lease, permit, license, or license agreement , or would invalidate any such contract, lease, permit, license or license agreement, and such prohibition or restriction has not been
waived or the consent of the other party to such contract, lease, permit, license, or license agreement has not been obtained (provided, that, (i) the foregoing exclusions of this clause (a) shall in no way be construed (A) to
apply to the extent that any described prohibition or restriction is ineffective under Section 9-406, 9-407, 9-408, or 9-409 of the UCC or other applicable law, or (B) to apply to the extent that any consent or waiver has been obtained that would permit the Administrative Agent’s security interest or lien to attach
notwithstanding the prohibition or restriction on the pledge of such contract, lease, permit, license, or license agreement and (ii) the foregoing exclusions of clause (a) shall in no way be construed to limit, impair, or otherwise affect
any of the Administrative Agent’s or any Lender’s continuing security interests in and liens upon any rights or interests of any Grantor in or to (A) monies due or to become due under or in connection with any described contract,
lease, permit, license, license agreement, or (B) any proceeds from the sale, license, lease, or other dispositions of any such contract, lease, permit, license, or license agreement); (b) any United States intent-to-use trademark or service mark applications to the extent that, and solely during the period in which, the grant of a security interest therein would impair the validity or enforceability of a
registration issuing from such intent-to-use trademark or service mark applications under applicable federal law, provided that upon submission and acceptance by the
United States Patent and Trademark Office of an amendment to allege use pursuant to 15 U.S.C. Section 1051(c) or a statement of use pursuant to 15 U.S.C. Section 1051(d) (or any successor provisions), such intent-to-use trademark or service mark application shall be considered Collateral; (c) any interest in any real property held by any Grantor; and (d) Excluded Deposit and Securities Accounts. 

  
 2 

 “Excluded Deposit and Securities Accounts” means the collective reference to:
(a) Deposit Accounts of Grantors specially and exclusively used for payroll, payroll taxes, trust or fiduciary purposes and other employee wage and benefit payments to or for the Grantors’ employees (provided that the amount on deposit in
such accounts does not exceed the then current amount of such payroll, payroll taxes and other employee wage and benefit obligations), and (b) Deposit Accounts specially and exclusively used for taxes, including sales taxes (provided that the
amount on deposit in such accounts does not exceed the then current amount of such tax obligations). 
 “Exhibit” refers to
a specific exhibit to this Security Agreement, unless another document is specifically referenced. 
 “Farm Products” shall
have the meaning set forth in Article 9 of the UCC. 
 “Fixtures” shall have the meaning set forth in Article 9 of the UCC.

 “General Intangibles” shall have the meaning set forth in Article 9 of the UCC. 

“Goods” shall have the meaning set forth in Article 9 of the UCC. 

“Instruments” shall have the meaning set forth in Article 9 of the UCC. 

“Inventory” shall have the meaning set forth in Article 9 of the UCC. 

“Investment Property” shall have the meaning set forth in Article 9 of the UCC. 

“Lenders” means the lenders party to the Credit Agreement and their successors and assigns. 

“Letter-of-Credit Rights” shall have the
meaning set forth in Article 9 of the UCC. 
 “Licenses” means, with respect to any Person, all of such Person’s
right, title, and interest in and to (a) any and all written licensing agreements or similar arrangements in and to its Patents, Copyrights, or Trademarks, (b) all income, royalties, damages, claims, and payments now or hereafter due or
payable under and with respect thereto, including, without limitation, damages and payments for past and future breaches thereof, and (c) all rights to sue for past, present, and future breaches thereof. 

“Patents” means, with respect to any Person, all of such Person’s right, title, and interest in and to: (a) any and
all patents and patent applications; (b) all inventions and improvements described and claimed therein; (c) all reissues, divisions, continuations, renewals, extensions, and
continuations-in-part thereof; (d) all income, royalties, damages, claims, and payments now or hereafter due or payable under and with respect thereto, including,
without limitation, damages and payments for past and future infringements thereof; (e) all rights to sue for past, present, and future infringements thereof; and (f) all rights corresponding to any of the foregoing throughout the world.

 “Pledged Collateral” means all Instruments, Securities and other Investment Property of the Grantors, to the extent
constituting Collateral, whether or not physically delivered to the Administrative Agent pursuant to this Security Agreement. 

“Receivables” means the Accounts, Chattel Paper, Documents, Investment Property, Instruments and any other rights or claims
to receive money which are General Intangibles or which are otherwise included as Collateral. 
 “Section” means a numbered
section of this Security Agreement, unless another document is specifically referenced. 

  
 3 

 “Secured Parties” shall have the meaning set forth in the Credit Agreement. 

“Security” shall have the meaning set forth in Article 8 of the UCC. 

“Stock Rights” means all dividends, instruments or other distributions and any other right or property which the Grantors
shall receive or shall become entitled to receive for any reason whatsoever with respect to, in substitution for or in exchange for any Equity Interest constituting Collateral, any right to receive an Equity Interest and any right to receive
earnings, in which the Grantors now have or hereafter acquire any right, issued by an issuer of such Equity Interest. 
 “Supporting
Obligations” shall have the meaning set forth in Article 9 of the UCC. 
 “Trademarks” means, with respect to any
Person, all of such Person’s right, title, and interest in and to the following: (a) all trademarks (including service marks), trade names, trade dress, and trade styles and the registrations and applications for registration thereof and
the goodwill of the business symbolized by the foregoing; (b) all licenses of the foregoing, whether as licensee or licensor; (c) all renewals of the foregoing; (d) all income, royalties, damages, and payments now or hereafter due or
payable with respect thereto, including, without limitation, damages, claims, and payments for past and future infringements thereof; (e) all rights to sue for past, present, and future infringements of the foregoing, including the right to
settle suits involving claims and demands for royalties owing; and (f) all rights corresponding to any of the foregoing throughout the world. 

“UCC” means the Uniform Commercial Code, as in effect from time to time, of the State of New York or of any other state the
laws of which are required as a result thereof to be applied in connection with the attachment, perfection or priority of, or remedies with respect to, Administrative Agent’s or any other Secured Party’s Lien on any Collateral. 

The foregoing definitions shall be equally applicable to both the singular and plural forms of the defined terms. 

ARTICLE II 
 GRANT OF
SECURITY INTEREST 
 Each Grantor hereby pledges, collaterally assigns and grants to the Administrative Agent, on behalf of and for the
ratable benefit of the Secured Parties, a security interest in all of its right, title and interest in, to and under the following personal property and assets, whether now owned by or owing to, or hereafter acquired by or arising in favor of such
Grantor (including under any trade name or derivations thereof), and whether owned or consigned by or to, or leased from or to, such Grantor, and regardless of where located (all of which will be collectively referred to as the
“Collateral”): 
  

	 	(i)	all Accounts; 

  

	 	(ii)	all Chattel Paper; 

  

	 	(iii)	all Copyrights, Patents and Trademarks; 

  

	 	(iv)	all Documents; 

  

	 	(v)	all Equipment; 

  

	 	(vi)	all Fixtures; 

  

	 	(vii)	all General Intangibles; 

  

	 	(viii)	all Goods; 

  

	 	(ix)	all Instruments; 

  
 4 

	 	(x)	all Inventory; 

  

	 	(xi)	all Investment Property; 

  

	 	(xii)	all cash or cash equivalents; 

  

	 	(xiii)	all letters of credit, Letter-of-Credit Rights and Supporting Obligations; 

 

	 	(xiv)	all Deposit Accounts with any bank or other financial institution; 

  

	 	(xv)	all Commercial Tort Claims; 

  

	 	(xvi)	all Farm Products; and 

  

	 	(xvii)	all accessions to, substitutions for and replacements, proceeds (including Stock Rights), insurance proceeds and products of the foregoing, together with all books and records, customer lists, credit files, computer
files, programs, printouts and other computer materials and records related thereto and any General Intangibles at any time evidencing or relating to any of the foregoing; 

to secure the prompt and complete payment and performance of the Secured Obligations. 

Notwithstanding anything contained in this Security Agreement to the contrary, the term “Collateral” and the foregoing grant shall not include, and
the security interest shall not attach to, any Excluded Collateral, provided, that if and when any property shall cease to be Excluded Collateral, such property shall be deemed at all times from and after such date to constitute Collateral to the
extent subject to the grant clause in this Article II. 
 ARTICLE III 

REPRESENTATIONS AND WARRANTIES 

Each Grantor represents and warrants to the Administrative Agent and the Secured Parties that: 

3.1. Title, Authorization, Validity, Enforceability, Perfection and Priority. Such Grantor has good and valid rights in or the power to
transfer the Collateral and title to the Collateral with respect to which it has purported to grant a security interest hereunder, free and clear of all Liens except for Liens permitted under Section 4.1(e), and has full power and authority to
grant to the Administrative Agent the security interest in the Collateral pursuant hereto. The execution and delivery by such Grantor of this Security Agreement has been duly authorized by proper corporate and limited liability company, as
applicable, proceedings of such Grantor, and this Security Agreement constitutes a legal valid and binding obligation of such Grantor and creates a security interest which is enforceable against such Grantor in all Collateral it now owns or
hereafter acquires, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in
equity or at law. When financing statements have been filed in the appropriate offices against such Grantor in the locations listed on Exhibit H, the Administrative Agent will have a fully perfected first priority security interest in that
Collateral of such Grantor in which a security interest may be perfected by such filings, subject only to Liens permitted under Section 4.1(e). 

3.2. Type and Jurisdiction of Organization, Organizational and Identification Numbers. The type of entity of such Grantor, its state of
organization, the organizational number issued to it by its state of organization and its federal employer identification number are set forth on Exhibit A. 

3.3. Principal Location. Such Grantor’s mailing address, which shall be its address for notices and other communications provided
for herein, and the location of its place of business (if it has only one) or its chief executive office (if it has more than one place of business), are disclosed in Exhibit A; such Grantor has no other places of business except those set
forth in Exhibit A. 

  
 5 

 3.4. Collateral Locations. All of such Grantor’s locations where Collateral in excess
of $50,000 in the aggregate is located (other than Collateral in transit in the ordinary course of business and personal property leased to customers pursuant to leases or Chattel Paper constituting Collateral) are listed on Exhibit A. All of
said locations are owned by such Grantor except for locations (i) which are leased by the Grantor as lessee and designated in Part VII(b) of Exhibit A and (ii) at which Inventory is held in a public warehouse or is otherwise
held by a bailee or on consignment as designated in Part VII(c) of Exhibit A. 
 3.5. Deposit Accounts. All of such
Grantor’s Deposit Accounts are listed on Exhibit B. 
 3.6. Exact Names. Such Grantor’s name in which it has
executed this Security Agreement is the exact name as it appears in such Grantor’s organizational documents, as amended, as filed with such Grantor’s jurisdiction of organization. Except as set forth in Exhibit A, Grantor has not, during
the past five years, been known by or used any other corporate or fictitious name, or been a party to any merger or consolidation, or been a party to any acquisition. 

3.7. Letter-of-Credit Rights and Chattel Paper.
Exhibit C lists all Letter-of-Credit Rights of such Grantor. All action by such Grantor necessary to protect and perfect the Administrative Agent’s Lien on
each item listed on Exhibit C has been duly taken by filing financing statements as directed in writing by the Administrative Agent. The Administrative Agent will have a fully perfected first priority security interest in the Collateral
listed on Exhibit C, subject only to Liens permitted under Section 4.1(e). Upon the request of the Administrative Agent, such Grantor will provide to the Administrative Agent a list of all Chattel Paper owned by such Grantor. Such
Grantor has not conveyed any interest in, or delivered possession of possession of, any Chattel Paper to any person and the originals of all Chattel Paper of such Grantor are in the possession of the Grantor at its principal place of business. 

3.8. Accounts and Chattel Paper. 

(a) The amounts owing, due dates and, to the knowledge of the Grantors, the correct legal names of the obligors and other information with
respect to its Accounts and Chattel Paper are and will be correctly stated in all material respects in all applicable records of such Grantor relating thereto and in all invoices with respect thereto furnished to the Administrative Agent by such
Grantor from time to time. As of the time when each Account or each item of Chattel Paper arises, such Grantor shall be deemed to have represented and warranted that such Account or Chattel Paper, as the case may be, and all records relating
thereto, are genuine and in all respects what they purport to be. 
 (b) With respect to its Accounts, (i) all Accounts represent bona
fide sales of Inventory or rendering of services to Account Debtors in the ordinary course of such Grantor’s business and are not evidenced by a judgment, Instrument or Chattel Paper; (ii) there are no material setoffs, claims or disputes
existing or asserted with respect thereto and such Grantor has not made any agreement with any Account Debtor for any extension of time for the payment thereof, any compromise or settlement for less than the full amount thereof, any release of any
Account Debtor from liability therefor, or any deduction therefrom except a discount or allowance allowed by such Grantor in the ordinary course of its business; (iii) to such Grantor’s knowledge, there are no facts, events or occurrences
which in any way materially impair the validity or enforceability thereof or could reasonably be expected to materially reduce the amount payable thereunder as shown on such Grantor’s books and records and any invoices, statements with respect
thereto; (iv) such Grantor has not received any written notice of proceedings or actions which are threatened or pending against any Account Debtor which are reasonably likely to result in any material adverse change in such Account
Debtor’s financial condition; and (v) such Grantor has no actual knowledge that any Account Debtor with respect to any material Accounts has become insolvent or is generally unable to pay its debts as they become due. 

(c) In addition, with respect to all of its Accounts, (i) the amounts shown on all invoices and statements with respect thereto are
actually and absolutely owing to such Grantor as indicated thereon and are not in any way contingent, and (ii) to such Grantor’s knowledge, all Account Debtors have the capacity to contract. 

  
 6 

 3.9. Inventory. With respect to any of its Inventory (a) such Inventory (other than
Inventory in transit) is located at one of such Grantor’s locations set forth on Exhibit A, (b) no Inventory (other than Inventory in transit) is now, or shall at any time or times hereafter be stored at any other location except as
permitted by Section 4.1(g), (c) such Grantor has good, indefeasible and merchantable title to such Inventory and such Inventory is not subject to any Lien or security interest or document whatsoever except for the security interest granted to
the Administrative Agent hereunder, for the benefit of the Administrative Agent and Secured Parties, and Permitted Encumbrances, (d) such Inventory is of good and merchantable quality, free from any known defects, (e) such Inventory is not
subject to any licensing, patent, royalty, trademark, trade name or copyright agreements with any third parties which would require any consent of any third party upon sale or disposition of that Inventory or the payment of any monies to any third
party upon such sale or other disposition, (f) such Inventory has been produced in accordance with the Federal Fair Labor Standards Act of 1938, as amended, and all rules, regulations and orders thereunder, and (g) the completion of
manufacture, sale or other disposition of such Inventory by the Administrative Agent following an Event of Default shall not require the consent of any Person and shall not constitute a breach or default under any contract or agreement to which such
Grantor is a party or to which such property is subject. 
 3.10. Intellectual Property. Such Grantor does not have any interest in,
or title to, any registered Patent, Trademark or Copyright except as set forth in Exhibit D. This Security Agreement is effective to create a valid and continuing Lien and, upon filing of appropriate financing statements in the offices listed
on Exhibit H and this Security Agreement with the United States Copyright Office and the United States Patent and Trademark Office, as applicable, fully perfected first priority security interests in favor of the Administrative Agent on such
Grantor’s U.S. Patents, Trademarks and Copyrights, such perfected security interests are enforceable as such as against any and all creditors of and purchasers from such Grantor, subject to applicable bankruptcy law and general principles of
equity. 
 3.11. Filing Requirements. None of its Equipment is covered by any certificate of title, except for the vehicles described
in Part I of Exhibit E. None of the Collateral owned by it is of a type for which security interests or liens may be perfected by filing under any federal statute except for (a) the vehicles described in Part II of Exhibit E and
(b) Patents, Trademarks and Copyrights held by such Grantor and described in Exhibit D. The legal description, county and street address of each property on which any Fixtures are located is set forth in Exhibit F together with
the name and address of the record owner of each such property. Notwithstanding anything contained in the Loan Documents to the contrary, as of the Effective Date, no Grantor shall be required to take any action required under the law of any non-U.S. jurisdiction to create or perfect any security interest in any Patents, Trademarks and Copyrights. 

3.12. No Financing Statements, Security Agreements. No effective financing statement or security agreement describing all or any
portion of the Collateral which has not lapsed or been terminated naming such Grantor as debtor has been filed or is of record in any jurisdiction except for financing statements or security agreements (a) naming the Administrative Agent on
behalf of the Secured Parties as the secured party and (b) in respect to other Liens permitted under Section 6.02 of the Credit Agreement. 

3.13. Pledged Collateral. 

(a) Exhibit G sets forth a complete and accurate list of all of the Pledged Collateral owned by such Grantor. Such Grantor is the direct, sole
beneficial owner and sole holder of record of the Pledged Collateral listed on Exhibit G as being owned by it, free and clear of any Liens, except for the security interest granted to the Administrative Agent for the benefit of the Secured Parties
hereunder and Permitted Encumbrances. Such Grantor further represents and warrants that (i) all Pledged Collateral owned by it constituting an Equity Interest has been (to the extent such concepts are relevant with respect to such Pledged
Collateral) duly authorized, validly issued, are fully paid and non-assessable, (ii) with respect to any certificates 

  
 7 

 
delivered to the Administrative Agent representing an Equity Interest, either such certificates are Securities as defined in Article 8 of the UCC as a result of actions by the issuer or
otherwise, or, if such certificates are not Securities, such Grantor has so informed the Administrative Agent so that the Administrative Agent may take steps to perfect its security interest therein as a General Intangible, (iii) all such
Pledged Collateral held by a securities intermediary is covered by a control agreement among such Grantor, the securities intermediary and the Administrative Agent pursuant to which the Administrative Agent has Control and (iv) to the knowledge
of the applicable Grantor, all Pledged Collateral which represents Indebtedness owed to such Grantor has been duly authorized, authenticated or issued and delivered by the issuer of such Indebtedness, is the legal, valid and binding obligation of
such issuer and such issuer (subject to debtor relief and bankruptcy laws and to general principles of equity) is not in default thereunder. 

(b) In addition, (i) none of the Pledged Collateral owned by it has been issued or transferred in violation of the securities
registration, securities disclosure or similar laws of any jurisdiction to which such issuance or transfer may be subject, (ii) no options, warrants, calls or commitments of any character whatsoever (A) exist relating to such Pledged
Collateral or (B) obligate the issuer of any Equity Interest included in the Pledged Collateral to issue additional Equity Interests, and (iii) no consent, approval, authorization, or other action by, and no giving of notice, filing with,
any governmental authority or any other Person is required for the pledge by such Grantor of such Pledged Collateral pursuant to this Security Agreement or for the execution, delivery and performance of this Security Agreement by such Grantor, or
for the exercise by the Administrative Agent of the voting or other rights provided for in this Security Agreement or for the remedies in respect of the Pledged Collateral pursuant to this Security Agreement, except as may be required in connection
with such disposition by laws affecting the offering and sale of securities generally. 
 (c) Except as set forth in Exhibit G, such
Grantor owns 100% of the issued and outstanding Equity Interests which constitute Pledged Collateral owned by it and none of the Pledged Collateral which represents Indebtedness owed to such Grantor is subordinated in right of payment to other
Indebtedness or subject to the terms of an indenture. 
 ARTICLE IV 

COVENANTS 
 From the date
of this Security Agreement, and thereafter until this Security Agreement is terminated, each Grantor agrees that: 
 4.1. General.

 (a) Collateral Records. Such Grantor will maintain complete and accurate books and records with respect to the Collateral owned by
it, and furnish to the Administrative Agent with sufficient copies for each of the Lenders, such reports relating to such Collateral as the Administrative Agent shall from time to time request. 

(b) Authorization to File Financing Statements; Ratification. Such Grantor hereby authorizes the Administrative Agent to file, and if
requested will deliver to the Administrative Agent, all financing statements and other documents and take such other actions as may from time to time be requested by the Administrative Agent in order to maintain a first perfected security interest
in and, if applicable, Control of, the Collateral owned by such Grantor. Any financing statement filed by the Administrative Agent may be filed in such offices as the Administrative Agent reasonably determines to be appropriate to perfect the
security interest of the Administrative Agent under this Security Agreement and may (i) indicate such Grantor’s Collateral (1) as all assets of the Grantor or words of similar effect, regardless of whether any particular asset
comprised in the Collateral falls within the scope of Article 9 of the UCC of such jurisdiction, or (2) by any other description which reasonably approximates the description contained in this Security Agreement, and (ii) contain any other
information required by part 5 of Article 9 of the UCC for the sufficiency or filing office acceptance of any financing statement or amendment, including (A) whether such Grantor is an organization,

  
 8 

 
the type of organization and any organization identification number issued to such Grantor, and (B) in the case of a financing statement filed as a fixture filing or indicating such
Grantor’s Collateral as as-extracted collateral or timber to be cut, a sufficient description of real property to which the Collateral relates. Such Grantor also agrees to furnish any such information
described in the foregoing sentence to the Administrative Agent promptly upon request. Such Grantor also ratifies its authorization for the Administrative Agent to have filed in any UCC jurisdiction any initial financing statements or amendments
thereto if filed prior to the date hereof. 
 (c) Further Assurances. Such Grantor will, if so requested by the Administrative Agent,
promptly furnish to the Administrative Agent, as often as the Administrative Agent reasonably requests, statements and schedules further identifying and describing the Collateral owned by it and such other reports and information in connection with
its Collateral as the Administrative Agent may reasonably request, all in such detail as the Administrative Agent may reasonably specify. Such Grantor also agrees to take any and all actions necessary to defend title to the Collateral against all
persons and to defend the security interest of the Administrative Agent in its Collateral and the priority thereof against any Lien not expressly permitted hereunder. 

(d) Disposition of Collateral. Such Grantor will not sell, lease or otherwise dispose of the Collateral except for dispositions
specifically permitted pursuant to Section 6.05 of the Credit Agreement. 
 (e) Liens. Such Grantor will not create, incur, or
suffer to exist any Lien on the Collateral except (i) the security interest created by this Security Agreement, and (ii) other Liens permitted under Section 6.02 of the Credit Agreement. 

(f) Other Financing Statements. Such Grantor will not authorize the filing of any financing statement naming it as debtor covering all
or any portion of the Collateral owned by it, except for financing statements (i) naming the Administrative Agent on behalf of the Secured Parties as the secured party, and (ii) in respect to other Liens permitted under Section 6.02
of the Credit Agreement. Such Grantor acknowledges that it is not authorized to file any financing statement or amendment or termination statement with respect to any financing statement referred to in clause (i) above without the prior written
consent of the Administrative Agent, subject to such Grantor’s rights under Section 9-509(d)(2) of the UCC. 

(g) Locations. Such Grantor will not (i) maintain any Collateral (other than Collateral in transit in the ordinary course of
business and personal property leased to customers pursuant to leases or Chattel Paper constituting Collateral) owned by it in excess of $50,000 in the aggregate at any location other than (x) those locations listed on Exhibit A and
(y) other locations promptly disclosed to Administrative Agent upon such Collateral being located at such location (and such Grantor will concurrently therewith obtain a Collateral Access Agreement for each such location to the extent required
by the Credit Agreement); or (ii) change its principal place of business or chief executive office from the location identified on Exhibit A, other than as permitted by the Credit Agreement. 

(h) Compliance with Terms. Such Grantor will perform and comply with all obligations in respect of the Collateral owned by it and all
agreements to which it is a party or by which it is bound relating to such Collateral. 
 4.2. Receivables. 

(a) Certain Agreements on Receivables. Such Grantor will not make or agree to make any material discount, credit, rebate or other
reduction in the original amount owing on a Receivable or accept in satisfaction of a Receivable less than the original amount thereof, except that, prior to the occurrence of an Event of Default, such Grantor may reduce the amount of Accounts
arising from the sale of Inventory in accordance with its present policies and in the ordinary course of business. 

  
 9 

 (b) Collection of Receivables. Except as otherwise provided in this Security Agreement,
such Grantor will collect and enforce, at such Grantor’s sole expense, all amounts due or hereafter due to such Grantor under the Receivables owned by it in accordance with past practice and in the ordinary course of business, subject to
discounts and allowances allowed by such Grantor in the ordinary course of its business. 
 (c) Delivery of Invoices. Such Grantor
will deliver to the Administrative Agent promptly upon its written request after the occurrence and during the continuation of an Event of Default duplicate invoices with respect to each Account owned by it and, after acceleration of the
Obligations, bearing such language of assignment as the Administrative Agent shall specify. 
 (d) Disclosure of Counterclaims on
Receivables. If (i) any material discount, credit or agreement to make a rebate or to otherwise reduce the amount owing on any Receivable owned by such Grantor exists or (ii) if, to the knowledge of such Grantor, any material dispute,
setoff, claim, counterclaim or defense exists or has been asserted or threatened with respect to any such Receivable, such Grantor will promptly disclose such fact to the Administrative Agent in writing. 

(e) Electronic Chattel Paper. Such Grantor shall take all steps requested by the Administrative Agent to grant the Administrative Agent
Control of all electronic chattel paper valued in excess of $50,000 in the aggregate for all such electronic chattel paper in accordance with the UCC and all “transferable records” as defined in each of the Uniform Electronic Transactions
Act and the Electronic Signatures in Global and National Commerce Act. 
 4.3. Inventory and Equipment. 

(a) Maintenance of Goods. Such Grantor will do all things necessary to maintain, preserve, protect and keep its Inventory and the
Equipment in good repair and working and saleable condition, except for damaged or defective goods arising in the ordinary course of such Grantor’s business and except for ordinary wear and tear in respect of the Equipment. 

(b) Returned Inventory. If an Account Debtor returns any Inventory to such Grantor when no Event of Default exists, then such Grantor
shall promptly determine the reason for such return and shall issue a credit memorandum to the Account Debtor in the appropriate amount. In the event any Account Debtor returns Inventory to such Grantor when an Event of Default exists, such Grantor,
upon the request of the Administrative Agent, shall: (i) hold the returned Inventory in trust for the Administrative Agent; (ii) segregate all returned Inventory from all of its other property; (iii) dispose of the returned Inventory
solely according to the Administrative Agent’s written instructions; and (iv) not issue any credits or allowances with respect thereto without the Administrative Agent’s prior written consent. All returned Inventory shall be subject
to the Administrative Agent’s Liens thereon. 
 (c) Inventory Count. Such Grantor will conduct or cause to be conducted a
physical count of its Inventory at least once per fiscal year, and after and during the continuation of an Event of Default, at such other times as the Administrative Agent requests. Such Grantor, at its own expense, shall deliver to the
Administrative Agent the results of each physical verification, which such Grantor has made, or has caused any other Person to make on its behalf, of all or any portion of its Inventory. 

(d) Equipment. Such Grantor shall not permit any Equipment to become a fixture with respect to real property or to become an accession
with respect to other personal property with respect to which real or personal property the Administrative Agent does not have a Lien. Such Grantor will not, without the Administrative Agent’s prior written consent, alter or remove any
identifying symbol or number on any of such Grantor’s Equipment constituting Collateral. 
 (e) Titled Vehicles. If requested by
the Administrative Agent, such Grantor will give the Administrative Agent notice of its acquisition of any vehicle covered by a certificate of title and deliver to the Administrative Agent, upon request, the original of any vehicle title certificate
and provide and/or file all other documents or instruments necessary to have the Lien of the Administrative Agent noted on any such certificate or with the appropriate state office. 

  
 10 

 4.4. Delivery of Instruments, Securities, Chattel Paper and Documents. Such Grantor will
(a) deliver to the Administrative Agent promptly upon execution of this Security Agreement the originals of all Securities and Instruments constituting Collateral owned by it (if any then exist), in each case solely to the extent such item of
Security, or Instrument exceeds $50,000 individually or $100,000 in the aggregate, (b) hold in trust for the Administrative Agent upon receipt and promptly thereafter deliver to the Administrative Agent any such Securities and Instruments
constituting Collateral, in each case solely to the extent such item of Security, or Instrument exceeds $50,000 individually or $100,000 in the aggregate and (c) upon the Administrative Agent’s request, deliver to the Administrative Agent
(and thereafter hold in trust for the Administrative Agent upon receipt and promptly deliver to the Administrative Agent) any Document evidencing or constituting Collateral. Such Grantor retains the originals of all Chattel Paper of such Grantor in
the possession of such Grantor at its principal place of business and will not deliver possession of any such Chattel Paper to any person; provided, that upon request of the Administrative Agent after and during the continuance of an Event of
Default, such Grantor will deliver such originals of all Chattel Paper to the Administrative Agent. 
 4.5. Uncertificated Pledged
Collateral. Such Grantor will permit the Administrative Agent from time to time to cause the appropriate issuers (and, if held with a securities intermediary, such securities intermediary) of uncertificated securities or other types of Pledged
Collateral owned by it not represented by certificates to mark their books and records with the numbers and face amounts of all such uncertificated securities or other types of Pledged Collateral not represented by certificates and all rollovers and
replacements therefor to reflect the Lien of the Administrative Agent granted pursuant to this Security Agreement. With respect to any Pledged Collateral owned by it, such Grantor will take any actions necessary to cause (a) the issuers of
uncertificated securities which are Pledged Collateral and (b) any securities intermediary which is the holder of any such Pledged Collateral, to cause the Administrative Agent to have and retain Control over such Pledged Collateral. Without
limiting the foregoing, such Grantor will, with respect to any such Pledged Collateral held with a securities intermediary, cause such securities intermediary to enter into a control agreement with the Administrative Agent, in form and substance
satisfactory to the Administrative Agent, giving the Administrative Agent Control. 
 4.6. Pledged Collateral. 

(a) Changes in Capital Structure of Issuers. Such Grantor will not (i) permit or suffer any issuer of an Equity Interest
constituting Pledged Collateral owned by it to dissolve, merge, liquidate, retire any of its Equity Interests or other Instruments or Securities evidencing ownership, reduce its capital, sell or encumber all or substantially all of its assets
(except for Permitted Encumbrances, sales of assets permitted pursuant to Section 4.1(d), and otherwise as permitted by the Credit Agreement) or merge or consolidate with any other entity, or (ii) vote any such Pledged
Collateral in favor of any of the foregoing. 
 (b) Issuance of Additional Securities. Such Grantor will not permit or suffer the
issuer of an Equity Interest constituting Pledged Collateral owned by it to issue additional Equity Interests, any right to receive the same or any right to receive earnings, except to such Grantor or as permitted by the Credit Agreement. 

(c) Registration of Pledged Collateral. Such Grantor will permit any registerable Pledged Collateral owned by it to be registered in
the name of the Administrative Agent or its nominee at any time at the option of the Required Lenders. 
 (d) Exercise of Rights in
Pledged Collateral. 
 (i) Without in any way limiting the foregoing and subject to clause (ii) below, such Grantor
shall have the right to exercise all voting rights or other rights relating to the Pledged Collateral 

  
 11 

 
owned by it for all purposes not inconsistent with this Security Agreement, the Credit Agreement or any other Loan Document; provided however, that no vote or other right shall be
exercised or action taken which would have the effect of impairing the rights of the Administrative Agent in respect of such Pledged Collateral. 

(ii) Such Grantor will permit the Administrative Agent or its nominee at any time after the occurrence and during the
continuance of an Event of Default, without notice, to exercise all voting rights or other rights relating to the Pledged Collateral owned by it, including, without limitation, exchange, subscription or any other rights, privileges, or options
pertaining to any Equity Interest or Investment Property constituting Pledged Collateral as if it were the absolute owner thereof. 

(iii) Such Grantor shall be entitled to collect and receive for its own use all cash dividends and interest paid in respect of
the Pledged Collateral owned by it, and cash payments in respect of principal of, or in redemption of, or in exchange for, such Pledged Collateral constituting an obligation of the Company to a Subsidiary or an obligation of a Subsidiary to the
Company or another Subsidiary, to the extent not in violation of the Credit Agreement other than any of the following distributions and payments (collectively referred to as the “Excluded Payments”): (A) dividends and
interest paid or payable other than in cash in respect of such Pledged Collateral, and instruments and other property received, receivable or otherwise distributed in respect of, or in exchange for, any Pledged Collateral; (B) dividends and
other distributions paid or payable in cash in respect of such Pledged Collateral in connection with a partial or total liquidation or dissolution or in connection with a reduction of capital, capital surplus or
paid-in capital of an issuer; and (C) cash paid, payable or otherwise distributed, in respect of principal of, or in redemption of, or in exchange for, such Pledged Collateral (excluding Pledged
Collateral constituting an obligation of the Company to a Subsidiary or an obligation of a Subsidiary to the Company or another Subsidiary); provided however, that until actually paid, all rights to such distributions shall remain subject to
the Lien created by this Security Agreement; and 
 (iv) All Excluded Payments and all other distributions in respect of any
of the Pledged Collateral owned by such Grantor, whenever paid or made, shall be delivered to the Administrative Agent to hold as Pledged Collateral and shall, if received by such Grantor, be received in trust for the benefit of the Administrative
Agent, be segregated from the other property or funds of such Grantor, and be forthwith delivered to the Administrative Agent as Pledged Collateral in the same form as so received (with any necessary endorsement). 

(e) Interests in Limited Liability Companies and Limited Partnerships. Each Grantor agrees that no ownership interests in a limited
liability company or a limited partnership which are included within the Collateral owned by such Grantor shall at any time constitute a Security under Article 8 of the UCC of the applicable jurisdiction. 

4.7. Intellectual Property. 

(a) Upon the reasonable request of the Administrative Agent, such Grantor will use its commercially reasonable efforts to secure all consents
and approvals necessary or appropriate for the assignment to or benefit of the Administrative Agent of any License held by such Grantor and to enforce the security interests granted hereunder. 

(b) Except as disclosed in Exhibit D, such Grantor shall notify the Administrative Agent promptly if it knows or has reason to know that any
application or registration relating to any material Patent, Trademark or Copyright (now or hereafter existing) may become abandoned or dedicated to the public, or of any adverse determination or development (including the institution of, or any
such determination or development in, any proceeding in the United States Patent and Trademark Office, the United States Copyright Office or any court) regarding such Grantor’s ownership of any Patent, Trademark or Copyright, its right to
register the same, or to keep and maintain the same. 

  
 12 

 (c) In no event shall such Grantor, either directly or through any agent, employee, licensee or
designee, file an application for the registration of any Patent, Trademark or Copyright with the United States Patent and Trademark Office, the United States Copyright Office or any similar office or agency without giving the Administrative Agent
prior written notice thereof, and, upon request of the Administrative Agent, such Grantor shall execute and deliver any and all security agreements as the Administrative Agent may request to evidence the Administrative Agent’s first priority
security interest on such Patent, Trademark or Copyright, and the General Intangibles of such Grantor relating thereto or represented thereby. 

(d) Such Grantor shall take such actions as it deems appropriate in its reasonable business judgment to maintain and pursue each application,
to obtain the relevant registration and to maintain the registration of each of its Patents, Trademarks and Copyrights (now or hereafter existing), including the filing of applications for renewal, affidavits of use, affidavits of noncontestability
and opposition and interference and cancellation proceedings, unless such Grantor shall reasonably determine that such Patent, Trademark or Copyright is not material to the conduct of such Grantor’s business. 

(e) Such Grantor shall, take such actions as it reasonably determines are appropriate, in its reasonable business judgment, to enforce its
rights against any infringement, misappropriation or dilution and to recover any and all damages for such infringement, misappropriation or dilution, of the Patents, Trademarks and Copyrights that such Grantor reasonably determines are material to
its business. In the event that such Grantor institutes suit because any of its Patents, Trademarks or Copyrights constituting Collateral is infringed upon, or misappropriated or diluted by a third party, such Grantor shall comply with
Section 4.8. 
 4.8 Commercial Tort Claims. Such Grantor shall promptly, and in any event within five (5) Business Days
after the same is acquired by it, notify the Administrative Agent of any Commercial Tort Claim (other than any such Commercial Tort Claims not in excess of $50,000 individually or $100,000 in the aggregate) acquired by it and, unless the
Administrative Agent otherwise consents, such Grantor shall enter into an amendment to this Security Agreement, in the form of Exhibit J hereto, granting to Administrative Agent a first priority security interest in such commercial tort
claim. 
 4.9. Letter-of-Credit Rights. If such
Grantor is or becomes the beneficiary of a letter of credit, it shall promptly, and in any event within five (5) Business Days after becoming a beneficiary, notify the Administrative Agent thereof and use its commercially reasonable efforts to
cause the issuer and/or confirmation bank to (i) consent to the assignment of any Letter-of-Credit Rights to the Administrative Agent and (ii) agree to direct
all payments thereunder to a Deposit Account at the Administrative Agent or subject to a Deposit Account Control Agreement for application to the Secured Obligations, in accordance with Section 2.18 of the Credit Agreement, all in form and
substance reasonably satisfactory to the Administrative Agent. 
 4.10. Federal, State or Municipal Claims. Such Grantor will
promptly notify the Administrative Agent of any Collateral with a face value in excess of $50,000 individually or $100,000 in the aggregate which constitutes a claim against the United States government or any state or local government or any
instrumentality or agency thereof, the assignment of which claim is restricted by federal, state or municipal law. 
 4.11. No
Interference. Such Grantor agrees that it will not interfere with any right, power and remedy of the Administrative Agent exercised in good faith provided for in this Security Agreement or now or hereafter existing at law or in equity or by
statute or otherwise, or the exercise or beginning of the exercise by the Administrative Agent of any one or more of such rights, powers or remedies in good faith. 

4.12. Insurance. (a) In the event any Collateral is located in any area that has been designated by the Federal Emergency
Management Agency as a “Special Flood Hazard Area”, such Grantor shall purchase and maintain flood insurance on such Collateral (including any personal property which is located on any real property leased by such Loan Party within a
“Special Flood Hazard Area”). The amount of flood insurance required by this Section shall at a minimum comply with applicable law, including the Flood Disaster Protection Act of 1973, as amended. 

  
 13 

 (b) All insurance policies required hereunder and under Section 5.10 of the Credit Agreement
shall name the Administrative Agent (for the benefit of the Administrative Agent and the Secured Parties) as an additional insured or as lender’s loss payee, as applicable, and shall contain lender loss payable clauses or mortgagee clauses,
through endorsements in form and substance satisfactory to the Administrative Agent, which provide that: (i) all proceeds thereunder with respect to any Collateral shall be payable to the Administrative Agent; (ii) no such insurance shall
be affected by any act or neglect of the insured or owner of the property described in such policy; and (iii) such policy and lender loss payable or mortgagee clauses may be canceled, amended, or terminated only upon at least thirty
(30) days prior written notice given to the Administrative Agent. 
 (c) All premiums on any such insurance shall be paid when due
(subject to any grace periods provided by the terms of such policy) by such Grantor, and copies of the policies delivered to the Administrative Agent. If such Grantor fails to obtain or maintain any insurance as required by this Section, the
Administrative Agent may obtain such insurance at the Borrower’s expense. By purchasing such insurance, the Administrative Agent shall not be deemed to have waived any Default arising from the Grantor’s failure to maintain such insurance
or pay any premiums therefor. 
 4.13. Collateral Access Agreements. Such Grantor shall use commercially reasonable efforts to obtain
a Collateral Access Agreement from the lessor of each leased property, mortgagee of owned property or bailee or consignee with respect to any warehouse, processor or converter facility or other location where Collateral is stored or located, which
agreement or letter shall provide access rights, contain a waiver or subordination of all Liens or claims that the landlord, mortgagee, bailee or consignee may assert against the Collateral at that location, and shall otherwise be reasonably
satisfactory in form and substance to the Administrative Agent. 
 4.14. Deposit Account Control Agreements. Such Grantor will
provide to the Administrative Agent upon the Administrative Agent’s request, a Deposit Account Control Agreement duly executed on behalf of each financial institution holding a deposit account of such Grantor as set forth in this Security
Agreement (excluding Excluded Deposit and Securities Accounts). 
 4.15. Change of Name or Location; Change of Fiscal Year. Such
Grantor shall not (a) change its name as it appears in official filings in the state of its incorporation or organization, (b) change its chief executive office, principal place of business, mailing address, corporate offices or warehouses
or locations at which Collateral is held or stored, or the location of its records concerning the Collateral as set forth in this Security Agreement, (c) change the type of entity that it is, (d) change its organization identification
number, if any, issued by its state of incorporation or other organization, or (e) change its state of incorporation or organization, in each case, unless the Administrative Agent shall have received at least thirty (30) days prior written
notice of such change and the Administrative Agent shall have acknowledged in writing that either (1) such change will not adversely affect the validity, perfection or priority of the Administrative Agent’s security interest in the
Collateral, or (2) any reasonable action requested by the Administrative Agent in connection therewith has been completed or taken (including any action to continue the perfection of any Liens in favor of the Administrative Agent, on behalf of
the Secured Parties, in any Collateral) or will be taken within any time period reasonably specified by the Administrative Agent, provided that, any new location shall be in the continental U.S. Such Grantor shall not change its fiscal year
which currently ends on December 31. 

  
 14 

 ARTICLE V 

EVENTS OF DEFAULT AND REMEDIES 

5.1.    Events of Default. The occurrence of any one or more of the following events shall constitute an Event of
Default hereunder: 
 (a)    Any representation or warranty made by or on behalf of any Grantor under or in connection
with this Security Agreement shall be materially false as of the date on which made. 
 (b)    Any Grantor shall fail to
observe or perform any of the terms or provisions of Article IV. 
 (c)    Any Grantor shall fail to observe or
perform any of the terms or provisions of this Security Agreement (other than a breach which constitutes an Event of Default under any other Section of this Article V), and such failure shall continue unremedied for a period of ten
(10) Business Days after the earlier of knowledge of such breach or notice thereof from the Administrative Agent. 

(d)    The occurrence of any “Event of Default” under, and as defined in, the Credit Agreement (subject to any
applicable cure or grace periods). 
 (e)    Any Equity Interest which is included within the Collateral shall at any
time constitute a Security or the issuer of any such Equity Interest shall take any action to have such interests treated as a Security unless (i) all certificates or other documents constituting such Security have been delivered to the
Administrative Agent and such Security is properly defined as such under Article 8 of the UCC of the applicable jurisdiction, whether as a result of actions by the issuer thereof or otherwise, or (ii) the Administrative Agent has entered into a
control agreement with the issuer of such Security or with a securities intermediary relating to such Security and such Security is defined as such under Article 8 of the UCC of the applicable jurisdiction, whether as a result of actions by the
issuer thereof or otherwise. 
 5.2. Remedies. 

(a)    Upon the occurrence and during the continuance of an Event of Default, the Administrative Agent may exercise any or
all of the following rights and remedies: 
 (i)    those rights and remedies provided in this Security
Agreement, the Credit Agreement, or any other Loan Document; provided that, this Section 5.2(a) shall not be understood to limit any rights or remedies available to the Administrative Agent and the other Secured Parties prior to an Event
of Default; 
 (ii)    those rights and remedies available to a secured party under the UCC (whether or
not the UCC applies to the affected Collateral) or under any other applicable law (including, without limitation, any law governing the exercise of a bank’s right of setoff or bankers’ lien) when a debtor is in default under a security
agreement; 
 (iii)    give notice of sole control or any other instruction under any Deposit Account
Control Agreement or and other control agreement with any securities intermediary and take any action therein with respect to such Collateral; 

(iv)    without notice (except as specifically provided in Section 8.1 or elsewhere herein), demand or
advertisement of any kind to any Grantor or any other Person, enter the premises of any Grantor where any Collateral is located (through self-help and without judicial process) to collect, receive, assemble, process, appropriate, sell, lease,
assign, grant an option or options to purchase or otherwise dispose of, deliver, or realize upon, the Collateral or any part thereof in one or more parcels at public or private sale or sales (which sales may be adjourned or continued from time to
time with or without notice and may take place at any Grantor’s premises or elsewhere), for cash, on credit or for future delivery without assumption of any credit risk, and upon such other terms as the Administrative Agent may deem
commercially reasonable; and 

  
 15 

 (v)    concurrently with written notice to the applicable
Grantor, transfer and register in its name or in the name of its nominee the whole or any part of the Pledged Collateral, exchange certificates or instruments representing or evidencing Pledged Collateral for certificates or instruments of smaller
or larger denominations, exercise the voting and all other rights as a holder with respect thereto, to collect and receive all cash dividends, interest, principal and other distributions made thereon and to otherwise act with respect to the Pledged
Collateral as though the Administrative Agent was the outright owner thereof. 
 (b)    The Administrative Agent, on
behalf of the Secured Parties, may comply with any applicable state or federal law requirements in connection with a disposition of the Collateral and compliance will not be considered to adversely affect the commercial reasonableness of any sale of
the Collateral. 
 (c)    The Administrative Agent shall have the right upon any such public sale or sales and, to the
extent permitted by law, upon any such private sale or sales, to purchase for the benefit of the Administrative Agent and the other Secured Parties, the whole or any part of the Collateral so sold, free of any right of equity redemption, which
equity redemption the Grantor hereby expressly releases. 
 (d)    Until the Administrative Agent is able to effect a
sale, lease, or other disposition of Collateral, the Administrative Agent shall have the right to hold or use Collateral, or any part thereof, to the extent that it deems appropriate for the purpose of preserving Collateral or its value or for any
other purpose deemed appropriate by the Administrative Agent. The Administrative Agent may, if it so elects, seek the appointment of a receiver or keeper to take possession of Collateral and to enforce any of the Administrative Agent’s remedies
(for the benefit of the Administrative Agent and the other Secured Parties), with respect to such appointment without prior notice or hearing as to such appointment. 

(e)    If, after the Credit Agreement has terminated by its terms and all of the Obligations have been paid in full, there
remain Swap Agreement Obligations outstanding, the Required Lenders may exercise the remedies provided in this Section 5.2 upon the occurrence of any event which would allow or require the termination or acceleration of any Swap Agreement
Obligations pursuant to the terms of the Swap Agreement. 
 (f)    Notwithstanding the foregoing, neither the
Administrative Agent nor any other Secured Party shall be required to (i) make any demand upon, or pursue or exhaust any of its rights or remedies against, any Grantor, any other obligor, guarantor, pledgor or any other Person with respect to
the payment of the Secured Obligations or to pursue or exhaust any of its rights or remedies with respect to any Collateral therefor or any direct or indirect guarantee thereof, (ii) marshal the Collateral or any guarantee of the Secured
Obligations or to resort to the Collateral or any such guarantee in any particular order, or (iii) effect a public sale of any Collateral. 

(g)    Each Grantor recognizes that the Administrative Agent may be unable to effect a public sale of any or all the
Pledged Collateral and may be compelled to resort to one or more private sales thereof in accordance with clause (a) above. Each Grantor also acknowledges that any private sale may result in prices and other terms less favorable to the
seller than if such sale were a public sale and, notwithstanding such circumstances, agrees that any such private sale shall not be deemed to have been made in a commercially unreasonable manner solely by virtue of such sale being private. The
Administrative Agent shall be under no obligation to delay a sale of any of the Pledged Collateral for the period of time necessary to permit any Grantor or the issuer of the Pledged Collateral to register such securities for public sale under the
Securities Act of 1933, as amended, or under applicable state securities laws, even if the applicable Grantor and the issuer would agree to do so. 

  
 16 

 5.3.    Grantor’s Obligations Upon Default. Upon the request of
the Administrative Agent after the occurrence and during the continuance of a Default, each Grantor will: 

(a)    assemble and make available to the Administrative Agent the Collateral and all books and records relating thereto
at any place or places specified by the Administrative Agent, whether at a Grantor’s premises or elsewhere; 

(b)    permit the Administrative Agent, by the Administrative Agent’s representatives and agents, to enter, occupy
and use any premises where all or any part of the Collateral, or the books and records relating thereto, or both, are located, to take possession of all or any part of the Collateral or the books and records relating thereto, or both, to remove all
or any part of the Collateral or the books and records relating thereto, or both, and to conduct sales of the Collateral, without any obligation to pay the Grantor for such use and occupancy; 

(c)    prepare and file, or cause an issuer of Pledged Collateral to prepare and file, with the Securities and Exchange
Commission or any other applicable government agency, registration statements, a prospectus and such other documentation in connection with the Pledged Collateral as the Administrative Agent may request, all in form and substance satisfactory to the
Administrative Agent, and furnish to the Administrative Agent, or cause an issuer of Pledged Collateral to furnish to the Administrative Agent, any information regarding the Pledged Collateral in such detail as the Administrative Agent may specify;

 (d)    take, or cause an issuer of Pledged Collateral to take, any and all actions necessary to register or qualify
the Pledged Collateral to enable the Administrative Agent to consummate a public sale or other disposition of the Pledged Collateral; and 

(e)    at its own expense, cause the independent certified public accountants then engaged by each Grantor to prepare and
deliver to the Administrative Agent and each Lender, at any time, and from time to time, promptly upon the Administrative Agent’s request, the following reports with respect to the applicable Grantor: (i) a reconciliation of all Accounts;
(ii) an aging of all Accounts; (iii) trial balances; and (iv) a test verification of such Accounts. 

5.4.    Grant of Intellectual Property License. For the purpose of enabling the Administrative Agent to exercise
the rights and remedies under this Article V at such time as the Administrative Agent shall be lawfully entitled to exercise such rights and remedies, each Grantor hereby (a) grants to the Administrative Agent, for the benefit of the
Administrative Agent and the other Secured Parties, an irrevocable (subject to termination pursuant to Section 7.14), nonexclusive license (exercisable without payment of royalty or other compensation to any Grantor) to use, license or
sublicense any intellectual property rights now owned or hereafter acquired by such Grantor, and wherever the same may be located, and including in such license access to all media in which any of the licensed items may be recorded or stored and to
all computer software and programs used for the compilation or printout thereof and (b) irrevocably agrees that the Administrative Agent may sell any of such Grantor’s Inventory directly to any person, including without limitation persons
who have previously purchased the Grantor’s Inventory from such Grantor and in connection with any such sale or other enforcement of the Administrative Agent’s rights under this Security Agreement, may sell Inventory which bears any
Trademark owned by or licensed to such Grantor and any Inventory that is covered by any Copyright owned by or licensed to such Grantor and the Administrative Agent may finish any work in process and affix any Trademark owned by or licensed to such
Grantor and sell such Inventory as provided herein. 
 ARTICLE VI 

ACCOUNT VERIFICATION; ATTORNEY IN FACT; PROXY 

6.1.    Account Verification. The Administrative Agent may at any time after the occurrence of an Event of Default,
in the Administrative Agent’s own name, in the name of a nominee of the Administrative Agent, or in the name of any Grantor communicate (by mail, telephone, facsimile or otherwise) with the 

  
 17 

 
Account Debtors of any such Grantor, parties to contracts with any such Grantor and obligors in respect of Instruments of any such Grantor to verify with such Persons, to the Administrative
Agent’s satisfaction, the existence, amount, terms of, and any other matter relating to, Accounts, Instruments, Chattel Paper, payment intangibles and/or other Receivables. 

6.2.    Authorization for Administrative Agent to Take Certain Action. 

(a)    After the occurrence and during the continuance of an Event of Default, each Grantor irrevocably authorizes the
Administrative Agent at any time and from time to time in the sole discretion of the Administrative Agent and appoints the Administrative Agent as its attorney-in-fact
(i) to endorse and collect any cash proceeds of the Collateral, (ii) to file any financing statement with respect to the Collateral and to file any other financing statement or amendment of a financing statement (which does not add new
collateral or add a debtor) in such offices as the Administrative Agent in its sole discretion deems necessary or desirable to perfect and to maintain the perfection and priority of the Administrative Agent’s security interest in the
Collateral, (iii) to contact and enter into one or more agreements with the issuers of uncertificated securities which are Pledged Collateral or with securities intermediaries holding Pledged Collateral as may be necessary or advisable to give
the Administrative Agent Control over such Pledged Collateral, (iv) to discharge past due taxes, assessments, charges, fees or Liens on the Collateral (except for such Liens that are permitted under Section 6.02 of the Credit Agreement),
(v) to contact Account Debtors for any reason, (vi) to demand payment or enforce payment of the Receivables in the name of the Administrative Agent or such Grantor and to endorse any and all checks, drafts, and other instruments for the payment
of money relating to the Receivables, (vii) to sign such Grantor’s name on any invoice or bill of lading relating to the Receivables, drafts against any Account Debtor of the Grantor, assignments and verifications of Receivables,
(viii) to exercise all of such Grantor’s rights and remedies with respect to the collection of the Receivables and any other Collateral, (ix) to settle, adjust, compromise, extend or renew the Receivables, (x) to settle, adjust
or compromise any legal proceedings brought to collect Receivables, (xi) to prepare, file and sign such Grantor’s name on a proof of claim in bankruptcy or similar document against any Account Debtor of such Grantor, (xii) to prepare,
file and sign such Grantor’s name on any notice of Lien, assignment or satisfaction of Lien or similar document in connection with the Receivables, (xiii) to change the address for delivery of mail addressed to such Grantor to such address
as the Administrative Agent may designate and to receive, open and dispose of all mail addressed to such Grantor, and (xiv) to do all other acts and things reasonably necessary to carry out this Security Agreement; and such Grantor agrees to
reimburse the Administrative Agent on demand for any reasonable, documented payment or expense made or incurred by the Administrative Agent in connection with any of the foregoing; provided that, this authorization shall not relieve such
Grantor of any of its obligations under this Security Agreement or under the Credit Agreement. 
 (b)    All acts of
said attorney or designee are hereby ratified and approved. The powers conferred on the Administrative Agent, for the benefit of the Administrative Agent and Secured Parties, under this Section 6.2 are solely to protect the Administrative
Agent’s interests in the Collateral and shall not impose any duty upon the Administrative Agent or any other Secured Party to exercise any such powers. The Administrative Agent agrees that, except for the powers granted in
Section 6.2(a)(i)-(iv) and Section 6.2(a)(xiv), it shall not exercise any power or authority granted to it unless an Event of Default has occurred and is continuing. 

6.3.    Proxy. EACH GRANTOR HEREBY IRREVOCABLY CONSTITUTES AND APPOINTS THE ADMINISTRATIVE AGENT AS ITS PROXY AND ATTORNEY-IN-FACT (AS SET FORTH IN SECTION 6.2 ABOVE) OF THE GRANTOR WITH RESPECT TO ITS PLEDGED COLLATERAL, INCLUDING THE RIGHT TO VOTE SUCH PLEDGED COLLATERAL, WITH FULL
POWER OF SUBSTITUTION TO DO SO. IN ADDITION TO THE RIGHT TO VOTE ANY SUCH PLEDGED COLLATERAL, THE APPOINTMENT OF THE ADMINISTRATIVE AGENT AS PROXY AND ATTORNEY-IN-FACT
SHALL INCLUDE THE RIGHT TO EXERCISE ALL OTHER RIGHTS, POWERS, PRIVILEGES AND REMEDIES TO WHICH A HOLDER OF SUCH PLEDGED COLLATERAL WOULD BE ENTITLED (INCLUDING GIVING OR WITHHOLDING WRITTEN CONSENTS OF

  
 18 

 
SHAREHOLDERS, CALLING SPECIAL MEETINGS OF SHAREHOLDERS AND VOTING AT SUCH MEETINGS). SUCH PROXY SHALL BE EFFECTIVE, AUTOMATICALLY AND WITHOUT THE NECESSITY OF ANY ACTION (INCLUDING ANY TRANSFER
OF ANY SUCH PLEDGED COLLATERAL ON THE RECORD BOOKS OF THE ISSUER THEREOF) BY ANY PERSON (INCLUDING THE ISSUER OF SUCH PLEDGED COLLATERAL OR ANY OFFICER OR AGENT THEREOF), UPON THE OCCURRENCE AND DURING THE CONTINUATION OF A DEFAULT. 

6.4.    Nature of Appointment; Limitation of Duty. THE APPOINTMENT OF THE ADMINISTRATIVE AGENT AS PROXY AND ATTORNEY-IN-FACT IN THIS ARTICLE VI IS COUPLED WITH AN INTEREST AND SHALL BE IRREVOCABLE UNTIL THE DATE ON WHICH THIS SECURITY AGREEMENT IS TERMINATED IN ACCORDANCE WITH
SECTION 7.14. NOTWITHSTANDING ANYTHING CONTAINED HEREIN, NONE OF THE ADMINISTRATIVE AGENT, ANY LENDER, ANY OTHER SECURED PARTY, ANY OF THEIR RESPECTIVE AFFILIATES, OR ANY OF THEIR OR THEIR AFFILIATES’ RESPECTIVE OFFICERS, DIRECTORS, EMPLOYEES,
AGENTS OR REPRESENTATIVES SHALL HAVE ANY DUTY TO EXERCISE ANY RIGHT OR POWER GRANTED HEREUNDER OR OTHERWISE OR TO PRESERVE THE SAME AND SHALL NOT BE LIABLE FOR ANY FAILURE TO DO SO OR FOR ANY DELAY IN DOING SO, EXCEPT IN RESPECT OF DAMAGES
ATTRIBUTABLE SOLELY TO SUCH PARTY’S OWN GROSS NEGLIGENCE OR WILLFUL MISCONDUCT AS FINALLY DETERMINED BY A COURT OF COMPETENT JURISDICTION; PROVIDED THAT, IN NO EVENT SHALL THEY BE LIABLE FOR ANY PUNITIVE, EXEMPLARY, INDIRECT OR CONSEQUENTIAL
DAMAGES. 
 ARTICLE VII 

GENERAL PROVISIONS 

7.1    Waivers. Each Grantor hereby waives notice of the time and place of any public sale or the time after which
any private sale or other disposition of all or any part of the Collateral may be made. To the extent such notice may not be waived under applicable law, any notice made shall be deemed reasonable if sent to Grantors, addressed as set forth in
Article IX, at least ten (10) Business Days prior to (i) the date of any such public sale or (ii) the time after which any such private sale or other disposition may be made. To the maximum extent permitted by applicable law, each
Grantor waives all claims, damages, and demands against the Administrative Agent or any Secured Party arising out of the repossession, retention or sale of the Collateral, except such as arise solely out of the gross negligence or willful misconduct
of the Administrative Agent or such Secured Party as finally determined by a court of competent jurisdiction. To the extent it may lawfully do so, each Grantor absolutely and irrevocably waives and relinquishes the benefit and advantage of, and
covenants not to assert against the Administrative Agent or any other Secured Party, any valuation, stay, appraisal, extension, moratorium, redemption or similar laws and any and all rights or defenses it may have as a surety now or hereafter
existing which, but for this provision, might be applicable to the sale of any Collateral made under the judgment, order or decree of any court, or privately under the power of sale conferred by this Security Agreement, or otherwise. Except as
otherwise specifically provided herein, each Grantor hereby waives presentment, demand, protest or any notice (to the maximum extent permitted by applicable law) of any kind in connection with this Security Agreement or any Collateral. 

7.2.    Limitation on Administrative Agent’s and Secured Parties’ Duty with Respect to the Collateral.
The Administrative Agent shall have no obligation to clean-up or otherwise prepare the Collateral for sale. The Administrative Agent and each other Secured Party shall use reasonable care with respect to the
Collateral in its possession or under its control. Neither the Administrative Agent nor any other Secured Party shall have any other duty as to any Collateral in its possession or control or in the possession or control of any agent or nominee of
the Administrative Agent or such other Secured Party, or any income thereon or as to the preservation of rights against prior parties or any other rights pertaining thereto. To the extent that applicable law imposes duties on the Administrative
Agent to exercise remedies in a commercially reasonable manner, each Grantor acknowledges and agrees that it is commercially reasonable for the Administrative Agent (i) to fail to incur expenses deemed significant by the Administrative Agent to
prepare Collateral for disposition or 

  
 19 

 
otherwise to transform raw material or work in process into finished goods or other finished products for disposition, (ii) to fail to obtain third party consents for access to Collateral to
be disposed of, or to obtain or, if not required by other law, to fail to obtain governmental or third party consents for the collection or disposition of Collateral to be collected or disposed of, (iii) to fail to exercise collection remedies
against Account Debtors or other Persons obligated on Collateral or to remove Liens on or any adverse claims against Collateral, (iv) to exercise collection remedies against Account Debtors and other Persons obligated on Collateral directly or
through the use of collection agencies and other collection specialists, (v) to advertise dispositions of Collateral through publications or media of general circulation, whether or not the Collateral is of a specialized nature, (vi) to
contact other Persons, whether or not in the same business as such Grantor, for expressions of interest in acquiring all or any portion of such Collateral, (vii) to hire one or more professional auctioneers to assist in the disposition of
Collateral, whether or not the Collateral is of a specialized nature, (viii) to dispose of Collateral by utilizing internet sites that provide for the auction of assets of the types included in the Collateral or that have the reasonable
capacity of doing so, or that match buyers and sellers of assets, (ix) to dispose of assets in wholesale rather than retail markets, (x) to disclaim disposition warranties, such as title, possession or quiet enjoyment, (xi) to
purchase insurance or credit enhancements to insure the Administrative Agent against risks of loss, collection or disposition of Collateral or to provide to the Administrative Agent a guaranteed return from the collection or disposition of
Collateral, or (xii) to the extent reasonably deemed appropriate by the Administrative Agent, to obtain the services of other brokers, investment bankers, consultants and other professionals to assist the Administrative Agent in the collection
or disposition of any of the Collateral. The Grantor acknowledges that the purpose of this Section 7.2 is to provide non-exhaustive indications of what actions or omissions by the Administrative Agent
would be commercially reasonable in the Administrative Agent’s exercise of remedies against the Collateral and that other actions or omissions by the Administrative Agent shall not be deemed commercially unreasonable solely on account of not
being indicated in this Section 7.2. Without limitation upon the foregoing, nothing contained in this Section 7.2 shall be construed to grant any rights to the Grantor or to impose any duties on the Administrative Agent that would not have
been granted or imposed by this Security Agreement or by applicable law in the absence of this Section 7.2. 

7.3.    Compromises and Collection of Collateral. The Grantors and the Administrative Agent recognize that setoffs,
counterclaims, defenses and other claims may be asserted by obligors with respect to certain of the Receivables, that certain of the Receivables may be or become uncollectible in whole or in part and that the expense and probability of success in
litigating a disputed Receivable may exceed the amount that reasonably may be expected to be recovered with respect to a Receivable. In view of the foregoing, each Grantor agrees that the Administrative Agent may at any time and from time to time,
if an Event of Default has occurred and is continuing, compromise with the obligor on any Receivable, accept in full payment of any Receivable such amount as the Administrative Agent in its sole discretion shall determine or abandon any Receivable,
and any such action by the Administrative Agent shall be commercially reasonable so long as the Administrative Agent acts in good faith based on information known to it at the time it takes any such action. 

7.4.    Secured Party Performance of Debtor Obligations. Upon the occurrence and during the continuance of an Event
of Default, without having any obligation to do so, the Administrative Agent may perform or pay any obligation which any Grantor has agreed to perform or pay in this Security Agreement and the Grantors shall reimburse the Administrative Agent for
any reasonable, documented amounts paid by the Administrative Agent pursuant to this Section 7.4. The Grantors’ obligation to reimburse the Administrative Agent pursuant to the preceding sentence shall be a Secured Obligation payable on
demand. 
 7.5    Specific Performance of Certain Covenants. Each Grantor acknowledges and agrees that a breach
of any of the covenants contained in Sections 4.1(d), 4.1(e), 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 4.10, 4.12, 4.13, 4.14, 4.15, 5.3, or 7.7 will cause irreparable injury to the Administrative Agent and the other Secured Parties, that the Administrative
Agent and the other Secured Parties have no adequate remedy at law in respect of such breaches and therefore agrees, without limiting the right of the Administrative Agent or the other Secured Parties to seek and obtain specific performance of other
obligations of the Grantors contained in this Security Agreement, that the covenants of the Grantors contained in the Sections referred to in this Section 7.5 shall be specifically enforceable against the Grantors. 

  
 20 

 7.6.    Dispositions Not Authorized. No Grantor is authorized to sell
or otherwise dispose of the Collateral except as set forth in Section 4.1(d) and notwithstanding any course of dealing between any Grantor and the Administrative Agent or other conduct of the Administrative Agent, no authorization to sell or
otherwise dispose of the Collateral (except as set forth in Section 4.1(d)) shall be binding upon the Administrative Agent or the other Secured Parties unless such authorization is in writing signed by the Administrative Agent with the consent
or at the direction of the Required Lenders. 
 7.7.    No Waiver; Amendments; Cumulative Remedies. No failure or
delay by the Administrative Agent or any other Secured Party in exercising any right or power under this Security Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or
discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the Administrative Agent and the other Secured Parties hereunder are
cumulative and are not exclusive of any rights or remedies that they would otherwise have. No waiver of any provision of this Security Agreement or consent to any departure by the Grantor therefrom shall in any event be effective unless in writing
signed by the Administrative Agent with the concurrence or at the direction of the Lenders required under Section 9.02 of the Credit Agreement and then only to the extent in such writing specifically set forth. 

7.8.    Limitation by Law; Severability of Provisions. All rights, remedies and powers provided in this Security
Agreement may be exercised only to the extent that the exercise thereof does not violate any applicable provision of law, and all the provisions of this Security Agreement are intended to be subject to all applicable mandatory provisions of law that
may be controlling and to be limited to the extent necessary so that they shall not render this Security Agreement invalid, unenforceable or not entitled to be recorded or registered, in whole or in part. Any provision in this Security Agreement
held to be invalid, illegal or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the
remaining provisions thereof; and the invalidity of a particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction, and to this end the provisions of this Security Agreement are declared to be
severable.. 
 7.9    Reinstatement. This Security Agreement shall remain in full force and effect and continue
to be effective should any petition be filed by or against any Grantor for liquidation or reorganization, should any Grantor become insolvent or make an assignment for the benefit of any creditor or creditors or should a receiver or trustee be
appointed for all or any significant part of any Grantor’s assets, and shall continue to be effective or be reinstated, as the case may be, if at any time payment and performance of the Secured Obligations, or any part thereof (including a
payment effected through exercise of a right of setoff), is, pursuant to applicable law, rescinded or reduced in amount, or must otherwise be restored or returned by any obligee of the Secured Obligations, whether as a “voidable
preference,” “fraudulent conveyance,” or otherwise (including pursuant to any settlement entered into by a Secured Party in its discretion), all as though such payment or performance had not been made. In the event that any payment,
or any part thereof (including a payment effected through exercise of a right of setoff), is rescinded, reduced, restored or returned, the Secured Obligations shall be reinstated and deemed reduced only by such amount paid and not so rescinded,
reduced, restored or returned. 
 7.10.    Benefit of Agreement. The terms and provisions of this Security
Agreement shall be binding upon and inure to the benefit of the Grantors, the Administrative Agent and the other Secured Parties and their respective successors and assigns (including all persons who become bound as a debtor to this Security
Agreement), except that no Grantor shall have the right to assign its rights or delegate its obligations under this Security Agreement or any interest herein, without the prior written consent of the Administrative Agent. No sales of participations,
assignments, transfers, or other dispositions of any agreement governing the Secured Obligations or any portion thereof or interest therein shall in any manner impair the Lien granted to the Administrative Agent, for the benefit of the
Administrative Agent and the other Secured Parties, hereunder. 

  
 21 

 7.11.    Survival of Representations. All representations and
warranties of the Grantors contained in this Security Agreement shall survive the execution and delivery of this Security Agreement. 

7.12.    Taxes and Expenses. Any taxes (including income taxes) payable or ruled payable by Federal or State
authority in respect of this Security Agreement shall be paid by the Grantors, together with interest and penalties, if any. The Grantors shall reimburse the Administrative Agent for any and all out-of-pocket expenses and internal charges (including reasonable attorneys’, auditors’ and accountants’ fees and reasonable time charges of attorneys, paralegals, auditors and accountants who
may be employees of the Administrative Agent) paid or incurred by the Administrative Agent in connection with the preparation, execution, delivery, administration, collection and enforcement of this Security Agreement and, to the extent provided in
the Credit Agreement in the audit, analysis, administration, collection, preservation or sale of the Collateral (including the expenses and charges associated with any periodic or special audit of the Collateral required to be paid by the Credit
Agreement). Any and all costs and expenses incurred by the Grantors in the performance of actions required pursuant to the terms hereof shall be borne solely by the Grantors. 

7.13.    Headings. The title of and section headings in this Security Agreement are for convenience of reference
only, and shall not govern the interpretation of any of the terms and provisions of this Security Agreement. 

7.14.    Termination. This Security Agreement shall continue in effect (notwithstanding the fact that from time to
time there may be no Secured Obligations outstanding) until (i) the Credit Agreement has terminated pursuant to its express terms and (ii) all of the Secured Obligations other than contingent indemnification obligations as to which no
claim has been made have been indefeasibly paid and performed in full (or with respect to any outstanding Letters of Credit, a cash deposit has been delivered to the Administrative Agent as required by the Credit Agreement) and no commitments of the
Administrative Agent or the Lenders which would give rise to any Secured Obligations are outstanding. 

7.15.    Entire Agreement. This Security Agreement and the other Loan Documents embody the entire agreement and
understanding between the Grantors and the Administrative Agent relating to the Collateral and supersedes all prior agreements and understandings between the Grantors and the Administrative Agent relating to the Collateral. 

7.16.    CHOICE OF LAW. THIS SECURITY AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH,
THE INTERNAL LAWS (AND NOT THE LAW OF CONFLICTS) OF THE STATE NEW YORK, BUT GIVING EFFECT TO FEDERAL LAWS APPLICABLE TO NATIONAL BANKS.  

7.17.    CONSENT TO JURISDICTION. EACH GRANTOR HEREBY IRREVOCABLY SUBMITS, FOR ITSELF AND ITS PROPERTY,
TO THE EXCLUSIVE JURISDICTION OF ANY U.S. FEDERAL OR NEW YORK STATE COURT SITTING IN NEW YORK, NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS SECURITY AGREEMENT OR ANY OTHER LOAN DOCUMENT OR FOR RECOGNITION OR ENFORCEMENT OF
ANY JUDGMENT, AND EACH GRANTOR HEREBY IRREVOCABLY AND UNCONDITIONALLY AGREES THAT ALL CLAIMS IN RESPECT OF SUCH ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED IN ANY SUCH COURT AND IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT IT
MAY LEGALLY AND EFFECTIVELY DO SO, ANY OBJECTION IT MAY NOW OR HEREAFTER HAVE AS TO THE VENUE OF ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN SUCH A COURT OR THAT SUCH COURT IS AN INCONVENIENT FORUM. EACH OF THE PARTIES HERETO AGREES THAT A FINAL
JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW. NOTHING HEREIN SHALL AFFECT THE RIGHT OF THE ADMINISTRATIVE AGENT OR ANY
LENDER TO BRING  

  
 22 

 
PROCEEDINGS AGAINST ANY GRANTOR IN THE COURTS OF ANY OTHER JURISDICTION. ANY JUDICIAL PROCEEDING BY ANY GRANTOR AGAINST THE ADMINISTRATIVE AGENT OR ANY LENDER OR ANY AFFILIATE OF THE
ADMINISTRATIVE AGENT OR ANY LENDER INVOLVING, DIRECTLY OR INDIRECTLY, ANY MATTER IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS SECURITY AGREEMENT OR ANY OTHER LOAN DOCUMENT SHALL BE BROUGHT ONLY IN A COURT IN NEW YORK, NEW YORK.

 7.18.    WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS SECURITY AGREEMENT, ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY
(WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE OR OTHER AGENT (INCLUDING ANY ATTORNEY) OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH
OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS SECURITY AGREEMENT BY, AMONG OTHER
THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. 
 7.19.    Indemnity. To the extent required
by Section 9.03 of the Credit Agreement, each Grantor hereby agrees to indemnify the Administrative Agent and the other Secured Parties, and their respective successors, assigns, agents and employees (each such Person, an
“Indemnitee”), from and against any and all liabilities, damages, penalties, suits, fees, costs, and expenses of any kind and nature (including, without limitation, all expenses of litigation or preparation therefor whether or not the
Administrative Agent or any Secured Party is a party thereto) imposed on, incurred by or asserted against the Administrative Agent or the other Secured Parties, or their respective successors, assigns, agents and employees, in any way relating to or
arising out of this Security Agreement, or the manufacture, purchase, acceptance, rejection, ownership, delivery, lease, possession, use, operation, condition, sale, return or other disposition of any Collateral (including, without limitation,
latent and other defects, whether or not discoverable by the Administrative Agent or the other Secured Parties or any Grantor, and any claim for Patent, Trademark or Copyright infringement); provided that such indemnity shall not, as to any
Indemnitee, be available to the extent that such losses, claims, damages, penalties, liabilities or related expenses are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted from (i) the gross
negligence or willful misconduct of any Indemnitee, or (ii) a material breach in bad faith of any Loan Document by any Indemnitee 

7.20.    Counterparts. This Security Agreement may be executed in any number of counterparts, all of which taken
together shall constitute one agreement, and any of the parties hereto may execute this Security Agreement by signing any such counterpart. Delivery of an executed counterpart of a signature page of this Security Agreement by facsimile or other
electronic transmission shall be effective as delivery of a manually executed counterpart of this Security Agreement. 
 ARTICLE VIII

 NOTICES 

8.1.    Sending Notices. Any notice required or permitted to be given under this Security Agreement shall be sent
in accordance with Section 9.01 of the Credit Agreement. 
 8.2.    Change in Address for Notices. Each of
the Grantors, the Administrative Agent and the Lenders may change the address for service of notice upon it by a notice in writing to the other parties. 

  
 23 

 ARTICLE IX 

THE ADMINISTRATIVE AGENT 

JPMorgan Chase Bank, N.A. has been appointed Administrative Agent for the Lenders hereunder pursuant to Article VIII of the Credit Agreement.
It is expressly understood and agreed by the parties to this Security Agreement that any authority conferred upon the Administrative Agent hereunder is subject to the terms of the delegation of authority made by the Lenders to the Administrative
Agent pursuant to Article VIII of the Credit Agreement, and that the Administrative Agent has agreed to act (and any successor Administrative Agent shall act) as such hereunder only on the express conditions contained in such Article VIII. Any
successor Administrative Agent appointed pursuant to Article VIII of the Credit Agreement shall be entitled to all the rights, interests and benefits of the Administrative Agent hereunder. 

[Signature Page Follows] 

  
 24 

 IN WITNESS WHEREOF, the Grantors and the Administrative Agent have executed this Security
Agreement as of the date first above written. 
  

			
	GRANTORS:
	
	HESKA CORPORATION
		
	By:	 	 /s/ John McMahon

	Name: John McMahon
	Title: Chief Financial Officer
	
	DIAMOND ANIMAL HEALTH, INC.
		
	By:	 	 /s/ John McMahon

	Name: John McMahon
	Title: Chief Financial Officer
	
	HESKA IMAGING, LLC
		
	By:	 	 /s/ John McMahon

	Name: John McMahon
	Title: Chief Financial Officer

  

			
	ADMINISTRATIVE AGENT:
	
	JPMORGAN CHASE BANK, N.A.,
	as Administrative Agent

 
			
		
	By:	 	 /s/ *

 
			
	Name: * [Personal Identifying Information Omitted]
	Title: Authorized Officer

 EXHIBIT A 

(See Sections 3.2, 3.3, 3.4, 3.9 and 8.1 of Security Agreement) 

NOTICE ADDRESS FOR ALL GRANTORS 

3760 Rocky Mountain Avenue 

Loveland, CO 80538 

Attention: Chief Financial Officer 

Facsimile: 970-619-3003 

INFORMATION AND COLLATERAL LOCATIONS OF HESKA CORPORATION 
  

	I.	Name of Grantor: Heska Corporation 

  

	II.	State of Incorporation or Organization: Delaware 

  

	III.	Type of Entity: corporation 

  

	IV.	Organizational Number assigned by State of Incorporation or Organization: 2733906 

  

	V.	Federal Identification Number: 77-0192527 

  

	VI.	Place of Business (if it has only one) or Chief Executive Office (if more than one place of business) and Mailing Address: 

3760 Rocky Mountain Ave.     

Loveland, Colorado 80538     

Attention: John McMahon 
  

	VII.	Locations of Collateral: 

  

	 	(a)	Properties Owned by the Grantor: 

  

	 	    	1959 Big Sandy Place, Loveland, Colorado 80538 

  

	 	(b)	Properties Leased by the Grantor (Include Landlord’s Name): 

  

	 	    	3760 Rocky Mountain Avenue, Loveland, Colorado 80538 

  

	 	(c)	Public Warehouses or other Locations pursuant to Bailment or Consignment Arrangements 

	 	 	(include name of Warehouse Operator or other Bailee or Consignee): 

  

	 	    	None 

 INFORMATION AND COLLATERAL LOCATIONS OF DIAMOND ANIMAL HEALTH, INC. 

 

	I.	Name of Grantor: Diamond Animal Health, Inc. 

  

	II.	State of Incorporation or Organization: Iowa 

  

	III.	Type of Entity: corporation 

  

	IV.	Organizational Number assigned by State of Incorporation or Organization: 170088 

  

	V.	Federal Identification Number: * [Personal Identifying Information Omitted] 

  

	VI.	Place of Business (if it has only one) or Chief Executive Office (if more than one place of business) and Mailing Address: 

2538 SE 43rd Street 

Des Moines, Iowa 50327 

Attention: John McMahon 
  

	VII.	Locations of Collateral: 

  

	 	(a)	Properties Owned by the Grantor: 

 2538 SE 43rd Street, Des Moines, Iowa 50327 
 4334
170th Ave, Carlisle, Iowa 50047 
 4770
170th Ave, Carlisle, Iowa 50047 
 4592
170th Ave, Carlisle, Iowa 50047 
  

	 	(b)	Properties Leased by the Grantor (Include Landlord’s Name): 

  

	 	    	None 

  

	 	(c)	Public Warehouses or other Locations pursuant to Bailment or Consignment Arrangements 

	 	 	(include name of Warehouse Operator or other Bailee or Consignee): 

  

	 	    	None 

 INFORMATION AND COLLATERAL LOCATIONS OF HESKA IMAGING, LLC 

 

	I.	Name of Grantor: Heska Imaging, LLC 

  

	II.	State of Incorporation or Organization: Delaware 

  

	III.	Type of Entity: limited liability company 

  

	IV.	Organizational Number assigned by State of Incorporation or Organization: 5988696 

  

	V.	Federal Identification Number: * [Personal Identifying Information Omitted] 

  

	VI.	Place of Business (if it has only one) or Chief Executive Office (if more than one place of business) and Mailing Address: 

3760 Rocky Mountain Ave. 

Loveland, Colorado 80538 

Attention: John McMahon 
 VII. Locations of
Collateral: 
  

	 	(a)	Properties Owned by the Grantor: 

  

	 	    	None 

  

	 	(b)	Properties Leased by the Grantor (Include Landlord’s Name): 

  

	 	    	None 

  

	 	(c)	Public Warehouses or other Locations pursuant to Bailment or Consignment Arrangements 

	 	 	(include name of Warehouse Operator or other Bailee or Consignee): 

  

	 	    	None 

 EXHIBIT B 

(See Section 3.5 of Security Agreement) 

DEPOSIT ACCOUNTS 
 Pursuant to the terms of the
Credit Agreement, the accounts below will be transferred to JP Morgan Chase Bank, N.A. after the Effective Date. 
  

							
	Heska Corp	  	*	  	Wells Fargo	    	Operating Account
	Heska Corp	  	*	  	Wells Fargo	    	Cash Collateral Account
	Heska Corp	  	*	  	Wells Fargo	    	Cash Collateral Account - Merchant
	Heska Corp	  	*	  	Wells Fargo	    	Multi-Currency Account - EUR
	Heska Corp	  	*	  	Wells Fargo	    	Multi-Currency Account - JPY
	Heska Corp	  	*	  	Wells Fargo	    	Multi-Currency Account - CAD
	Heska Corp	  	*	  	Bank of the West	    	Flexible Spending
	Heska Imaging, LLC	  	*	  	Wells Fargo	    	Operating Account
	Heska Imaging, LLC	  	*	  	Wells Fargo	    	Cash Disbursement Account
	Diamond Animal Health	  	*	  	Wells Fargo	    	Operating Account

 * Personal identifying information omitted 

 EXHIBIT C 

(See Section 3.7 of Security Agreement) 

LETTER-OF-CREDIT RIGHTS 

None 

 EXHIBIT D 

(See Section 3.10 and 3.11 of Security Agreement) 

INTELLECTUAL PROPERTY RIGHTS 

PATENTS (1) 
  

							
	 Name of Grantor
	  	 Patent Description
	  	 Patent Number
	  	 Issue Date

	See Exhibit D-1	  		  		  	

 PATENT APPLICATIONS (1) 
  

							
	 Name of Grantor
	  	 Patent Application
	  	 Application Filing Date
	  	 Application Serial Number

	See Exhibit D-1	  		  		  	

 TRADEMARKS 
  

							
	 Name of Grantor
	  	 Trademark
	  	 Registration Date
	  	 Registration Number

	See Exhibit D-2	  		  		  	

 TRADEMARK APPLICATIONS 
  

							
	 Name of Grantor
	  	 Trademark Application
	  	 Application Filing Date
	  	 Application Serial Number

	See Exhibit D-2	  		  		  	

 COPYRIGHTS 
  

							
	 Name of Grantor
	  	 Copyright
	  	 Registration Date
	  	 Registration Number

	None	  		  		  	

 COPYRIGHT APPLICATIONS 
  

							
	 Name of Grantor
	  	 Copyright Application
	  	 Application Filing Date
	  	 Application Serial Number

	None	  		  		  	

 INTELLECTUAL PROPERTY LICENSES 
  

							
	 Name of Grantor
	  	 Name of Agreement
	  	 Date of Agreement
	  	 Parties to Agreement

	Heska Corporation	  	Collaboration and License Agreement	  	July 29, 1998	  	Heska Corporation and Ralston Purina Company (nka Nestle Purina Petcare Company)

  

	(1)	On an ongoing basis, and in the ordinary course of business, Heska Corporation evaluates its patent and patent application portfolio. As patents and/or patent applications come up for renewal, Heska Corporation
will evaluate whether a patent or patent application is material to the business of the Borrowers and whether such patent or patent application will be renewed. 

 U.S. Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  

													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILE DATE	  	U.S. PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	
2618-17-C2-PUS-1
	  	Ectoparasite Saliva Proteins	  	10/271,344	  	10/14/2002	  	7,166,693 B2	  	1/23/2007	  	ISSUED
	
2618-17-C5-PUS-1
	  	Ectoparasite Saliva Proteins and Apparatus to Collect Such Proteins	  	09/004,730	  	1/8/1998	  	6,485,968 B1	  	11/26/2002	  	ISSUED
	
2618-25-C1-2

	  	Flea Protease Proteins, Nucleic Acid Molecules and Uses Thereof	  	08/485,443	  	6/7/1995	  	6,146,870	  	11/14/2000	  	ISSUED
	
2618-25-C6
	  	Flea Protease Proteins, Nucleic Acid Molecules and Uses Thereof	  	09/032,215	  	2/27/1998	  	6,204,010 B1	  	3/20/2001	  	ISSUED
	
2618-43-1-1

	  	Anti-Parasitic Helminth Macrophage Migration Inhibitory Factor Antibodies and Uses Thereof	  	09/774,377	  	1/30/2001	  	6,455,039 B2	  	9/24/2002	  	ISSUED
	 2618-45-2
	  	Antiparasitic Helminth Larval Thiol Specific Antioxidant Antibodies and Uses Thereof	  	09/477,510	  	1/4/2000	  	6,489,448 B1	  	12/3/2002	  	ISSUED
	 AD-1
	  	Canine COX-2 Nucleic Acid Molecules and Uses Thereof	  	09/919,060	  	7/31/2001	  	6,638,744 B2	  	10/28/2003	  	ISSUED
	 AD-1-3
	  	Canine COX-2 Proteins and Uses Thereof	  	12/352,511	  	1/12/2009	  	7,666,641	  	2/23/2010	  	ISSUED
	 AL-2-C3
	  	Dermatophagoides Nucleic Acid Molecules, Proteins and Uses Thereof	  	09/292,225	  	4/15/1999	  	6,455,686 B1	  	9/24/2002	  	ISSUED
	
AL-2-C3-1

	  	Novel Dermatophagoides Proteins and Uses Thereof	  	10/218,743	  	8/13/2002	  	7,256,263 B2	  	8/14/2007	  	ISSUED
	 AL-2-C4
	  	Novel Dermatophagoides Proteins and Uses Thereof	  	09/662,293	  	9/14/2000	  	7,128,921 B1	  	10/31/2006	  	ISSUED
	
AL-2-C4-1

	  	Novel Dermatophagoides Proteins and Uses Thereof	  	11/506,444	  	8/18/2006	  	7,891,187	  	9/15/2009	  	ISSUED
	 AL-4
	  	Feline Immunoglobulin E Molecules and Compositions Thereof	  	09/479,614	  	1/7/2000	  	6,573,372 B2	  	6/3/2003	  	ISSUED
	 AL-4-1
	  	Feline Immunoglobulin E Molecules and Related Methods	  	10/409,772	  	4/7/2003	  	7,183,386 B2	  	2/27/2007	  	ISSUED
	 AL-5
	  	Canine Low Affinity IgE Receptor (CD23) Nucleic Acid Molecules and Uses Thereof	  	09/535,521	  	3/24/2000	  	6,410,714 B1	  	6/25/2002	  	ISSUED

 U.S. Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  

													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILE DATE	  	U.S. PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	 AL-7
	  	Compositions and Methods Related to Canine IgG and Canine IL-13 Receptor	  	09/828,995	  	4/9/2001	  	6,703,360 B2	  	3/9/2004	  	ISSUED
	 AL-7-1
	  	Canine IL-13 Receptor Alpha-1 Subunit Nucleic Acid Molecules	  	10/753,159	  	1/7/2004	  	7,378,275 B2	  	5/27/2008	  	ISSUED
	 AS-1
	  	Detection of Anti-FcEpsilonR Autoantibodies in Asthmatics	  	08/985,863	  	12/5/1997	  	6,165,799	  	12/26/2000	  	ISSUED
	 DE-1
	  	Delivery Method for Recombinant Raccoon Poxvirus	  	09/018,798	  	2/4/1998	  	6,106,841	  	8/22/2000	  	ISSUED
	
DE-3-C2-PUS-1
	  	Cationic Lipid-Mediated Enhancement of Nucleic Acid Immunization of Cats	  	10/864,903	  	6/9/2004	  	7,314,627 B2	  	1/1/2008	  	ISSUED
	
DE-3-C2-PUS-2
	  	Cationic Lipid-Mediated Enhancement of Nucleic Acid Immunization of Cats	  	11/866,558	  	10/3/2007	  	8,029,776 B2	  	10/4/2011	  	ISSUED
	 DI-13-C2
	  	Methods for Detecting Early Renal Disease in Animals	  	10/112,648	  	3/28/2002	  	7,172,873 B2	  	2/6/2007	  	ISSUED
	
DI-13-C2-1

	  	Methods of Detecting Early Renal Disease in Animals	  	11/627,784	  	1/26/2007	  	7,935,495 B2	  	5/3/2011	  	ISSUED
	 DI-4
	  	Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules and Uses Thereof	  	09/015,734	  	1/29/1998	  	6,057,127	  	5/2/2000	  	ISSUED
	 DI-4-1
	  	Equine Fc Epsilon Receptor Alpha Chain Proteins and Uses Thereof	  	09/515,311	  	2/29/2000	  	6,582,701 B1	  	6/24/2003	  	ISSUED
	 DI-4-2
	  	Anti-Equine Fc Epsilon Receptor Alpha Chain Antibodies and Method to Detect IgE	  	10/434,817	  	5/8/2003	  	6,887,672 B2	  	5/3/2005	  	ISSUED
	 DI-4-3
	  	Equine Fc Epsilon Receptor Alpha Chain Protein	  	11/086,903	  	3/21/2005	  	7,226,996 B2	  	6/5/2007	  	ISSUED
	 DI-6-C1
	  	Haemobartonella PCR Methods and Materials	  	09/398,577	  	9/17/1999	  	6,518,020 B1	  	2/11/2003	  	ISSUED
	 DI-7-C1
	  	PCR Methods and Materials	  	09/398,179	  	9/17/1999	  	6,300,072 B1	  	10/9/2001	  	ISSUED
	 EQ-2
	  	Intranasal Delivery System	  	09/408,584	  	9/29/1999	  	6,398,774 B1	  	6/4/2002	  	ISSUED
	
EQ-2-C1-PUS

	  	Intranasal Delivery System	  	10/089,224	  	3/27/2002	  	7,204,822 B1	  	4/17/2007	  	ISSUED
	
EQ-2-C1-PUS-1
	  	Equine Intranasal Delivery System	  	10/941,727	  	9/15/2004	  	7,678,087 B2	  	3/16/2010	  	ISSUED

 U.S. Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  

													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILE DATE	  	U.S. PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	
FC-11-PUS-1

	  	Flea Octopamine Receptor Nucleic Acid Molecules, Proteins and Uses Thereof	  	12/200,456	  	8/28/2008	  	7,932,371 B2	  	4/26/2011	  	ISSUED
	 FC-2-1
	  	Serine Protease Inhibitor Nucleic Acid Molecules and Uses Thereof	  	09/005,352	  	1/9/1998	  	6,479,253 B1	  	11/12/2002	  	ISSUED
	 FC-3
	  	Novel Flea Epoxide Hydrolase Nucleic Acid Molecules, Proteins and Uses Thereof	  	08/989,510	  	12/12/1997	  	6,037,160	  	3/14/2000	  	ISSUED
	 FC-3-C1
	  	Flea Epoxide Hydrolase Nucleic Acid Molecules, Proteins and Uses Thereof	  	09/182,816	  	10/29/1998	  	6,143,542	  	11/7/2000	  	ISSUED
	
FC-3-C1-1

	  	Flea Epoxide Hydrolase Proteins and Uses Thereof	  	09/471,528	  	12/27/1999	  	6,153,397	  	11/28/2000	  	ISSUED
	
FC-3-C1-2

	  	Anti-Flea Epoxide Hydrolase Antibodies and Uses Thereof	  	09/634,530	  	8/8/2000	  	6,290,958 B1	  	9/18/2001	  	ISSUED
	 FC-4
	  	Flea Ecdysone and Ultraspiracle Nucleic Acid Molecules, Proteins and Uses Thereof	  	09/435,019	  	11/5/1999	  	6,489,140 B1	  	12/3/2002	  	ISSUED
	 FC-4-2
	  	Flea Ultraspiracle Nucleic Acid Molecules and Uses Thereof	  	10/855,541	  	5/27/2004	  	7,208,589 B2	  	4/24/2007	  	ISSUED
	 FC-4-3
	  	Flea Ultraspiracle Nucleic Acid Molecules	  	11/697,551	  	4/6/2007	  	7,667,019	  	2/23/2010	  	ISSUED
	 FC-5-C1
	  	Flea Chitinase Nucleic Acid Molecules and Uses Thereof	  	09/545,814	  	4/7/2000	  	6,416,977 B1	  	7/9/2002	  	ISSUED
	
FC-6-C1-C1-1
	  	Flea Allantoinase Proteins and Uses Thereof	  	10/180,165	  	6/26/2002	  	6,905,682 B2	  	6/14/2005	  	ISSUED
	
FC-6-C2-2

	  	Flea Peritrophin Nucleic Acid Molecules	  	11/778,533	  	7/16/2007	  	7,662,622 B2	  	2/16/2010	  	ISSUED
	
FC-7-PUS-1

	  	Flea GABA Receptor Subunit Nucleic Acid Molecules	  	12/352,535	  	1/12/2009	  	8,268,976	  	9/18/2012	  	ISSUED
	
FC-8-C3-1

	  	Flea Head, Nerve Cord, Hindgut and Malpighian Tubule Nucleic Acid Molecules, Proteins and Uses Thereof	  	11/565,729	  	12/1/2006	  	8,088,903 B2	  	1/3/2012	  	ISSUED
	 FO-3-C1
	  	Method and Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	09/387,809	  	9/1/1999	  	6,203,825 B1	  	3/20/2001	  	ISSUED
	
HW-5-C1-1

	  	Dirofilaria and Brugia Ankyrin Proteins and Uses Thereof	  	09/557,034	  	4/21/2000	  	6,365,569 B1	  	4/2/2002	  	ISSUED

 U.S. Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  

													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILE DATE	  	U.S. PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	 HW-8
	  	Parasitic Helminth Cuticlin Nucleic Acid Molecules and Uses Thereof	  	09/323,427	  	6/1/1999	  	6,248,329 B1	  	6/19/2001	  	ISSUED
	 HW-8-1
	  	Parasitic Helminth Cuticlin Nucleic Acid Molecules and Uses Thereof	  	09/812,642	  	3/20/2001	  	6,368,600 B1	  	4/9/2002	  	ISSUED
	 HW-9
	  	Parasitic Helminth DiAg2 Proteins, Nucleic Acid Molecules, and Uses Thereof	  	09/361,434	  	7/27/1999	  	6,136,963	  	10/24/2000	  	ISSUED
	 HW-9-1
	  	Parasitic Helminth DiAg2 Proteins and Uses Thereof	  	09/635,025	  	8/4/2000	  	6,392,017 B1	  	5/21/2002	  	ISSUED
	
IM-1-C1-PUS-1
	  	Canine and Feline B7-2 Proteins, Compositions and Uses Thereof	  	10/790,396	  	3/1/2004	  	7,053,181 B2	  	5/30/2006	  	ISSUED
	
IM-2-C1-1

	  	Canine IL-4 Nucleic Acid Molecules and Uses Thereof	  	10/218,654	  	8/13/2002	  	7,078,506 B2	  	7/18/2006	  	ISSUED
	
IM-2-C1-2

	  	Feline Granulocyte Macrophage Colony Stimulating Factor Nucleic Acid Molecules	  	11/486,995	  	7/14/2006	  	7,780,959 B2	  	8/24/2010	  	ISSUED
	
IM-2-C1-3

	  	Feline Granulocyte Macrophage Colony Stimulating Factor Nucleic Acid Molecules	  	12/819,964	  	6/21/2010	  	8,263,559	  	9/11/2012	  	ISSUED
	
IM-2-C1-C1-1
	  	Canine IL-5 Nucleic Acid Molecules	  	10/787,382	  	2/24/2004	  	7,183,080 B2	  	2/27/2007	  	ISSUED
	
IM-2-C1-C1-2
	  	Canine IL-5 Proteins and Fragments Thereof	  	11/561,562	  	11/20/2006	  	7,427,661 B2	  	9/23/2008	  	ISSUED
	
IM-2-C1-R

	  	Canine IL-4 Immunoregulatory Proteins and Uses Thereof	  	10/916,286	  	8/11/2004	  	RE39,614 E
 (Reissue)
	  	05/08/2007
 (10/29/2002)
	  	ISSUED
	
IM-2-C2-1

	  	Canine IL-13 Nucleic Acid Molecules and Uses Thereof	  	10/262,439	  	9/30/2002	  	7,026,139 B2	  	4/11/2006	  	ISSUED
	
IM-2-C2-R

	  	Canine IL-13 Immunoregulatory Proteins and Uses Thereof	  	10/918,292	  	8/13/2004	  	RE40,374 E
 (Reissue)
	  	06/10/2008
 (11/19/2002)
	  	ISSUED
	 IM-5-1
	  	Feline IL-12 Single Chain Nucleic Acid Molecules	  	10/821,670	  	4/9/2004	  	7,205,143 B2	  	4/17/2007	  	ISSUED
	 IM-5-3
	  	Feline IL-18 Nucleic Acid Molecules	  	12/128,440	  	5/28/2008	  	7,928,197 B2	  	4/19/2011	  	ISSUED
	 IN-1-C5
	  	Electrode for Evaluating Cardiac Functions Via Esophagus	  	09/513,737	  	2/22/2000	  	6,438,400 B1	  	8/20/2002	  	ISSUED

 U.S. Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  

													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILE DATE	  	U.S. PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	 TX-1-C2
	  	Methods for the Detection of Encysted Parasites	  	09/216,393	  	12/18/1998	  	6,514,694 B2	  	2/4/2003	  	ISSUED
	
TX-1-C2-1

	  	Methods for the Detection of Encysted Parasites	  	10/321,856	  	12/17/2002	  	7,052,899 B2	  	5/30/2006	  	ISSUED

 Foreign Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  

													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILING
DATE	  	GRANTED
PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	
AL-2-C3-PAU

	  	Novel Dermatophagoides Nucleic Acid Molecules, Proteins and Uses Thereof	  	36521/99	  	4/16/1999	  	762249	  	10/2/2003	  	GRANTED
	
DI-13-C2-PEP

	  	Methods of Detecting Early Renal Disease in Animals	  	02733963.9	  	3/28/2002	  	02733963.9	  	12/16/2009	  	GRANTED
	 DI-1-CH
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	0943097	  	7/30/2003	  	GRANTED
	 DI-1-DE
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	69723860.1-08	  	7/30/2003	  	GRANTED
	 DI-1-DK
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	0943097	  	7/30/2003	  	GRANTED
	 DI-1-ES
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	0943097	  	7/30/2003	  	GRANTED
	 DI-1-FR
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	0943097	  	7/30/2003	  	GRANTED
	 DI-1-GB
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	0943097	  	7/30/2003	  	GRANTED
	 DI-1-IE
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	0943097	  	7/30/2003	  	GRANTED
	 DI-1-IT
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	0943097	  	7/30/2003	  	GRANTED
	
DI-1-PAU-1

	  	Method to Detect IgE	  	57951/01	  	11/24/1997	  	769954	  	5/27/2004	  	GRANTED
	 DI-1-PCA
	  	Method to Detect IgE	  	2,270,868	  	11/24/1997	  	2,270,868	  	1/24/2006	  	GRANTED
	 DI-1-PEP
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	943097	  	7/30/2003	  	GRANTED
	 DI-1-PJP
	  	Method to Detect IgE	  	10-526731	  	11/24/1997	  	3993245	  	8/3/2007	  	GRANTED
	 DI-2-PCA
	  	Novel Feline FC Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	2,273,855	  	12/16/1997	  	2,273,855	  	5/27/2003	  	GRANTED
	 DI-4-BE
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-CH
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-DE
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	National no. to
be assigned	  	7/14/2010	  	GRANTED
	 DI-4-DK
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED

 Foreign Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  

													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILING
DATE	  	GRANTED
PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	 DI-4-ES
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	2348971	  	7/14/2010	  	GRANTED
	 DI-4-FI
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-FR
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-GB
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-IE
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-IT
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-NL
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-PAU
	  	Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	25674/99	  	1/28/1999	  	746218	  	8/1/2002	  	GRANTED
	 DI-4-PCA
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	2,319,310	  	1/28/1999	  	2,319,310	  	5/24/2011	  	GRANTED
	 DI-4-PEP
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-PT
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-SE
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	99905532.0	  	7/14/2010	  	GRANTED
	
EQ-2-C1-PAU

	  	Intranasal Delivery System	  	77376/00	  	9/29/2000	  	774757	  	10/28/2004	  	GRANTED
	
EQ-2-C1-PAU-1
	  	Intranasal Delivery System	  	20044218666	  	10/7/2004	  	20044218666	  	12/14/2006	  	GRANTED
	
EQ-2-C1-PAU-2
	  	Intranasal Delivery System	  	2006236004	  	11/14/2006	  	2006236004	  	6/26/2008	  	GRANTED
	
EQ-2-C1-PCA

	  	Intranasal Delivery System	  	2,386,110	  	9/29/2000	  	2,386,110	  	5/30/2006	  	GRANTED

 Foreign Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  

													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILING
DATE	  	GRANTED
PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	
EQ-2-C1-PCA-1
	  	Intranasal Delivery System	  	2,541,848	  	9/29/2000	  	2,541,848	  	12/2/2008	  	GRANTED
	
EQ-2-C1-PCA-2
	  	Intranasal Delivery System	  	2,640,663	  	9/25/2008	  	2,640,663	  	9/13/2011	  	GRANTED
	
FC-6-C1-PEP

	  	Flea Head, Nerve Cord, Hindgut and Malpighian Tubule Nucleic Acid Molecules, Proteins and Uses Thereof	  	918540.6	  	4/7/2000	  	1169343	  	5/24/2006	  	GRANTED
	
FC-6-C2-PEP

	  	Flea Peritrophin Nucleic Acid Molecules, Proteins and Uses Thereof	  	1977740.8	  	10/11/2001	  	1328662	  	9/8/2010	  	GRANTED
	
FO-3-C1-AT

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	E243943	  	7/2/2003	  	GRANTED
	
FO-3-C1-DE

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	01109457	  	7/2/2003	  	GRANTED
	
FO-3-C1-ES

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	01109457	  	7/2/2003	  	GRANTED
	
FO-3-C1-FR

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	01109457	  	7/2/2003	  	GRANTED
	
FO-3-C1-GB

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	01109457	  	7/2/2003	  	GRANTED
	
FO-3-C1-IT

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	01109457	  	7/2/2003	  	GRANTED
	
FO-3-C1-NL

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	01109457	  	7/2/2003	  	GRANTED

 Foreign Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  

													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILING
DATE	  	GRANTED
PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	
FO-3-C1-PAU

	  	Method and Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	60252/99	  	9/1/1999	  	769669	  	5/13/2004	  	GRANTED
	
FO-3-C1-PCA

	  	Method and Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	2,342,861	  	9/1/1999	  	2,342,861	  	6/9/2009	  	GRANTED
	
FO-3-C1-PEP

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	1109457	  	7/2/2003	  	GRANTED
	
FO-3-C1-SE

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	01109457	  	7/2/2003	  	GRANTED

 U.S. and Foreign Registered Trademarks and Pending Trademark Applications owned solely by Heska Corporation 

(as of June 12, 2017) 
  

																	
	 HESKA FILE
NUMBER
	  	 COUNTRY
	  	 TRADEMARK
	  	 REGISTRATION
NUMBER
	  	REGISTRATION
DATE	  	APPLICATION
NUMBER	  	FILING
DATE	  	CLASS (ES)	  	 STATUS

	 2618-105
	  	USA	  	IMMUCHECK	  	2,913,428	  	12/21/2004	  	75/912,501	  	2/8/2000	  	42	  	REGISTERED
	
2618-105-CTM
	  	European Union	  	IMMUCHECK	  	002685154	  	12/1/2003	  	002685154	  	4/3/2002	  	05, 42, 44	  	REGISTERED
	
2618-117-CH
	  	Switzerland	  	E-SCREEN	  	493 504	  	7/1/2002	  	252520.1	  	10/27/2000	  	10	  	REGISTERED
	
2618-117-CTM
	  	European Union	  	E-SCREEN	  	001933282	  	7/25/2003	  	001933282	  	10/27/2000	  	10	  	REGISTERED
	
2618-117-NO
	  	Norway	  	E-SCREEN	  	212129	  	12/6/2001	  	2000 13104	  	10/26/2000	  	10	  	REGISTERED
	
2618-122-JP
	  	Japan	  	HESKA in Katakana	  	4624176	  	11/22/2002	  	2001-112667	  	12/18/2001	  	05, 10, 42	  	REGISTERED
	
2618-123-HK
	  	Hong Kong	  	TRI-HEART	  	300580554	  	7/13/2006	  	300580554	  	2/14/2006	  	05	  	REGISTERED
	
2618-123-KR
	  	South Korea	  	TRI-HEART	  	40-0685701	  	11/15/2006	  	40-2006-0011110	  	3/3/2006	  	05	  	REGISTERED
	
2618-123-TH
	  	Thailand	  	TRI-HEART	  	TM269052	  	10/16/2007	  	619166	  	2/28/2006	  	05	  	REGISTERED
	
2618-123-TW
	  	Taiwan	  	TRI-HEART	  	1233979	  	11/1/2006	  	95006936	  	2/15/2006	  	05	  	REGISTERED
	
2618-123-TW-1

	  	Taiwan	  	TRI-HEART	  	1418709	  	7/16/2010	  	98047611	  	10/28/2009	  	05	  	REGISTERED
	
2618-130-AU
	  	Australia	  	E.R.D.-HEALTHSCREEN	  	953376	  	6/28/2004	  	953376	  	5/12/2003	  	10	  	REGISTERED
	
2618-130-CA
	  	Canada	  	E.R.D.-HEALTHSCREEN	  	TMA651,278	  	10/24/2005	  	1177640	  	5/12/2003	  	10	  	REGISTERED
	
2618-130-JP-1

	  	Japan	  	ERD -HEALTHSCREEN w/ Katakana	  	5141567	  	6/13/2008	  	2006-100052	  	10/27/2006	  	10	  	REGISTERED
	
2618-136-2
	  	USA	  	ERD	  	3,753,400	  	2/23/2010	  	78/981,276	  	2/23/2010	  	44	  	REGISTERED
	 2618-142
	  	USA	  	HEMATRUE	  	3,509,683	  	9/30/2008	  	77/243,946	  	8/1/2007	  	05, 10	  	REGISTERED
	
2618-142-CA
	  	Canada	  	HEMATRUE	  	TMA741650	  	9/9/2009	  	1,385,154	  	3/4/2008	  	05	  	REGISTERED
	 2618-143
	  	USA	  	HESKAVIEW INTEGRATED SOFTWARE	  	3,538,197	  	11/25/2008	  	77/273,909	  	9/7/2007	  	09	  	REGISTERED
	
2618-143-CA
	  	Canada	  	HESKAVIEW INTEGRATED SOFTWARE	  	TMA746550	  	8/31/2009	  	1,380,774	  	1/25/2008	  	09	  	REGISTERED
	 2618-41
	  	USA	  	HESKA	  	2,494,527	  	10/2/2001	  	75/034,381	  	12/19/1995	  	05, 42	  	REGISTERED
	 2618-41-1
	  	USA	  	HESKA	  	2,655,214	  	12/3/2002	  	75/420,172	  	1/20/1998	  	05	  	REGISTERED
	 2618-41-2
	  	USA	  	HESKA	  	2,177,633	  	7/28/1998	  	75/977,369	  	12/19/1995	  	42	  	REGISTERED
	 2618-41-3
	  	USA	  	HESKA	  	2,948,416	  	5/10/2005	  	76/144,611	  	10/10/2000	  	05	  	REGISTERED
	 2618-41-4
	  	USA	  	HESKA	  	2,474,543	  	7/31/2001	  	75/980,370	  	1/20/1998	  	10	  	REGISTERED
	 2618-41-5
	  	USA	  	HESKA	  	3,336,031	  	11/13/2007	  	78/531,627	  	12/13/2004	  	05	  	REGISTERED
	
2618-41-AU
	  	Australia	  	HESKA	  	702979	  	5/29/1997	  	702979	  	2/23/1996	  	05	  	REGISTERED
	
2618-41-AU-1

	  	Australia	  	HESKA	  	732620	  	2/9/1998	  	732620	  	4/16/1997	  	42	  	REGISTERED
	
2618-41-AU-2

	  	Australia	  	HESKA	  	890675	  	8/5/2002	  	890675	  	9/28/2001	  	10	  	REGISTERED
	
2618-41-BR
	  	Brazil	  	HESKA	  	819225568	  	10/17/2000	  	819225568	  	5/10/1996	  	05	  	REGISTERED
	
2618-41-BR-2

	  	Brazil	  	HESKA	  	830902880	  	6/17/2014	  	830902880	  	1/11/2011	  	10	  	REGISTERED
	
2618-41-CA
	  	Canada	  	HESKA	  	TMA558,841	  	3/6/2002	  	805330	  	2/26/1996	  	05	  	REGISTERED
	
2618-41-CA-1

	  	Canada	  	HESKA	  	TMA545,654	  	5/28/2001	  	842405	  	4/16/1997	  	42	  	REGISTERED
	
2618-41-CA-2

	  	Canada	  	HESKA	  	TMA574,232	  	1/22/2003	  	1,096,586	  	3/20/2001	  	10, 31	  	REGISTERED
	
2618-41-CH
	  	Switzerland	  	HESKA	  	444 805	  	9/22/1997	  	01478/1996	  	3/4/1996	  	05, 10	  	REGISTERED
	
2618-41-CH-1

	  	Switzerland	  	HESKA	  	446 156	  	11/17/1997	  	03226/1997	  	4/24/1997	  	42	  	REGISTERED

 U.S. and Foreign Registered Trademarks and Pending Trademark Applications owned solely by Heska Corporation 

(as of June 12, 2017) 
  

																	
	 HESKA FILE
NUMBER
	  	 COUNTRY
	  	 TRADEMARK
	  	 REGISTRATION
NUMBER
	  	REGISTRATION
DATE	  	APPLICATION
NUMBER	  	FILING
DATE	  	CLASS (ES)	  	 STATUS

	
2618-41-CN
	  	China	  	HESKA	  	1068630	  	8/7/1997	  	960038820	  	3/21/1996	  	05	  	REGISTERED
	
2618-41-CN-2

	  	China	  	HESKA	  	1906801	  	8/7/2002	  	2001056270	  	4/11/2001	  	05	  	REGISTERED
	
2618-41-CN-3

	  	China	  	HESKA	  	2015580	  	9/21/2002	  	2001056271	  	4/11/2001	  	42	  	REGISTERED
	
2618-41-CO
	  	Colombia	  	HESKA	  	218815	  	7/8/1999	  	98056943	  	9/30/1998	  	05	  	REGISTERED
	
2618-41-CTM
	  	European Union	  	HESKA	  	35055	  	9/6/1999	  	35055	  	4/1/1996	  	05	  	REGISTERED
	
2618-41-CTM-1

	  	European Union	  	HESKA	  	521740	  	12/14/1998	  	521740	  	4/16/1997	  	42	  	REGISTERED
	
2618-41-HK-3

	  	Hong Kong	  	HESKA	  	200200488AA	  	12/4/2000	  	200200488AA	  	12/4/2000	  	05, 10, 42	  	REGISTERED
	
2618-41-JP
	  	Japan	  	HESKA	  	4638918	  	1/25/2003	  	8-32003	  	3/25/1996	  	05	  	REGISTERED
	
2618-41-JP-1

	  	Japan	  	HESKA	  	4215403	  	11/27/1998	  	9-120112	  	5/23/1997	  	42	  	REGISTERED
	
2618-41-KR
	  	South Korea	  	HESKA	  	40-0714321	  	6/21/2007	  	40-2006-0011109	  	3/3/2006	  	10	  	REGISTERED
	
2618-41-MX-4

	  	Mexico	  	HESKA	  	1260578	  	1/16/2012	  	1146865	  	1/11/2011	  	05	  	REGISTERED
	
2618-41-NO
	  	Norway	  	HESKA	  	197881	  	6/9/1999	  	96.1270	  	3/27/1996	  	05	  	REGISTERED
	
2618-41-NO-1

	  	Norway	  	HESKA	  	187509	  	12/18/1997	  	97.3116	  	4/17/1997	  	42	  	REGISTERED
	
2618-41-NZ
	  	New Zealand	  	HESKA	  	259206	  	7/30/1998	  	259206	  	2/26/1996	  	05	  	REGISTERED
	
2618-41-NZ-2

	  	New Zealand	  	HESKA	  	708642	  	2/25/2004	  	708642	  	2/25/2004	  	44	  	REGISTERED
	
2618-41-SG
	  	Singapore	  	HESKA	  	T96/02766Z	  	12/19/1995	  	T96/02766Z	  	3/22/1996	  	05	  	REGISTERED
	
2618-41-SG-1

	  	Singapore	  	HESKA	  	T97/05350H	  	5/8/1997	  	T97/05350H	  	5/8/1997	  	42	  	REGISTERED
	
2618-41-TH
	  	Thailand	  	HESKA	  	269424	  	10/22/2007	  	619165	  	2/28/2006	  	05	  	REGISTERED
	
2618-41-TW
	  	Taiwan	  	HESKA	  	756827	  	4/16/1997	  	(85)9563	  	2/29/1996	  	05	  	REGISTERED
	
2618-41-TW-1

	  	Taiwan	  	HESKA	  	097332	  	1/31/1998	  	(86)19642	  	4/11/1997	  	42	  	REGISTERED
	 2618-51
	  	USA	  	HESKA AND DESIGN	  	2,628,459	  	10/1/2002	  	75/189,883	  	10/30/1996	  	05,42	  	REGISTERED
	 2618-51-1
	  	USA	  	HESKA AND DESIGN	  	2,623,862	  	9/24/2002	  	76/221,281	  	3/7/2001	  	10	  	REGISTERED
	
2618-51-AU
	  	Australia	  	HESKA AND DESIGN	  	730379	  	1/30/1998	  	730379	  	3/20/1997	  	05, 42	  	REGISTERED
	
2618-51-AU-1

	  	Australia	  	HESKA AND DESIGN	  	890674	  	5/8/2002	  	890674	  	9/28/2001	  	10	  	REGISTERED
	
2618-51-BR-1

	  	Brazil	  	HESKA AND DESIGN	  	819954926	  	12/14/1999	  	819905496	  	4/30/1997	  	44	  	REGISTERED
	
2618-51-CA
	  	Canada	  	HESKA AND DESIGN	  	TMA559,861	  	4/3/2002	  	840115	  	3/21/1997	  	05, 42	  	REGISTERED
	
2618-51-CA-1

	  	Canada	  	HESKA AND DESIGN	  	TMA574,233	  	1/22/2003	  	1096585	  	3/20/2001	  	10, 31	  	REGISTERED
	
2618-51-CH
	  	Switzerland	  	HESKA AND DESIGN	  	445 463	  	10/22/1997	  	2677/1997	  	4/7/1997	  	05, 10, 42	  	REGISTERED
	
2618-51-CN-2

	  	China	  	HESKA AND DESIGN	  	1906799	  	9/21/2002	  	2001056260	  	4/11/2001	  	05	  	REGISTERED
	
2618-51-CN-3

	  	China	  	HESKA AND DESIGN	  	2015583	  	9/21/2002	  	2001056261	  	4/11/2001	  	42	  	REGISTERED
	
2618-51-CTM
	  	European Union	  	HESKA AND DESIGN	  	494021	  	11/4/1998	  	494021	  	3/20/1997	  	05, 42	  	REGISTERED
	
2618-51-HK-3

	  	Hong Kong	  	HESKA AND DESIGN	  	200106759AA	  	12/4/2000	  	200106759AA	  	12/4/2000	  	05, 10, 42	  	REGISTERED
	
2618-51-JP
	  	Japan	  	HESKA AND DESIGN	  	4638919	  	1/25/2003	  	9-111471	  	4/25/1997	  	05	  	REGISTERED
	
2618-51-JP-1

	  	Japan	  	HESKA AND DESIGN	  	4215387	  	11/27/1998	  	9-111472	  	4/25/1997	  	42	  	REGISTERED
	
2618-51-NO
	  	Norway	  	HESKA AND DESIGN	  	200166	  	11/11/1999	  	19972388	  	3/21/1997	  	05, 42	  	REGISTERED
	
2618-51-NZ
	  	New Zealand	  	HESKA AND DESIGN	  	274355	  	10/30/1996	  	274355	  	3/20/1997	  	05	  	REGISTERED
	
2618-51-NZ-1

	  	New Zealand	  	HESKA AND DESIGN	  	274356	  	10/30/1996	  	274356	  	3/20/1997	  	42	  	REGISTERED
	
2618-51-TW
	  	Taiwan	  	HESKA AND DESIGN	  	816354	  	9/16/1998	  	(86)17443	  	4/11/1997	  	05	  	REGISTERED

 U.S. and Foreign Registered Trademarks and Pending Trademark Applications owned solely by Heska Corporation 

(as of June 12, 2017) 
  

																	
	 HESKA FILE
NUMBER
	  	 COUNTRY
	  	 TRADEMARK
	  	 REGISTRATION
NUMBER
	  	REGISTRATION
DATE	  	APPLICATION
NUMBER	  	FILING
DATE	  	CLASS (ES)	  	 STATUS

	
2618-51-TW-1

	  	Taiwan	  	HESKA AND DESIGN	  	097209	  	1/1/1998	  	(86)17444	  	4/11/1997	  	42	  	REGISTERED
	
2618-51-VE
	  	Venezuela	  	HESKA AND DESIGN	  	P-213.369	  	6/8/1999	  	5.952/97	  	4/1/1997	  	05	  	REGISTERED
	
2618-51-VE-1

	  	Venezuela	  	HESKA AND DESIGN	  	S-10.293	  	6/8/1999	  	5.953/97	  	4/1/1997	  	42	  	REGISTERED
	 2618-63
	  	USA	  	ALLERCEPT	  	2,612,937	  	8/27/2002	  	75/325,290	  	7/16/1997	  	05	  	REGISTERED
	 2618-63-2
	  	USA	  	ALLERCEPT	  	2,530,646	  	1/15/2002	  	75/980,372	  	7/16/1997	  	42	  	REGISTERED
	
2618-63-AU
	  	Australia	  	ALLERCEPT	  	1190788	  	6/10/2013	  	1190788	  	6/10/2013	  	05, 44	  	REGISTERED
	
2618-63-CA
	  	Canada	  	ALLERCEPT	  		  		  	1631209	  	6/14/2013	  	05, 44	  	REGISTERED
	
2618-63-CH
	  	Switzerland	  	ALLERCEPT	  	501047	  	7/16/2002	  	8557/2001	  	8/30/2001	  	05, 44	  	REGISTERED
	
2618-63-CN
	  	China	  	ALLERCEPT	  	1190788	  	6/10/2013	  	1190788	  	6/10/2013	  	05, 44	  	REGISTERED
	
2618-63-CTM
	  	European Union	  	ALLERCEPT	  	620138	  	11/18/1999	  	620138	  	8/29/1997	  	05, 42	  	REGISTERED
	
2618-63-JP
	  	Japan	  	ALLERCEPT	  	1190788	  	6/10/2013	  	1190788	  	6/10/2013	  	05, 44	  	REGISTERED
	
2618-63-MX
	  	Mexico	  	ALLERCEPT	  	1546775	  	6/15/2015	  	1190788	  	6/10/2013	  	05, 44	  	REGISTERED
	
2618-63-NO
	  	Norway	  	ALLERCEPT	  	212.574	  	12/27/2001	  	2001 10495	  	8/31/2001	  	05, 42	  	REGISTERED
	
2618-63-NZ
	  	New Zealand	  	ALLERCEPT	  	1190788	  	6/10/2013	  	1190788	  	6/10/2013	  	05, 44	  	REGISTERED
	
2618-63-PL
	  	Poland	  	ALLERCEPT	  	1190788	  	6/10/2013	  	1190788	  	6/10/2013	  	05, 44	  	REGISTERED
	
2618-63-RU
	  	Russia	  	ALLERCEPT	  	1190788	  	8/14/2015	  	1190788	  	6/10/2013	  	44	  	REGISTERED
	
2618-63-SG
	  	Singapore	  	ALLERCEPT	  		  		  	1190788	  	6/10/2013	  	05, 44	  	PENDING
	
2618-63-KR
	  	South Korea	  	ALLERCEPT	  	1190788	  	6/10/2013	  	1190788	  	6/10/2013	  	05, 44	  	REGISTERED
	 2618-76-3
	  	USA	  	SOLO STEP	  	2,509,741	  	11/20/2001	  	76/169,305	  	11/21/2000	  	10	  	REGISTERED
	
2618-76-3-CA

	  	Canada	  	SOLO STEP	  	TMA636,108	  	3/24/2005	  	1136071	  	5/7/2002	  	10	  	REGISTERED
	
2618-76-JP
	  	Japan	  	SOLO STEP	  	4406804	  	8/4/2000	  	11-88921	  	9/29/1999	  	10	  	REGISTERED
	
2618-76-JP-1

	  	Japan	  	SOLO STEP w/ Katakana	  	4454194	  	2/16/2001	  	2000-24733	  	3/14/2000	  	05, 10	  	REGISTERED
	 2618-96
	  	USA	  	VET/SENSOR	  	2,454,228	  	5/22/2001	  	75/612,052	  	12/21/1998	  	10	  	REGISTERED
	 2618-170
	  	USA	  	VITALPATH	  	3,908,910	  	1/18/2011	  	77/830223	  	9/18/2009	  	10	  	REGISTERED
	
2618-170-CA
	  	CANADA	  	VITALPATH	  	841,936	  	1/13/2013	  	1,478,308	  	3/16/2010	  	10	  	REGISTERED
	 2618-207
	  	USA	  	ELEMENT DC	  	4,318,224	  	4/9/2013	  	85/501,345	  	12/21/2011	  	10	  	REGISTERED
	 2618-209
	  	USA	  	ELEMENT i	  	4,851,518	  	11/10/2015	  	85/531,712	  	2/2/2012	  	10	  	REGISTERED
	 2618-213
	  	USA	  	ELEMENT POC	  	4,550,666	  	6/17/2014	  	86/062,771	  	9/12/2013	  	10	  	REGISTERED
	 2618-215
	  	USA	  	ELEMENT HT5	  	4,849,883	  	11/10/2015	  	86/548,170	  	2/27/2015	  	05, 10	  	REGISTERED
	
2618-215-AU
	  	Australia	  	ELEMENT HT5	  	1728208	  	1/28/2016	  	1268876	  	10/15/2015	  	05, 10	  	REGISTERED
	
2618-215-CH
	  	Switzerland	  	ELEMENT HT5	  	1268876	  	3/25/2017	  	1268876	  	10/15/2015	  	05, 10	  	REGISTERED
	
2618-215-CTM
	  	European Union	  	ELEMENT HT5	  	1268876	  	8/17/2016	  	1268876	  	10/15/2015	  	05, 10	  	REGISTERED
	
2618-215-NO
	  	Norway	  	ELEMENT HT5	  	1268876	  	9/16/2016	  	1268876	  	10/15/2015	  	05, 10	  	PENDING
	
2618-215-NZ
	  	New Zealand	  	ELEMENT HT5	  	1029762	  	1/3/2016	  	1268876	  	10/15/2015	  	05, 10	  	REGISTERED
	 T00014US0
	  	USA	  	DIAMOND AND DESIGN	  	1917148	  	9/5/1995	  	74-491,987	  	2/18/1994	  	5	  	REGISTERED

 EXHIBIT E 

(See Section 3.11 of Security Agreement) 

TITLE DOCUMENTS 
 I. Vehicles subject to
certificates of title: 
  

							
	 Name of Grantor
	  	 Description
	  	 Title Number
	  	 State Where Issued

	None	  		  		  	

 II. Aircraft/engines/parts, ships, railcars and other vehicles governed by federal statute: 

 

					
	 Name of Grantor
	  	 Description
	  	 Registration Number

	None	  		  	

 EXHIBIT F 

(See Section 3.11 of Security Agreement) 

FIXTURES 
 I. Legal description, county and
street address of property on which Fixtures are located (by Grantor): 
  

							
	 Address
	  	Type	  	Owned/Leased	  	Borrower
	 3760 Rocky Mountain Avenue,
 Loveland, Colorado
80538
	  	Building	  	Leased	  	Heska Corporation
	 1959 Big Sandy Place,
 Loveland, Colorado
80538
	  	Townhome	  	Owned	  	Heska Corporation
	 2538 SE 43rd Street
 Des Moines, Iowa
50327
	  	Building	  	Owned	  	Diamond Animal
Health
	 4334 170th Ave
 Carlisle, Iowa 50047

4770 170th Ave
 Carlisle, Iowa 50047
	  	Farm	  	Owned	  	Diamond Animal
Health
	 4592 170th Ave
 Carlisle, Iowa 50047
	  	Residence	  	Owned	  	Diamond Animal
Health

 II. Name and Address of Record Owner: 

Millbrae Square Company 
 717 Broadway, 

Millbrae, CA 94030 

 EXHIBIT G 

(See Section 3.13 of Security Agreement and Definition of “Pledged Collateral”) 

LIST OF PLEDGED COLLATERAL, SECURITIES AND OTHER INVESTMENT PROPERTY 

STOCKS 
  

											
	 Name of Grantor
	  	 Issuer
	  	Certificate
Number(s)	  	 Number of Shares
	  	 Class of Stock
	  	Percentage of
Outstanding
Shares
	Heska Corporation	  	Diamond Animal Health, Inc.	  	32	  	100	  	Common Stock	  	100%
	Heska Corporation	  	Heska Imaging, LLC	  	N/A	  	100% of Percentage Interests	  	Percentage Interests	  	100%
	Heska Corporation	  	Heska AG	  	N/A	  		  		  	100%
	Heska Corporation	  	Heska Canada Limited	  	N/A	  	1	  	Common	  	100%

 BONDS 
  

											
	 Name of Grantor
	  	 Issuer
	  	 Number
	  	 Face Amount
	  	 Coupon Rate
	  	 Maturity

	None	  		  		  		  		  	

 GOVERNMENT SECURITIES 
  

													
	 Name of Grantor
	  	 Issuer
	  	 Number
	  	 Type
	  	 Face Amount
	  	 Coupon Rate
	  	 Maturity

	None	  		  		  		  		  		  	

 OTHER SECURITIES OR OTHER INVESTMENT PROPERTY 

(CERTIFICATED AND UNCERTIFICATED) 
  

							
	 Name of Grantor
	  	 Issuer
	  	 Description of Collateral
	  	 Percentage Ownership

Interest

	None	  		  		  	

 EXHIBIT H 

(See Section 3.1 of Security Agreement) 

OFFICES IN WHICH FINANCING STATEMENTS HAVE BEEN FILED 

Colorado 
 Iowa 

Delaware 

 EXHIBIT I 

(See Definition of “Commercial Tort Claim”) 

COMMERCIAL TORT CLAIMS 
 {NOTE:
SPECIFICALLY DESCRIBE THE CLAIM (I.E. PARTIES, DESCRIPTION OF THE 
 DISPUTE, CASE NUMBER – IF AVAILABLE) - SEE OFFICIAL COMMENT 5
TO SECTION 9-108 
 OF THE UCC}. 

 

							
	 Name of Grantor
	  	 Description of Claim
	  	 Parties
	  	 Case Number; Name of Court

where Case was Filed

	None	  		  		  	

 EXHIBIT J 

(See Section 4.8 of Security Agreement) 

AMENDMENT 
 This Amendment, dated
                        ,              is delivered
pursuant to Section 4.8 of the Security Agreement referred to below. All defined terms herein shall have the meanings ascribed thereto or incorporated by reference in the Security Agreement. The undersigned hereby certifies that the
representations and warranties in Article III of the Security Agreement are and continue to be true and correct. The undersigned further agrees that this Amendment may be attached to that certain Pledge and Security Agreement, dated
                        ,             , between the
undersigned, as the Grantors, and JPMorgan Chase Bank, N.A., as the Administrative Agent, (as amended, restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Security Agreement”) and that the
Collateral listed on Schedule I to this Amendment shall be and become a part of the Collateral referred to in said Security Agreement and shall secure all Secured Obligations referred to in the Security Agreement. 

 

							
	      

 

		
	By:	 	
	Name:	 		 		 	          

	Title:	 		 	          

 Schedule I to Amendment to Security Agreement 

COMMERCIAL TORT CLAIMS 
 {NOTE:
SPECIFICALLY DESCRIBE THE CLAIM (I.E. PARTIES, DESCRIPTION OF THE 
 DISPUTE, CASE NUMBER – IF AVAILABLE) - SEE OFFICIAL COMMENT 5
TO SECTION 9-108 
 OF THE UCC}. 

 

							
	 Name of Grantor
	  	 Description of Claim
	  	 Parties
	  	 Case Number; Name of
Court
where Case was FiledEX-4.4

 Exhibit 4.4 

ADURO BIOTECH, INC., 

Issuer 
 AND 

[TRUSTEE], 
 Trustee

  
  

INDENTURE 
 Dated as of
[•], 20  
  
  

Debt Securities 

 TABLE OF CONTENTS
  

							
	 	  	 	  	PAGE	 
	 ARTICLE 1
	  	 DEFINITIONS
	  	 	1	 
			
	 Section 1.01
	  	 Definitions of Terms
	  	 	1	 
			
	 ARTICLE 2
	  	 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES
	  	 	5	 
			
	 Section 2.01
	  	 Designation and Terms of Securities
	  	 	5	 
			
	 Section 2.02
	  	 Form of Securities and Trustee’s Certificate
	  	 	8	 
			
	 Section 2.03
	  	 Denominations: Provisions for Payment
	  	 	8	 
			
	 Section 2.04
	  	 Execution and Authentications
	  	 	10	 
			
	 Section 2.05
	  	 Registration of Transfer and Exchange
	  	 	10	 
			
	 Section 2.06
	  	 Temporary Securities
	  	 	12	 
			
	 Section 2.07
	  	 Mutilated, Destroyed, Lost or Stolen Securities
	  	 	12	 
			
	 Section 2.08
	  	 Cancellation
	  	 	13	 
			
	 Section 2.09
	  	 Benefits of Indenture
	  	 	13	 
			
	 Section 2.10
	  	 Authenticating Agent
	  	 	13	 
			
	 Section 2.11
	  	 Global Securities
	  	 	14	 
			
	 Section 2.12
	  	 CUSIP Numbers
	  	 	15	 
			
	 ARTICLE 3
	  	 REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS
	  	 	15	 
			
	 Section 3.01
	  	 Redemption
	  	 	15	 
			
	 Section 3.02
	  	 Notice of Redemption
	  	 	15	 
			
	 Section 3.03
	  	 Payment Upon Redemption
	  	 	17	 
			
	 Section 3.04
	  	 Sinking Fund
	  	 	17	 
			
	 Section 3.05
	  	 Satisfaction of Sinking Fund Payments with Securities
	  	 	17	 
			
	 Section 3.06
	  	 Redemption of Securities for Sinking Fund
	  	 	18	 
			
	 ARTICLE 4
	  	 COVENANTS
	  	 	18	 
			
	 Section 4.01
	  	 Payment of Principal, Premium and Interest
	  	 	18	 
			
	 Section 4.02
	  	 Maintenance of Office or Agency
	  	 	18	 
			
	 Section 4.03
	  	 Paying Agents
	  	 	19	 
			
	 Section 4.04
	  	 Appointment to Fill Vacancy in Office of Trustee
	  	 	20	 

  

  
 i. 

 TABLE OF CONTENTS

(CONTINUED) 
  

							
	 	  	 	  	PAGE	 
	 ARTICLE 5
	  	 SECURITYHOLDERS’ LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE
	  	 	20	 
			
	 Section 5.01
	  	 Company to Furnish Trustee Names and Addresses of Securityholders
	  	 	20	 
			
	 Section 5.02
	  	 Preservation Of Information; Communications With Securityholders
	  	 	20	 
			
	 Section 5.03
	  	 Reports by the Company
	  	 	21	 
			
	 Section 5.04
	  	 Reports by the Trustee
	  	 	21	 
			
	 ARTICLE 6
	  	 REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT
	  	 	22	 
			
	 Section 6.01
	  	 Events of Default
	  	 	22	 
			
	 Section 6.02
	  	 Collection of Indebtedness and Suits for Enforcement by Trustee
	  	 	24	 
			
	 Section 6.03
	  	 Application of Moneys Collected
	  	 	25	 
			
	 Section 6.04
	  	 Limitation on Suits
	  	 	25	 
			
	 Section 6.05
	  	 Rights and Remedies Cumulative; Delay or Omission Not Waiver
	  	 	26	 
			
	 Section 6.06
	  	 Control by Securityholders
	  	 	26	 
			
	 Section 6.07
	  	 Undertaking to Pay Costs
	  	 	27	 
			
	 ARTICLE 7
	  	 CONCERNING THE TRUSTEE
	  	 	28	 
			
	 Section 7.01
	  	 Certain Duties and Responsibilities of Trustee
	  	 	28	 
			
	 Section 7.02
	  	 Certain Rights of Trustee
	  	 	29	 
			
	 Section 7.03
	  	 Trustee Not Responsible for Recitals or Issuance or Securities
	  	 	31	 
			
	 Section 7.04
	  	 May Hold Securities
	  	 	31	 
			
	 Section 7.05
	  	 Moneys Held in Trust
	  	 	32	 
			
	 Section 7.06
	  	 Compensation and Reimbursement
	  	 	32	 
			
	 Section 7.07
	  	 Reliance on Officer’s Certificate
	  	 	33	 
			
	 Section 7.08
	  	 Disqualification; Conflicting Interests
	  	 	33	 
			
	 Section 7.09
	  	 Corporate Trustee Required; Eligibility
	  	 	33	 
			
	 Section 7.10
	  	 Resignation and Removal; Appointment of Successor
	  	 	33	 
			
	 Section 7.11
	  	 Acceptance of Appointment By Successor
	  	 	35	 
			
	 Section 7.12
	  	 Merger, Conversion, Consolidation or Succession to Business
	  	 	36	 
			
	 Section 7.13
	  	 Preferential Collection of Claims Against the Company
	  	 	36	 
			
	 Section 7.14
	  	 Notice of Default
	  	 	36	 

  

  
 ii. 

 TABLE OF CONTENTS

(CONTINUED) 
  

							
	 	  	 	  	PAGE	 
	 ARTICLE 8
	  	 CONCERNING THE SECURITYHOLDERS
	  	 	37	 
			
	 Section 8.01
	  	 Evidence of Action by Securityholders
	  	 	37	 
			
	 Section 8.02
	  	 Proof of Execution by Securityholders
	  	 	37	 
			
	 Section 8.03
	  	 Who May be Deemed Owners
	  	 	38	 
			
	 Section 8.04
	  	 Certain Securities Owned by Company Disregarded
	  	 	38	 
			
	 Section 8.05
	  	 Actions Binding on Future Securityholders
	  	 	38	 
			
	 ARTICLE 9
	  	 SUPPLEMENTAL INDENTURES
	  	 	39	 
			
	 Section 9.01
	  	 Supplemental Indentures Without the Consent of Securityholders
	  	 	39	 
			
	 Section 9.02
	  	 Supplemental Indentures With Consent of Securityholders
	  	 	40	 
			
	 Section 9.03
	  	 Effect of Supplemental Indentures
	  	 	40	 
			
	 Section 9.04
	  	 Securities Affected by Supplemental Indentures
	  	 	40	 
			
	 Section 9.05
	  	 Execution of Supplemental Indentures
	  	 	41	 
			
	 ARTICLE 10
	  	 SUCCESSOR ENTITY
	  	 	41	 
			
	 Section 10.01
	  	 Company May Consolidate, Etc.
	  	 	41	 
			
	 Section 10.02
	  	 Successor Entity Substituted
	  	 	42	 
			
	 ARTICLE 11
	  	 SATISFACTION AND DISCHARGE
	  	 	42	 
			
	 Section 11.01
	  	 Satisfaction and Discharge of Indenture
	  	 	42	 
			
	 Section 11.02
	  	 Discharge of Obligations
	  	 	43	 
			
	 Section 11.03
	  	 Deposited Moneys to be Held in Trust
	  	 	43	 
			
	 Section 11.04
	  	 Payment of Moneys Held by Paying Agents
	  	 	43	 
			
	 Section 11.05
	  	 Repayment to Company
	  	 	44	 
			
	 ARTICLE 12
	  	 IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS
	  	 	44	 
			
	 Section 12.01
	  	 No Recourse
	  	 	44	 
			
	 ARTICLE 13
	  	 MISCELLANEOUS PROVISIONS
	  	 	45	 
			
	 Section 13.01
	  	 Effect on Successors and Assigns
	  	 	45	 
			
	 Section 13.02
	  	 Actions by Successor
	  	 	45	 
			
	 Section 13.03
	  	 Surrender of Company Powers
	  	 	45	 

  
 iii. 

 TABLE OF CONTENTS

(CONTINUED) 
  

							
	 	  	 	  	PAGE	 
	 Section 13.04
	  	 Notices
	  	 	45	 
			
	 Section 13.05
	  	 Governing Law; Jury Trial Waiver
	  	 	45	 
			
	 Section 13.06
	  	 Treatment of Securities as Debt
	  	 	46	 
			
	 Section 13.07
	  	 Certificates and Opinions as to Conditions Precedent
	  	 	46	 
			
	 Section 13.08
	  	 Payments on Business Days
	  	 	46	 
			
	 Section 13.09
	  	 Conflict with Trust Indenture Act
	  	 	47	 
			
	 Section 13.10
	  	 Counterparts
	  	 	47	 
			
	 Section 13.11
	  	 Separability
	  	 	47	 
			
	 Section 13.12
	  	 Compliance Certificates
	  	 	47	 
			
	 Section 13.13
	  	 Patriot Act
	  	 	47	 
			
	 Section 13.14
	  	 Force Majeure
	  	 	48	 
			
	 Section 13.15
	  	 Table of Contents; Headings
	  	 	48	 

  

  
 iv. 

 INDENTURE 

INDENTURE, dated as of [•], 20 , among ADURO BIOTECH, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as
trustee (the “Trustee”): 
 WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this
Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as
registered Securities without coupons, to be authenticated by the certificate of the Trustee; 
 WHEREAS, to provide the terms and conditions upon
which the Securities are to be authenticated, issued and delivered, the Company has duly authorized the execution of this Indenture; and 
 WHEREAS,
all things necessary to make this Indenture a valid agreement of the Company, in accordance with its terms, have been done. 
 NOW, THEREFORE, in
consideration of the premises and the purchase of the Securities by the holders thereof, it is mutually covenanted and agreed as follows for the equal and ratable benefit of the holders of Securities: 

ARTICLE 1 
 DEFINITIONS

 Section 1.01 Definitions of Terms. 
 The
terms defined in this Section (except as in this Indenture or any indenture supplemental hereto otherwise expressly provided or unless the context otherwise requires) for all purposes of this Indenture and of any indenture supplemental hereto shall
have the respective meanings specified in this Section and shall include the plural as well as the singular. All other terms used in this Indenture that are defined in the Trust Indenture Act of 1939, as amended, or that are by reference in such Act
defined in the Securities Act of 1933, as amended (except as herein or any indenture supplemental hereto otherwise expressly provided or unless the context otherwise requires), shall have the meanings assigned to such terms in said Trust Indenture
Act and in said Securities Act as in force at the date of the execution of this instrument. 
 “Authenticating Agent” means the
Trustee or an authenticating agent with respect to all or any of the series of Securities appointed by the Trustee pursuant to Section 2.10. 

“Bankruptcy Law” means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors. 

“Board of Directors” means the Board of Directors (or the functional equivalent thereof) of the Company or any duly authorized
committee of such Board. 

  
 1 

 “Board Resolution” means a copy of a resolution certified by the Secretary or an
Assistant Secretary of the Company to have been duly adopted by the Board of Directors (or duly authorized committee thereof) and to be in full force and effect on the date of such certification. 

“Business Day” means, with respect to any series of Securities, any day other than a day on which federal or state banking
institutions in the Borough of Manhattan, the City of New York, or in the city of the Corporate Trust Office of the Trustee, are authorized or obligated by law, executive order or regulation to close. 

“Commission” means the Securities and Exchange Commission, as from time to time constituted, created under the Exchange Act, or, if at
any time after the execution of this instrument such Commission is not existing and performing the duties now assigned to it under the Trust Indenture Act, then the body performing such duties at such time. 

“Company” means ADURO BIOTECH, INC., a corporation duly organized and existing under the laws of the State of Delaware, and,
subject to the provisions of Article Ten, shall also include its successors and assigns. 
 “Corporate Trust Office” means the
office of the Trustee at which, at any particular time, its corporate trust business shall be principally administered, which office at the date hereof is located at . 

“Custodian” means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law. 

“Defaulted Interest” has the meaning set forth in Section 2.03. 

“Depositary” means, with respect to Securities of any series for which the Company shall determine that such Securities will be issued
as a Global Security, The Depository Trust Company, another clearing agency, or any successor registered as a clearing agency under the Exchange Act, or other applicable statute or regulation, which, in each case, shall be designated by the Company
pursuant to either Section 2.01 or 2.11. 
 “Event of Default” means, with respect to Securities of a particular series, any
event specified in Section 6.01, continued for the period of time, if any, therein designated. 
 “Exchange Act” means the
United States Securities and Exchange Act of 1934, as amended, and the rules and regulations promulgated by the Commission thereunder. 
 “Global
Security” means a Security issued to evidence all or a part of any series of Securities which is executed by the Company and authenticated and delivered by the Trustee to the Depositary or pursuant to the Depositary’s instruction,
all in accordance with the Indenture, which shall be registered in the name of the Depositary or its nominee. 
 “Governmental
Obligations” means securities that are (a) direct obligations of the United States of America for the payment of which its full faith and credit is pledged or 

  
 2 

 
(b) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States of America, the payment of which is unconditionally guaranteed as a full
faith and credit obligation by the United States of America that, in either case, are not callable or redeemable at the option of the issuer thereof at any time prior to the stated maturity of the Securities, and shall also include a depositary
receipt issued by a bank or trust company as custodian with respect to any such Governmental Obligation or a specific payment of principal of or interest on any such Governmental Obligation held by such custodian for the account of the holder of
such depositary receipt; provided, however, that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depositary receipt from any amount received by the custodian in respect
of the Governmental Obligation or the specific payment of principal of or interest on the Governmental Obligation evidenced by such depositary receipt. 

“herein”, “hereof” and “hereunder”, and other words of similar import, refer to
this Indenture as a whole and not to any particular Article, Section or other subdivision. 
 “Indenture” means this instrument as
originally executed or as it may from time to time be supplemented or amended by one or more indentures supplemental hereto entered into in accordance with the terms hereof and shall include the terms of particular series of Securities established
as contemplated by Section 2.01. 
 “Interest Payment Date”, when used with respect to any installment of interest on a
Security of a particular series, means the date specified in such Security or in a Board Resolution or in an indenture supplemental hereto with respect to such series as the fixed date on which an installment of interest with respect to Securities
of that series is due and payable. 
 “Officer” means, with respect to the Company, the chairman of the Board of Directors, a chief
executive officer, a president, a chief financial officer, a chief operating officer, any executive vice president, any senior vice president, any vice president, the treasurer or any assistant treasurer, the controller or any assistant controller
or the secretary or any assistant secretary. 
 “Officer’s Certificate” means a certificate signed by any Officer. Each such
certificate shall include the statements provided for in Section 13.07, if and to the extent required by the provisions thereof. 
 “Opinion
of Counsel” means an opinion in writing subject to customary exceptions of legal counsel, who may be an employee of or counsel for the Company, that is delivered to the Trustee in accordance with the terms hereof. Each such opinion
shall include the statements provided for in Section 13.07, if and to the extent required by the provisions thereof. 

“Outstanding”, when used with reference to Securities of any series, means, subject to the provisions of Section 8.04, as of any
particular time, all Securities of that series theretofore authenticated and delivered by the Trustee under this Indenture, except (a) Securities theretofore canceled by the Trustee or any paying agent, or delivered to the Trustee or any paying
agent for cancellation or that have previously been canceled; (b) Securities or portions thereof for the payment or redemption of which moneys or Governmental Obligations in the necessary amount

  
 3 

 
shall have been deposited in trust with the Trustee or with any paying agent (other than the Company) or shall have been set aside and segregated in trust by the Company (if the Company shall act
as its own paying agent); provided, however, that if such Securities or portions of such Securities are to be redeemed prior to the maturity thereof, notice of such redemption shall have been given as provided in Article Three, or provision
satisfactory to the Trustee shall have been made for giving such notice; and (c) Securities in lieu of or in substitution for which other Securities shall have been authenticated and delivered pursuant to the terms of Section 2.07. 

“Person” means any individual, corporation, partnership, joint venture, joint-stock company, limited liability company, association,
trust, unincorporated organization, any other entity or organization, including a government or political subdivision or an agency or instrumentality thereof. 

“Predecessor Security” of any particular Security means every previous Security evidencing all or a portion of the same debt as that
evidenced by such particular Security; and, for the purposes of this definition, any Security authenticated and delivered under Section 2.07 in lieu of a lost, destroyed or stolen Security shall be deemed to evidence the same debt as the lost,
destroyed or stolen Security. 
 “Responsible Officer” when used with respect to the Trustee means any officer within the Corporate
Trust Office of the Trustee (or any successor group of the Trustee) or any other officer of the Trustee customarily performing functions similar to those performed by any of the above designated officers and also means, with respect to a particular
corporate trust matter, any other officer to whom such matter is referred because of his or her knowledge of and familiarity with the particular subject and in each case who shall have direct responsibility for the administration of this Indenture.

 “Securities” has the meaning stated in the first recital of this Indenture and more particularly means any Securities
authenticated and delivered under this Indenture. 
 “Securities Act” means the Securities Act of 1933, as amended. 

“Securityholder”, “holder of Securities”, “registered holder”, or other similar term,
means the Person or Persons in whose name or names a particular Security is registered on the Security Register kept for that purpose in accordance with the terms of this Indenture. 

“Security Register” and “Security Registrar” shall have the meanings as set forth in Section 2.05. 

“Subsidiary” means, with respect to any Person, any corporation, association, partnership or other business entity of which more than
50% of the total voting power of shares of capital stock or other interests (including partnership interests) entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers, general partners or trustees
thereof is at the time owned or controlled, directly or indirectly, by (i) such Person; (ii) such Person and one or more Subsidiaries of such Person; or (iii) one or more Subsidiaries of such Person. 

  
 4 

 “Trustee” means , and, subject to the provisions of Article Seven, shall also include its
successors and assigns, and, if at any time there is more than one Person acting in such capacity hereunder, “Trustee” shall mean each such Person. The term “Trustee” as used with respect to a particular series of the Securities
shall mean the trustee with respect to that series. 
 “Trust Indenture Act” means the Trust Indenture Act of 1939, as amended. 

“U.S.A. Patriot Act” means the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct
Terrorism Act of 2001, Pub. L. 107-56, as amended and signed into law October 26, 2001. 
 ARTICLE 2 

ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND 

EXCHANGE OF SECURITIES 

Section 2.01 Designation and Terms of Securities. 

(a) The aggregate principal amount of Securities that may be authenticated and delivered under this Indenture is unlimited. The Securities may be issued
in one or more series up to the aggregate principal amount of Securities of that series from time to time authorized by or pursuant to a Board Resolution or pursuant to one or more indentures supplemental hereto. Prior to the initial issuance of
Securities of any series, there shall be established in or pursuant to a Board Resolution, and set forth in an Officer’s Certificate, or established in one or more indentures supplemental hereto: 

(1) the title of the Securities of the series (which shall distinguish the Securities of that series from all other Securities); 

(2) any limit upon the aggregate principal amount of the Securities of that series that may be authenticated and delivered under this Indenture (except
for Securities authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of that series); 

(3) the maturity date or dates on which the principal of the Securities of the series is payable; 

(4) the form of the Securities of the series including the form of the certificate of authentication for such series; 

(5) the applicability of any guarantees; 
 (6)
whether or not the Securities will be secured or unsecured, and the terms of any secured debt; 

  
 5 

 (7) whether the Securities rank as senior debt, senior subordinated debt, subordinated debt or any
combination thereof, and the terms of any subordination; 
 (8) if the price (expressed as a percentage of the aggregate principal amount thereof) at
which such Securities will be issued is a price other than the principal amount thereof, the portion of the principal amount thereof payable upon declaration of acceleration of the maturity thereof, or if applicable, the portion of the principal
amount of such Securities that is convertible into another security or the method by which any such portion shall be determined; 
 (9) the interest
rate or rates, which may be fixed or variable, or the method for determining the rate and the date interest will begin to accrue, the dates interest will be payable and the regular record dates for interest payment dates or the method for
determining such dates; 
 (10) the Company’s right, if any, to defer the payment of interest and the maximum length of any such deferral
period; 
 (11) if applicable, the date or dates after which, or the period or periods during which, and the price or prices at which, the Company
may at its option, redeem the series of Securities pursuant to any optional or provisional redemption provisions and the terms of those redemption provisions; 

(12) the date or dates, if any, on which, and the price or prices at which the Company is obligated, pursuant to any mandatory sinking fund or
analogous fund provisions or otherwise, to redeem, or at the Securityholder’s option to purchase, the series of Securities and the currency or currency unit in which the Securities are payable; 

(13) the denominations in which the Securities of the series shall be issuable, if other than denominations of one thousand U.S. dollars ($1,000) or
any integral multiple thereof; 
 (14) any and all terms, if applicable, relating to any auction or remarketing of the Securities of that series and
any security for the obligations of the Company with respect to such Securities and any other terms which may be advisable in connection with the marketing of Securities of that series; 

(15) whether the Securities of the series shall be issued in whole or in part in the form of a Global Security or Securities; the terms and conditions,
if any, upon which such Global Security or Securities may be exchanged in whole or in part for other individual Securities; and the Depositary for such Global Security or Securities; 

(16) if applicable, the provisions relating to conversion or exchange of any Securities of the series and the terms and conditions upon which such
Securities will be so convertible or exchangeable, including the conversion or exchange price, as applicable, or how it will be calculated and may be adjusted, any mandatory or optional (at the Company’s option or the holders’ option)
conversion or exchange features, the applicable conversion or exchange period and the manner of settlement for any conversion or exchange, which may, without limitation, include the payment of cash as well as the delivery of securities; 

  
 6 

 (17) if other than the full principal amount thereof, the portion of the principal amount of Securities of
the series which shall be payable upon declaration of acceleration of the maturity thereof pursuant to Section 6.01; 
 (18) additions to or
changes in the covenants applicable to the series of Securities being issued, including, among others, the consolidation, merger or sale covenant; 

(19) additions to or changes in the Events of Default with respect to the Securities and any change in the right of the Trustee or the Securityholders
to declare the principal, premium, if any, and interest, if any, with respect to such Securities to be due and payable; 
 (20) additions to or
changes in or deletions of the provisions relating to covenant defeasance and legal defeasance; 
 (21) additions to or changes in the provisions
relating to satisfaction and discharge of this Indenture; 
 (22) additions to or changes in the provisions relating to the modification of this
Indenture both with and without the consent of Securityholders of Securities issued under this Indenture; 
 (23) the currency of payment of
Securities if other than U.S. dollars and the manner of determining the equivalent amount in U.S. dollars; 
 (24) whether interest will be payable
in cash or additional Securities at the Company’s or the Securityholders’ option and the terms and conditions upon which the election may be made; 

(25) the terms and conditions, if any, upon which the Company shall pay amounts in addition to the stated interest, premium, if any and principal
amounts of the Securities of the series to any Securityholder that is not a “United States person” for federal tax purposes; 
 (26) any
restrictions on transfer, sale or assignment of the Securities of the series; and 
 (27) any other specific terms, preferences, rights or
limitations of, or restrictions on, the Securities, any other additions or changes in the provisions of this Indenture, and any terms that may be required by us or advisable under applicable laws or regulations. 

All Securities of any one series shall be substantially identical except as may otherwise be provided in or pursuant to any such Board Resolution or in any
indentures supplemental hereto. 

  
 7 

 If any of the terms of the series are established by action taken pursuant to a Board Resolution of the Company,
a copy of an appropriate record of such action shall be certified by the secretary or an assistant secretary of the Company and delivered to the Trustee at or prior to the delivery of the Officer’s Certificate of the Company setting forth the
terms of the series. 
 Securities of any particular series may be issued at various times, with different dates on which the principal or any installment
of principal is payable, with different rates of interest, if any, or different methods by which rates of interest may be determined, with different dates on which such interest may be payable and with different redemption dates. 

Section 2.02 Form of Securities and Trustee’s Certificate. 

The Securities of any series and the Trustee’s certificate of authentication to be borne by such Securities shall be substantially of the tenor and
purport as set forth in one or more indentures supplemental hereto or as provided in a Board Resolution, and set forth in an Officer’s Certificate, and they may have such letters, numbers or other marks of identification or designation and such
legends or endorsements printed, lithographed or engraved thereon as the Company may deem appropriate and as are not inconsistent with the provisions of this Indenture, or as may be required to comply with any law or with any rule or regulation made
pursuant thereto or with any rule or regulation of any securities exchange on which Securities of that series may be listed, or to conform to usage. 

Section 2.03 Denominations: Provisions for Payment. 

The Securities shall be issuable as registered Securities and in the denominations of one thousand U.S. dollars ($1,000) or any integral multiple thereof,
subject to Section 2.01(a)(13). The Securities of a particular series shall bear interest payable on the dates and at the rate specified with respect to that series. Subject to Section 2.01(a)(23), the principal of and the interest on the
Securities of any series, as well as any premium thereon in case of redemption or repurchase thereof prior to maturity, and any cash amount due upon conversion or exchange thereof, shall be payable in the coin or currency of the United States of
America that at the time is legal tender for public and private debt, at the office or agency of the Company maintained for that purpose. Each Security shall be dated the date of its authentication. Interest on the Securities shall be computed on
the basis of a 360-day year composed of twelve 30-day months. 
 The interest installment on any Security that is payable, and is punctually paid or duly
provided for, on any Interest Payment Date for Securities of that series shall be paid to the Person in whose name said Security (or one or more Predecessor Securities) is registered at the close of business on the regular record date for such
interest installment. In the event that any Security of a particular series or portion thereof is called for redemption and the redemption date is subsequent to a regular record date with respect to any Interest Payment Date and prior to such
Interest Payment Date, interest on such Security will be paid upon presentation and surrender of such Security as provided in Section 3.03. 
 Any
interest on any Security that is payable, but is not punctually paid or duly provided for, on any Interest Payment Date for Securities of the same series (herein called “Defaulted Interest”) shall forthwith cease to be payable to the
registered holder on the relevant regular record date by virtue of having been such holder; and such Defaulted Interest shall be paid by the Company, at its election, as provided in clause (1) or clause (2) below: 

  
 8 

 (1) The Company may make payment of any Defaulted Interest on Securities to the Persons in whose names
such Securities (or their respective Predecessor Securities) are registered at the close of business on a special record date for the payment of such Defaulted Interest, which shall be fixed in the following manner: the Company shall notify the
Trustee in writing of the amount of Defaulted Interest proposed to be paid on each such Security and the date of the proposed payment, and at the same time the Company shall deposit with the Trustee an amount of money equal to the aggregate amount
proposed to be paid in respect of such Defaulted Interest or shall make arrangements satisfactory to the Trustee for such deposit prior to the date of the proposed payment, such money when deposited to be held in trust for the benefit of the Persons
entitled to such Defaulted Interest as in this clause provided. Thereupon the Trustee shall fix a special record date for the payment of such Defaulted Interest which shall not be more than 15 nor less than 10 days prior to the date of the proposed
payment and not less than 10 days after the receipt by the Trustee of the notice of the proposed payment. The Trustee shall promptly notify the Company of such special record date and, in the name and at the expense of the Company, shall cause
notice of the proposed payment of such Defaulted Interest and the special record date therefor to be mailed, first class postage prepaid, to each Securityholder at his or her address as it appears in the Security Register (as hereinafter defined),
not less than 10 days prior to such special record date. Notice of the proposed payment of such Defaulted Interest and the special record date therefor having been mailed as aforesaid, such Defaulted Interest shall be paid to the Persons in whose
names such Securities (or their respective Predecessor Securities) are registered on such special record date. 
 (2) The Company may make payment of
any Defaulted Interest on any Securities in any other lawful manner not inconsistent with the requirements of any securities exchange on which such Securities may be listed, and upon such notice as may be required by such exchange, if, after notice
given by the Company to the Trustee of the proposed payment pursuant to this clause, such manner of payment shall be deemed practicable by the Trustee. 

Unless otherwise set forth in a Board Resolution or one or more indentures supplemental hereto establishing the terms of any series of Securities pursuant to
Section 2.01 hereof, the term “regular record date” as used in this Section with respect to a series of Securities and any Interest Payment Date for such series shall mean either the fifteenth day of the month immediately preceding
the month in which an Interest Payment Date established for such series pursuant to Section 2.01 hereof shall occur, if such Interest Payment Date is the first day of a month, or the first day of the month in which an Interest Payment Date
established for such series pursuant to Section 2.01 hereof shall occur, if such Interest Payment Date is the fifteenth day of a month, whether or not such date is a Business Day. 

Subject to the foregoing provisions of this Section, each Security of a series delivered under this Indenture upon transfer of or in exchange for or in lieu
of any other Security of such series shall carry the rights to interest accrued and unpaid, and to accrue, that were carried by such other Security. 

  
 9 

 Section 2.04 Execution and Authentications. 

The Securities shall be signed on behalf of the Company by one of its Officers. Signatures may be in the form of a manual or facsimile signature. 

The Company may use the facsimile signature of any Person who shall have been an Officer (at the time of execution), notwithstanding the fact that at the time
the Securities shall be authenticated and delivered or disposed of such Person shall have ceased to be such an officer of the Company. The Securities may contain such notations, legends or endorsements required by law, stock exchange rule or usage.
Each Security shall be dated the date of its authentication by the Trustee. 
 A Security shall not be valid until authenticated manually by an authorized
signatory of the Trustee, or by an Authenticating Agent. Such signature shall be conclusive evidence that the Security so authenticated has been duly authenticated and delivered hereunder and that the holder is entitled to the benefits of this
Indenture. At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver Securities of any series executed by the Company to the Trustee for authentication, together with a written order of the Company
for the authentication and delivery of such Securities, signed by an Officer, and the Trustee in accordance with such written order shall authenticate and deliver such Securities. 

Upon the Company’s delivery of any such authentication order to the Trustee at any time after the initial issuance of Securities under this Indenture,
the Trustee shall be provided with, and (subject to Sections 315(a) through 315(d) of the Trust Indenture Act) shall be fully protected in relying upon, (1) an Opinion of Counsel or reliance letter and (2) an Officer’s Certificate
stating that all conditions precedent to the execution, authentication and delivery of such Securities are in conformity with the provisions of this Indenture. 

The Trustee shall not be required to authenticate such Securities if the issue of such Securities pursuant to this Indenture will affect the Trustee’s
own rights, duties or immunities under the Securities and this Indenture or otherwise in a manner that is not reasonably acceptable to the Trustee. 

Section 2.05 Registration of Transfer and Exchange. 

(a) Securities of any series may be exchanged upon presentation thereof at the office or agency of the Company designated for such purpose, for other
Securities of such series of authorized denominations, and for a like aggregate principal amount, upon payment of a sum sufficient to cover any tax or other governmental charge in relation thereto, all as provided in this Section. In respect of any
Securities so surrendered for exchange, the Company shall execute, the Trustee shall authenticate and such office or agency shall deliver in exchange therefor the Security or Securities of the same series that the Securityholder making the exchange
shall be entitled to receive, bearing numbers not contemporaneously outstanding. 
 (b) The Company shall keep, or cause to be kept, at its office or
agency designated for such purpose a register or registers (herein referred to as the “Security Register”) in which, subject to such reasonable regulations as it may prescribe, the Company shall register 

  
 10 

 the Securities and the transfers of Securities as in this Article provided and which at all reasonable times
shall be open for inspection by the Trustee. The registrar for the purpose of registering Securities and transfer of Securities as herein provided shall be appointed as authorized by Board Resolution (the “Security Registrar”). 

Upon surrender for transfer of any Security at the office or agency of the Company designated for such purpose, the Company shall execute, the Trustee shall
authenticate and such office or agency shall deliver in the name of the transferee or transferees a new Security or Securities of the same series as the Security presented for a like aggregate principal amount. 

All Securities presented or surrendered for exchange or registration of transfer, as provided in this Section, shall be accompanied (if so required by the
Company or the Security Registrar) by a written instrument or instruments of transfer, in form satisfactory to the Company or the Security Registrar, duly executed by the registered holder or by such holder’s duly authorized attorney in
writing. 
 (c) Except as provided pursuant to Section 2.01 pursuant to a Board Resolution, and set forth in an Officer’s Certificate, or
established in one or more indentures supplemental to this Indenture, no service charge shall be made for any exchange or registration of transfer of Securities, or issue of new Securities in case of partial redemption of any series or repurchase,
conversion or exchange of less than the entire principal amount of a Security, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge in relation thereto, other than exchanges pursuant to
Section 2.06, Section 3.03(b) and Section 9.04 not involving any transfer. 
 (d) The Company shall not be required (i) to issue,
exchange or register the transfer of any Securities during a period beginning at the opening of business 15 days before the day of the mailing of a notice of redemption of less than all the Outstanding Securities of the same series and ending at the
close of business on the day of such mailing, nor (ii) to register the transfer of or exchange any Securities of any series or portions thereof called for redemption or surrendered for repurchase, but not validly withdrawn, other than the
unredeemed portion of any such Securities being redeemed in part or not surrendered for repurchase, as the case may be. The provisions of this Section 2.05 are, with respect to any Global Security, subject to Section 2.11 hereof. 

The Trustee shall have no obligation or duty to monitor, determine or inquire as to compliance with any restrictions on transfer imposed under this Indenture
or under applicable law with respect to any transfer of any interest in any Security (including any transfers between or among depositary participants or beneficial owners of interests in any Global Security) other than to require delivery of such
certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly required by the terms of, this Indenture, and to examine the same to determine substantial compliance as to form with the express
requirements hereof. 

  
 11 

 Section 2.06 Temporary Securities. 

Pending the preparation of definitive Securities of any series, the Company may execute, and the Trustee shall authenticate and deliver, temporary Securities
(printed, lithographed or typewritten) of any authorized denomination. Such temporary Securities shall be substantially in the form of the definitive Securities in lieu of which they are issued, but with such omissions, insertions and variations as
may be appropriate for temporary Securities, all as may be determined by the Company. Every temporary Security of any series shall be executed by the Company and be authenticated by the Trustee upon the same conditions and in substantially the same
manner, and with like effect, as the definitive Securities of such series. Without unnecessary delay the Company will execute and will furnish definitive Securities of such series and thereupon any or all temporary Securities of such series may be
surrendered in exchange therefor (without charge to the holders), at the office or agency of the Company designated for the purpose, and the Trustee shall authenticate and such office or agency shall deliver in exchange for such temporary Securities
an equal aggregate principal amount of definitive Securities of such series, unless the Company advises the Trustee to the effect that definitive Securities need not be executed and furnished until further notice from the Company. Until so
exchanged, the temporary Securities of such series shall be entitled to the same benefits under this Indenture as definitive Securities of such series authenticated and delivered hereunder. 

Section 2.07 Mutilated, Destroyed, Lost or Stolen Securities. 

In case any temporary or definitive Security shall become mutilated or be destroyed, lost or stolen, the Company (subject to the next succeeding sentence)
shall execute, and upon the Company’s request the Trustee (subject as aforesaid) shall authenticate and deliver, a new Security of the same series, bearing a number not contemporaneously outstanding, in exchange and substitution for the
mutilated Security, or in lieu of and in substitution for the Security so destroyed, lost or stolen. In every case the applicant for a substituted Security shall furnish to the Company and the Trustee such security or indemnity as may be required by
them to save each of them harmless, and, in every case of destruction, loss or theft, the applicant shall also furnish to the Company and the Trustee evidence to their satisfaction of the destruction, loss or theft of the applicant’s Security
and of the ownership thereof. The Trustee may authenticate any such substituted Security and deliver the same upon the written request or authorization of any officer of the Company. Upon the issuance of any substituted Security, the Company may
require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Trustee) connected therewith. 

In case any Security that has matured or is about to mature shall become mutilated or be destroyed, lost or stolen, the Company may, instead of issuing a
substitute Security, pay or authorize the payment of the same (without surrender thereof except in the case of a mutilated Security) if the applicant for such payment shall furnish to the Company and the Trustee such security or indemnity as they
may require to save them harmless, and, in case of destruction, loss or theft, evidence to the satisfaction of the Company and the Trustee of the destruction, loss or theft of such Security and of the ownership thereof. 

  
 12 

 Every replacement Security issued pursuant to the provisions of this Section shall constitute an additional
contractual obligation of the Company whether or not the mutilated, destroyed, lost or stolen Security shall be found at any time, or be enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally and proportionately
with any and all other Securities of the same series duly issued hereunder. All Securities shall be held and owned upon the express condition that the foregoing provisions are exclusive with respect to the replacement or payment of mutilated,
destroyed, lost or stolen Securities, and shall preclude (to the extent lawful) any and all other rights or remedies, notwithstanding any law or statute existing or hereafter enacted to the contrary with respect to the replacement or payment of
negotiable instruments or other securities without their surrender. 
 Section 2.08 Cancellation. 

All Securities surrendered for the purpose of payment, redemption, repurchase, exchange, registration of transfer or conversion shall, if surrendered to the
Company or any paying agent (or any other applicable agent), be delivered to the Trustee for cancellation, or, if surrendered to the Trustee, shall be cancelled by it, and no Securities shall be issued in lieu thereof except as expressly required or
permitted by any of the provisions of this Indenture. On request of the Company at the time of such surrender, the Trustee shall deliver to the Company canceled Securities held by the Trustee. In the absence of such request the Trustee may dispose
of canceled Securities in accordance with its standard procedures and deliver a certificate of disposition to the Company. If the Company shall otherwise acquire any of the Securities, however, such acquisition shall not operate as a redemption or
satisfaction of the indebtedness represented by such Securities unless and until the same are delivered to the Trustee for cancellation. 

Section 2.09 Benefits of Indenture. 
 Nothing in this
Indenture or in the Securities, express or implied, shall give or be construed to give to any Person, other than the parties hereto and the holders of the Securities any legal or equitable right, remedy or claim under or in respect of this
Indenture, or under any covenant, condition or provision herein contained; all such covenants, conditions and provisions being for the sole benefit of the parties hereto and of the holders of the Securities. 

Section 2.10 Authenticating Agent. 
 So long as any
of the Securities of any series remain Outstanding there may be an Authenticating Agent for any or all such series of Securities which the Trustee shall have the right to appoint. Said Authenticating Agent shall be authorized to act on behalf of the
Trustee to authenticate Securities of such series issued upon exchange, transfer or partial redemption, repurchase or conversion thereof, and Securities so authenticated shall be entitled to the benefits of this Indenture and shall be valid and
obligatory for all purposes as if authenticated by the Trustee hereunder. All references in this Indenture to the authentication of Securities by the Trustee shall be deemed to include authentication by an Authenticating Agent for such series. Each
Authenticating Agent shall be acceptable to the Company and shall be a corporation that has a combined capital and surplus, as most recently reported or determined by it, sufficient under the laws of any jurisdiction under which it is organized or
in which it is doing business to 

  
 13 

 
conduct a trust business, and that is otherwise authorized under such laws to conduct such business and is subject to supervision or examination by federal or state authorities. If at any time
any Authenticating Agent shall cease to be eligible in accordance with these provisions, it shall resign immediately. 
 Any Authenticating Agent may at any
time resign by giving written notice of resignation to the Trustee and to the Company. The Trustee may at any time (and upon request by the Company shall) terminate the agency of any Authenticating Agent by giving written notice of termination to
such Authenticating Agent and to the Company. Upon resignation, termination or cessation of eligibility of any Authenticating Agent, the Trustee may appoint an eligible successor Authenticating Agent acceptable to the Company. Any successor
Authenticating Agent, upon acceptance of its appointment hereunder, shall become vested with all the rights, powers and duties of its predecessor hereunder as if originally named as an Authenticating Agent pursuant hereto. 

Section 2.11 Global Securities. 
 (a) If the
Company shall establish pursuant to Section 2.01 that the Securities of a particular series are to be issued as a Global Security, then the Company shall execute and the Trustee shall, in accordance with Section 2.04, authenticate and
deliver, a Global Security that (i) shall represent, and shall be denominated in an amount equal to the aggregate principal amount of, all of the Outstanding Securities of such series, (ii) shall be registered in the name of the Depositary
or its nominee, (iii) shall be delivered by the Trustee to the Depositary or pursuant to the Depositary’s instruction (or if the Depositary names the Trustee as its custodian, retained by the Trustee), and (iv) shall bear a legend
substantially to the following effect: “Except as otherwise provided in Section 2.11 of the Indenture, this Security may be transferred, in whole but not in part, only to another nominee of the Depositary or to a successor Depositary or to
a nominee of such successor Depositary.” 
 (b) Notwithstanding the provisions of Section 2.05, the Global Security of a series may be
transferred, in whole but not in part and in the manner provided in Section 2.05, only to another nominee of the Depositary for such series, or to a successor Depositary for such series selected or approved by the Company or to a nominee of
such successor Depositary. 
 (c) If at any time the Depositary for a series of the Securities notifies the Company that it is unwilling or unable to
continue as Depositary for such series or if at any time the Depositary for such series shall no longer be registered or in good standing under the Exchange Act, or other applicable statute or regulation, and a successor Depositary for such series
is not appointed by the Company within 90 days after the Company receives such notice or becomes aware of such condition, as the case may be, or if an Event of Default has occurred and is continuing and the Company has received a request from the
Depositary or from the Trustee, this Section 2.11 shall no longer be applicable to the Securities of such series and the Company will execute, and subject to Section 2.04, the Trustee will authenticate and deliver the Securities of such
series in definitive registered form without coupons, in authorized denominations, and in an aggregate principal amount equal to the principal amount of the Global Security of such series in exchange for such Global Security. In addition, the
Company may at any time determine that the Securities of any series shall no longer be represented by a Global 

  
 14 

 
Security and that the provisions of this Section 2.11 shall no longer apply to the Securities of such series. In such event the Company will execute and, subject to Section 2.04, the
Trustee, upon receipt of an Officer’s Certificate evidencing such determination by the Company, will authenticate and deliver the Securities of such series in definitive registered form without coupons, in authorized denominations, and in an
aggregate principal amount equal to the principal amount of the Global Security of such series in exchange for such Global Security. Upon the exchange of the Global Security for such Securities in definitive registered form without coupons, in
authorized denominations, the Global Security shall be canceled by the Trustee. Such Securities in definitive registered form issued in exchange for the Global Security pursuant to this Section 2.11(c) shall be registered in such names and in
such authorized denominations as the Depositary, pursuant to instructions from its direct or indirect participants or otherwise, shall instruct the Trustee. The Trustee shall deliver such Securities to the Depositary for delivery to the Persons in
whose names such Securities are so registered. 
 Section 2.12 CUSIP Numbers. 

The Company in issuing the Securities may use “CUSIP” numbers (if then generally in use), and, if so, the Trustee shall use “CUSIP” numbers
in notices of redemption as a convenience to Holders; provided that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Securities or as contained in any notice of a redemption and
that reliance may be placed only on the other elements of identification printed on the Securities, and any such redemption shall not be affected by any defect in or omission of such numbers. The Company will promptly notify the Trustee of any
change in the “CUSIP” numbers. 
 ARTICLE 3 

REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS 

Section 3.01 Redemption. 
 The Company may redeem the
Securities of any series issued hereunder on and after the dates and in accordance with the terms established for such series pursuant to Section 2.01 hereof. 

Section 3.02 Notice of Redemption. 
 (a) In
case the Company shall desire to exercise such right to redeem all or, as the case may be, a portion of the Securities of any series in accordance with any right the Company reserved for itself to do so pursuant to Section 2.01 hereof, the
Company shall, or shall cause the Trustee to, give notice of such redemption to holders of the Securities of such series to be redeemed by mailing, first class postage prepaid (or with regard to any Global Security held in book entry form, by
electronic mail), a notice of such redemption not less than 30 days and not more than 90 days before the date fixed for redemption of that series to such holders at their last addresses as they shall appear upon the Security Register, unless a
shorter period is specified in 

  
 15 

 
the Securities to be redeemed. Any notice that is mailed in the manner herein provided shall be conclusively presumed to have been duly given, whether or not the registered holder receives the
notice. In any case, failure duly to give such notice to the holder of any Security of any series designated for redemption in whole or in part, or any defect in the notice, shall not affect the validity of the proceedings for the redemption of any
other Securities of such series or any other series. In the case of any redemption of Securities prior to the expiration of any restriction on such redemption provided in the terms of such Securities or elsewhere in this Indenture, the Company shall
furnish the Trustee with an Officer’s Certificate evidencing compliance with any such restriction. 
 Each such notice of redemption shall identify the
Securities to be redeemed (including CUSIP numbers, if any), specify the date fixed for redemption and the redemption price at which Securities of that series are to be redeemed, and shall state that payment of the redemption price of such
Securities to be redeemed will be made at the office or agency of the Company, upon presentation and surrender of such Securities, that interest accrued to the date fixed for redemption will be paid as specified in said notice, that from and after
said date interest will cease to accrue and that the redemption is from a sinking fund, if such is the case. If less than all the Securities of a series are to be redeemed, the notice to the holders of Securities of that series to be redeemed in
part shall specify the particular Securities to be so redeemed. 
 In case any Security is to be redeemed in part only, the notice that relates to such
Security shall state the portion of the principal amount thereof to be redeemed, and shall state that on and after the redemption date, upon surrender of such Security, a new Security or Securities of such series in principal amount equal to the
unredeemed portion thereof will be issued. 
 (b) If less than all the Securities of a series are to be redeemed, the Company shall give the Trustee
at least 45 days’ notice (unless a shorter notice shall be satisfactory to the Trustee) in advance of the date fixed for redemption as to the aggregate principal amount of Securities of the series to be redeemed, and thereupon the Trustee shall
select, by lot or in such other manner as it shall deem appropriate and fair in its discretion and that may provide for the selection of a portion or portions (equal to one thousand U.S. dollars ($1,000) or any integral multiple thereof) of the
principal amount of such Securities of a denomination larger than $1,000, the Securities to be redeemed and shall thereafter promptly notify the Company in writing of the numbers of the Securities to be redeemed, in whole or in part. The Company
may, if and whenever it shall so elect, by delivery of instructions signed on its behalf by an Officer, instruct the Trustee or any paying agent to call all or any part of the Securities of a particular series for redemption and to give notice of
redemption in the manner set forth in this Section, such notice to be in the name of the Company or its own name as the Trustee or such paying agent may deem advisable. In any case in which notice of redemption is to be given by the Trustee or any
such paying agent, the Company shall deliver or cause to be delivered to, or permit to remain with, the Trustee or such paying agent, as the case may be, such Security Register, transfer books or other records, or suitable copies or extracts
therefrom, sufficient to enable the Trustee or such paying agent to give any notice by mail that may be required under the provisions of this Section. 

  
 16 

 Section 3.03 Payment Upon Redemption. 

(a) If the giving of notice of redemption shall have been completed as above provided, the Securities or portions of Securities of the series to be
redeemed specified in such notice shall become due and payable on the date and at the place stated in such notice at the applicable redemption price, together with interest accrued to the date fixed for redemption and interest on such Securities or
portions of Securities shall cease to accrue on and after the date fixed for redemption, unless the Company shall default in the payment of such redemption price and accrued interest with respect to any such Security or portion thereof. On
presentation and surrender of such Securities on or after the date fixed for redemption at the place of payment specified in the notice, said Securities shall be paid and redeemed at the applicable redemption price for such series, together with
interest accrued thereon to the date fixed for redemption (but if the date fixed for redemption is an Interest Payment Date, the interest installment payable on such date shall be payable to the registered holder at the close of business on the
applicable record date pursuant to Section 2.03). 
 (b) Upon presentation of any Security of such series that is to be redeemed in part only,
the Company shall execute and the Trustee shall authenticate and the office or agency where the Security is presented shall deliver to the holder thereof, at the expense of the Company, a new Security of the same series of authorized denominations
in principal amount equal to the unredeemed portion of the Security so presented. 
 Section 3.04 Sinking Fund. 

The provisions of Sections 3.04, 3.05 and 3.06 shall be applicable to any sinking fund for the retirement of Securities of a series, except as otherwise
specified as contemplated by Section 2.01 for Securities of such series. 
 The minimum amount of any sinking fund payment provided for by the terms of
Securities of any series is herein referred to as a “mandatory sinking fund payment,” and any payment in excess of such minimum amount provided for by the terms of Securities of any series is herein referred to as an “optional sinking
fund payment”. If provided for by the terms of Securities of any series, the cash amount of any sinking fund payment may be subject to reduction as provided in Section 3.05. Each sinking fund payment shall be applied to the redemption of
Securities of any series as provided for by the terms of Securities of such series. 
 Section 3.05 Satisfaction of Sinking Fund Payments with
Securities. 
 The Company (i) may deliver Outstanding Securities of a series and (ii) may apply as a credit Securities of a series that have
been redeemed either at the election of the Company pursuant to the terms of such Securities or through the application of permitted optional sinking fund payments pursuant to the terms of such Securities, in each case in satisfaction of all or any
part of any sinking fund payment with respect to the Securities of such series required to be made pursuant to the terms of such Securities as provided for by the terms of such series, provided that such Securities have not been previously so
credited. Such Securities shall be received and credited for such purpose by the Trustee at the redemption price specified in such Securities for redemption through operation of the sinking fund and the amount of such sinking fund payment shall be
reduced accordingly. 

  
 17 

 Section 3.06 Redemption of Securities for Sinking Fund. 

Not less than 45 days prior to each sinking fund payment date for any series of Securities (unless a shorter period shall be satisfactory to the Trustee), the
Company will deliver to the Trustee an Officer’s Certificate specifying the amount of the next ensuing sinking fund payment for that series pursuant to the terms of the series, the portion thereof, if any, that is to be satisfied by delivering
and crediting Securities of that series pursuant to Section 3.05 and the basis for such credit and will, together with such Officer’s Certificate, deliver to the Trustee any Securities to be so delivered. Not less than 30 days before each
such sinking fund payment date the Trustee shall select the Securities to be redeemed upon such sinking fund payment date in the manner specified in Section 3.02 and cause notice of the redemption thereof to be given in the name of and at the
expense of the Company in the manner provided in Section 3.02. Such notice having been duly given, the redemption of such Securities shall be made upon the terms and in the manner stated in Section 3.03. 

ARTICLE 4 
 COVENANTS

 Section 4.01 Payment of Principal, Premium and Interest. 

The Company will duly and punctually pay or cause to be paid the principal of (and premium, if any) and interest on the Securities of that series at the time
and place and in the manner provided herein and established with respect to such Securities. Payments of principal on the Securities may be made at the time provided herein and established with respect to such Securities by U.S. dollar check drawn
on and mailed to the address of the Securityholder entitled thereto as such address shall appear in the Security Register, or U.S. dollar wire transfer to, a U.S. dollar account if such Securityholder shall have furnished wire instructions to the
Trustee no later than 15 days prior to the relevant payment date. Payments of interest on the Securities may be made at the time provided herein and established with respect to such Securities by U.S. dollar check mailed to the address of the
Securityholder entitled thereto as such address shall appear in the Security Register, or U.S. dollar wire transfer to, a U.S. dollar account if such Securityholder shall have furnished wire instructions in writing to the Security Registrar and the
Trustee no later than 15 days prior to the relevant payment date. 
 Section 4.02 Maintenance of Office or Agency. 

So long as any series of the Securities remain Outstanding, the Company agrees to maintain an office or agency with respect to each such series and at such
other location or locations as may be designated as provided in this Section 4.02, where (i) Securities of that series may be presented for payment, (ii) Securities of that series may be presented as herein above authorized for
registration of transfer and exchange, and (iii) notices and demands to or upon the Company in respect of the Securities of that series and this Indenture may be given or served, such designation to continue with respect to such office or
agency until the Company shall, by 

  
 18 

 
written notice signed by any officer authorized to sign an Officer’s Certificate and delivered to the Trustee, designate some other office or agency for such purposes or any of them. If at
any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, notices and demands may be made or served at the Corporate Trust Office of the Trustee,
and the Company hereby appoints the Trustee as its agent to receive all such presentations, notices and demands. The Company initially appoints the Corporate Trust Office of the Trustee as its paying agent with respect to the Securities. 

Section 4.03 Paying Agents. 
 (a) If the
Company shall appoint one or more paying agents for all or any series of the Securities, other than the Trustee, the Company will cause each such paying agent to execute and deliver to the Trustee an instrument in which such agent shall agree with
the Trustee, subject to the provisions of this Section: 
 (1) that it will hold all sums held by it as such agent for the payment of the principal
of (and premium, if any) or interest on the Securities of that series (whether such sums have been paid to it by the Company or by any other obligor of such Securities) in trust for the benefit of the Persons entitled thereto; 

(2) that it will give the Trustee notice of any failure by the Company (or by any other obligor of such Securities) to make any payment of the
principal of (and premium, if any) or interest on the Securities of that series when the same shall be due and payable; 
 (3) that it will, at any
time during the continuance of any failure referred to in the preceding paragraph (a)(2) above, upon the written request of the Trustee, forthwith pay to the Trustee all sums so held in trust by such paying agent; and 

 

	(4)	that it will perform all other duties of paying agent as set forth in this Indenture. 

 (b) If the
Company shall act as its own paying agent with respect to any series of the Securities, it will on or before each due date of the principal of (and premium, if any) or interest on Securities of that series, set aside, segregate and hold in trust for
the benefit of the Persons entitled thereto a sum sufficient to pay such principal (and premium, if any) or interest so becoming due on Securities of that series until such sums shall be paid to such Persons or otherwise disposed of as herein
provided and will promptly notify the Trustee of such action, or any failure (by it or any other obligor on such Securities) to take such action. Whenever the Company shall have one or more paying agents for any series of Securities, it will, prior
to each due date of the principal of (and premium, if any) or interest on any Securities of that series, deposit with the paying agent a sum sufficient to pay the principal (and premium, if any) or interest so becoming due, such sum to be held in
trust for the benefit of the Persons entitled to such principal, premium or interest, and (unless such paying agent is the Trustee) the Company will promptly notify the Trustee of this action or failure so to act. 

  
 19 

 (c) Notwithstanding anything in this Section to the contrary, (i) the agreement to hold sums in trust
as provided in this Section is subject to the provisions of Section 11.05, and (ii) the Company may at any time, for the purpose of obtaining the satisfaction and discharge of this Indenture or for any other purpose, pay, or direct any
paying agent to pay, to the Trustee all sums held in trust by the Company or such paying agent, such sums to be held by the Trustee upon the same terms and conditions as those upon which such sums were held by the Company or such paying agent; and,
upon such payment by the Company or any paying agent to the Trustee, the Company or such paying agent shall be released from all further liability with respect to such money. 

Section 4.04 Appointment to Fill Vacancy in Office of Trustee. 

The Company, whenever necessary to avoid or fill a vacancy in the office of Trustee, will appoint, in the manner provided in Section 7.10, a Trustee, so
that there shall at all times be a Trustee hereunder. 
 ARTICLE 5 

SECURITYHOLDERS’ LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE 

Section 5.01 Company to Furnish Trustee Names and Addresses of Securityholders. 

The Company will furnish or cause to be furnished to the Trustee (a) within 15 days after each regular record date (as defined in Section 2.03) a
list, in such form as the Trustee may reasonably require, of the names and addresses of the holders of each series of Securities as of such regular record date, provided that the Company shall not be obligated to furnish or cause to furnish such
list at any time that the list shall not differ in any respect from the most recent list furnished to the Trustee by the Company and (b) at such other times as the Trustee may request in writing within 30 days after the receipt by the Company
of any such request, a list of similar form and content as of a date not more than 15 days prior to the time such list is furnished; provided, however, that, in either case, no such list need be furnished for any series for which the Trustee shall
be the Security Registrar. 
 Section 5.02 Preservation Of Information; Communications With Securityholders. 

(a) The Trustee shall preserve, in as current a form as is reasonably practicable, all information as to the names and addresses of the holders of
Securities contained in the most recent list furnished to it as provided in Section 5.01 and as to the names and addresses of holders of Securities received by the Trustee in its capacity as Security Registrar (if acting in such capacity). 

(b) The Trustee may destroy any list furnished to it as provided in Section 5.01 upon receipt of a new list so furnished. 

  
 20 

 (c) Securityholders may communicate as provided in Section 312(b) of the Trust Indenture Act with
other Securityholders with respect to their rights under this Indenture or under the Securities, and, in connection with any such communications, the Trustee shall satisfy its obligations under Section 312(b) of the Trust Indenture Act in
accordance with the provisions of Section 312(b) of the Trust Indenture Act. 
 Section 5.03 Reports by the Company. 

(a) The Company will at all times comply with Section 314(a) of the Trust Indenture Act. The Company covenants and agrees to provide (which
delivery may be via electronic mail) to the Trustee within 30 days, after the Company files the same with the Commission, copies of the annual reports and of the information, documents and other reports (or copies of such portions of any of the
foregoing as the Commission may from time to time by rules and regulations prescribe) that the Company is required to file with the Commission pursuant to Section 13 or Section 15(d) of the Exchange Act; provided, however, the Company
shall not be required to deliver to the Trustee any correspondence filed with the Commission or any materials for which the Company has sought and received confidential treatment by the Commission; and provided further, that so long as such filings
by the Company are available on the Commission’s Electronic Data Gathering, Analysis and Retrieval System (EDGAR), or any successor system, such filings shall be deemed to have been filed with the Trustee for purposes hereof without any further
action required by the Company. For the avoidance of doubt, a failure by the Company to file annual reports, information and other reports with the SEC within the time period prescribed thereof by the Commission shall not be deemed a breach of this
Section 5.03. 
 (b) Delivery of reports, information and documents to the Trustee under Section 5.03 is for informational purposes only
and the information and the Trustee’s receipt of the foregoing shall not constitute constructive notice of any information contained therein, or determinable from information contained therein including the Company’s compliance with any of
their covenants thereunder (as to which the Trustee is entitled to rely exclusively on an Officer’s Certificate). The Trustee is under no duty to examine any such reports, information or documents delivered to the Trustee or filed with the SEC
via EDGAR to ensure compliance with the provision of this Indenture or to ascertain the correctness or otherwise of the information or the statements contained therein. The Trustee shall have no responsibility or duty whatsoever to ascertain or
determine whether the above referenced filings with the SEC on EDGAR (or any successor system) has occurred. 
 Section 5.04 Reports by the Trustee.

 (a) If required by Section 313(a) of the Trust Indenture Act, the Trustee, within sixty (60) days after each May 1, shall
transmit by mail, first class postage prepaid, to the Securityholders, as their names and addresses appear upon the Security Register, a brief report dated as of such May 1, which complies with Section 313(a) of the Trust Indenture Act.

 (b) The Trustee shall comply with Section 313(b) and 313(c) of the Trust Indenture Act. 

  
 21 

 (c) A copy of each such report shall, at the time of such transmission to Securityholders, be filed by the
Trustee with the Company, with each securities exchange upon which any Securities are listed (if so listed) and also with the Commission. The Company agrees to notify the Trustee when any Securities become listed on any securities exchange. 

ARTICLE 6 
 REMEDIES OF
THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT 
 Section 6.01 Events of Default. 

(a) Whenever used herein with respect to Securities of a particular series, “Event of Default” means any one or more of the following events
that has occurred and is continuing: 
 (1) the Company defaults in the payment of any installment of interest upon any of the Securities of that
series, as and when the same shall become due and payable, and such default continues for a period of 90 days; provided, however, that a valid extension of an interest payment period by the Company in accordance with the terms of any indenture
supplemental hereto shall not constitute a default in the payment of interest for this purpose; 
 (2) the Company defaults in the payment of the
principal of (or premium, if any, on) any of the Securities of that series as and when the same shall become due and payable whether at maturity, upon redemption, by declaration or otherwise, or in any payment required by any sinking or analogous
fund established with respect to that series; provided, however, that a valid extension of the maturity of such Securities in accordance with the terms of any indenture supplemental hereto shall not constitute a default in the payment of principal
or premium, if any; 
 (3) the Company fails to observe or perform any other of its covenants or agreements with respect to that series contained in
this Indenture or otherwise established with respect to that series of Securities pursuant to Section 2.01 hereof (other than a covenant or agreement that has been expressly included in this Indenture solely for the benefit of one or more
series of Securities other than such series) for a period of 90 days after the date on which written notice of such failure, requiring the same to be remedied and stating that such notice is a “Notice of Default” hereunder, shall have been
given to the Company by the Trustee, by registered or certified mail, or to the Company and the Trustee by the holders of at least 25% in principal amount of the Securities of that series at the time Outstanding; 

(4) the Company pursuant to or within the meaning of any Bankruptcy Law (i) commences a voluntary case, (ii) consents to the entry of an
order for relief against it in an involuntary case, (iii) consents to the appointment of a Custodian of it or for all or substantially all of its property or (iv) makes a general assignment for the benefit of its creditors; or 

  
 22 

 (5) a court of competent jurisdiction enters an order under any Bankruptcy Law that (i) is for relief
against the Company in an involuntary case, (ii) appoints a Custodian of the Company for all or substantially all of its property or (iii) orders the liquidation of the Company, and the order or decree remains unstayed and in effect for 90
days. 
 (b) In each and every such case (other than an Event of Default specified in clause (4) or clause (5) above), unless the principal
of all the Securities of that series shall have already become due and payable, either the Trustee or the holders of not less than 25% in aggregate principal amount of the Securities of that series then Outstanding hereunder, by notice in writing to
the Company (and to the Trustee if given by such Securityholders), may declare the principal of (and premium, if any, on) and accrued and unpaid interest on all the Securities of that series to be due and payable immediately, and upon any such
declaration the same shall become and shall be immediately due and payable. If an Event of Default specified in clause (4) or clause (5) above occurs, the principal of and accrued and unpaid interest on all the Securities of that series
shall automatically be immediately due and payable without any declaration or other act on the part of the Trustee or the holders of the Securities. 

(c) At any time after the principal of (and premium, if any, on) and accrued and unpaid interest on the Securities of that series shall have been so
declared due and payable, and before any judgment or decree for the payment of the moneys due shall have been obtained or entered as hereinafter provided, the holders of a majority in aggregate principal amount of the Securities of that series then
Outstanding hereunder, by written notice to the Company and the Trustee, may rescind and annul such declaration and its consequences if: (i) the Company has paid or deposited with the Trustee a sum sufficient to pay all matured installments of
interest upon all the Securities of that series and the principal of (and premium, if any, on) any and all Securities of that series that shall have become due otherwise than by acceleration (with interest upon such principal and premium, if any,
and, to the extent that such payment is enforceable under applicable law, upon overdue installments of interest, at the rate per annum expressed in the Securities of that series to the date of such payment or deposit) and the amount payable to the
Trustee under Section 7.06, and (ii) any and all Events of Default under the Indenture with respect to such series, other than the nonpayment of principal on (and premium, if any, on) and accrued and unpaid interest on Securities of that
series that shall not have become due by their terms, shall have been remedied or waived as provided in Section 6.06. 
 No such rescission and
annulment shall extend to or shall affect any subsequent default or impair any right consequent thereon. 
 (d) In case the Trustee shall have
proceeded to enforce any right with respect to Securities of that series under this Indenture and such proceedings shall have been discontinued or abandoned because of such rescission or annulment or for any other reason or shall have been
determined adversely to the Trustee, then and in every such case, subject to any determination in such proceedings, the Company and the Trustee shall be restored respectively to their former positions and rights hereunder, and all rights, remedies
and powers of the Company and the Trustee shall continue as though no such proceedings had been taken. 

  
 23 

 Section 6.02 Collection of Indebtedness and Suits for Enforcement by Trustee. 

(a) The Company covenants that (i) in case it shall default in the payment of any installment of interest on any of the Securities of a series, or
in any payment required by any sinking or analogous fund established with respect to that series as and when the same shall have become due and payable, and such default shall have continued for a period of 90 days, or (ii) in case it shall
default in the payment of the principal of (or premium, if any, on) any of the Securities of a series when the same shall have become due and payable, whether upon maturity of the Securities of a series or upon redemption or upon declaration or
otherwise then, upon demand of the Trustee, the Company will pay to the Trustee, for the benefit of the holders of the Securities of that series, the whole amount that then shall have been become due and payable on all such Securities for principal
(and premium, if any) or interest, or both, as the case may be, with interest upon the overdue principal (and premium, if any) and (to the extent that payment of such interest is enforceable under applicable law) upon overdue installments of
interest at the rate per annum expressed in the Securities of that series; and, in addition thereto, such further amount as shall be sufficient to cover the costs and expenses of collection, and the amount payable to the Trustee under
Section 7.06. 
 (b) If the Company shall fail to pay such amounts forthwith upon such demand, the Trustee, in its own name and as trustee of an
express trust, shall be entitled and empowered to institute any action or proceedings at law or in equity for the collection of the sums so due and unpaid, and may prosecute any such action or proceeding to judgment or final decree, and may enforce
any such judgment or final decree against the Company or other obligor upon the Securities of that series and collect the moneys adjudged or decreed to be payable in the manner provided by law or equity out of the property of the Company or other
obligor upon the Securities of that series, wherever situated. 
 (c) In case of any receivership, insolvency, liquidation, bankruptcy,
reorganization, readjustment, arrangement, composition or judicial proceedings affecting the Company, or its creditors or property, the Trustee shall have power to intervene in such proceedings and take any action therein that may be permitted by
the court and shall (except as may be otherwise provided by law) be entitled to file such proofs of claim and other papers and documents as may be necessary or advisable in order to have the claims of the Trustee and of the holders of Securities of
such series allowed for the entire amount due and payable by the Company under the Indenture at the date of institution of such proceedings and for any additional amount that may become due and payable by the Company after such date, and to collect
and receive any moneys or other property payable or deliverable on any such claim, and to distribute the same after the deduction of the amount payable to the Trustee under Section 7.06; and any receiver, assignee or trustee in bankruptcy or
reorganization is hereby authorized by each of the holders of Securities of such series to make such payments to the Trustee, and, in the event that the Trustee shall consent to the making of such payments directly to such Securityholders, to pay to
the Trustee any amount due it under Section 7.06. 
 (d) All rights of action and of asserting claims under this Indenture, or under any of the
terms established with respect to Securities of that series, may be enforced by the Trustee without the possession of any of such Securities, or the production thereof at any trial or 

  
 24 

 
other proceeding relative thereto, and any such suit or proceeding instituted by the Trustee shall be brought in its own name as trustee of an express trust, and any recovery of judgment shall,
after provision for payment to the Trustee of any amounts due under Section 7.06, be for the ratable benefit of the holders of the Securities of such series. 

In case of an Event of Default hereunder, the Trustee may in its discretion proceed to protect and enforce the rights vested in it by this Indenture by such
appropriate judicial proceedings as the Trustee shall deem most effectual to protect and enforce any of such rights, either at law or in equity or in bankruptcy or otherwise, whether for the specific enforcement of any covenant or agreement
contained in the Indenture or in aid of the exercise of any power granted in this Indenture, or to enforce any other legal or equitable right vested in the Trustee by this Indenture or by law. 

Nothing contained herein shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Securityholder any plan of
reorganization, arrangement, adjustment or composition affecting the Securities of that series or the rights of any holder thereof or to authorize the Trustee to vote in respect of the claim of any Securityholder in any such proceeding. 

Section 6.03 Application of Moneys Collected. 
 Any
moneys collected by the Trustee pursuant to this Article with respect to a particular series of Securities shall be applied in the following order, at the date or dates fixed by the Trustee and, in case of the distribution of such moneys on account
of principal (or premium, if any) or interest, upon presentation of the Securities of that series, and notation thereon of the payment, if only partially paid, and upon surrender thereof if fully paid: 

FIRST: To the payment of costs and expenses of collection and of all amounts payable to the Trustee under Section 7.06; 

SECOND: To the payment of the amounts then due and unpaid upon Securities of such series for principal (and premium, if any) and interest, in respect of which
or for the benefit of which such money has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable on such Securities for principal (and premium, if any) and interest, respectively; and 

THIRD: To the payment of the remainder, if any, to the Company or any other Person lawfully entitled thereto. 

Section 6.04 Limitation on Suits. 
 No holder of any
Security of any series shall have any right by virtue or by availing of any provision of this Indenture to institute any suit, action or proceeding in equity or at law upon or under or with respect to this Indenture or for the appointment of a
receiver or trustee, or for any other remedy hereunder, unless (i) such holder previously shall have given to the Trustee written notice of an Event of Default and of the continuance thereof with respect to the Securities of such series
specifying such Event of Default, as hereinbefore provided; (ii) the holders of not 

  
 25 

 
less than 25% in aggregate principal amount of the Securities of such series then Outstanding shall have made written request upon the Trustee to institute such action, suit or proceeding in its
own name as Trustee hereunder; (iii) such holder or holders shall have offered to the Trustee indemnity satisfactory to it against the costs, expenses and liabilities to be incurred in compliance with such request; (iv) the Trustee for 90
days after its receipt of such notice, request and offer of indemnity, shall have failed to institute any such action, suit or proceeding and (v) during such 90 day period, the holders of a majority in principal amount of the Securities of that
series do not give the Trustee a direction inconsistent with the request. 
 Notwithstanding anything contained herein to the contrary or any other
provisions of this Indenture, the right of any holder of any Security to receive payment of the principal of (and premium, if any) and interest on such Security, as therein provided, on or after the respective due dates expressed in such Security
(or in the case of redemption, on the redemption date), or to institute suit for the enforcement of any such payment on or after such respective dates or redemption date, shall not be impaired or affected without the consent of such holder and by
accepting a Security hereunder it is expressly understood, intended and covenanted by the taker and holder of every Security of such series with every other such taker and holder and the Trustee, that no one or more holders of Securities of such
series shall have any right in any manner whatsoever by virtue or by availing of any provision of this Indenture to affect, disturb or prejudice the rights of the holders of any other of such Securities, or to obtain or seek to obtain priority over
or preference to any other such holder, or to enforce any right under this Indenture, except in the manner herein provided and for the equal, ratable and common benefit of all holders of Securities of such series. For the protection and enforcement
of the provisions of this Section, each and every Securityholder and the Trustee shall be entitled to such relief as can be given either at law or in equity. 

Section 6.05 Rights and Remedies Cumulative; Delay or Omission Not Waiver. 

(a) Except as otherwise provided in Section 2.07, all powers and remedies given by this Article to the Trustee or to the Securityholders shall, to
the extent permitted by law, be deemed cumulative and not exclusive of any other powers and remedies available to the Trustee or the holders of the Securities, by judicial proceedings or otherwise, to enforce the performance or observance of the
covenants and agreements contained in this Indenture or otherwise established with respect to such Securities. 
 (b) No delay or omission of the
Trustee or of any holder of any of the Securities to exercise any right or power accruing upon any Event of Default occurring and continuing as aforesaid shall impair any such right or power, or shall be construed to be a waiver of any such default
or an acquiescence therein; and, subject to the provisions of Section 6.04, every power and remedy given by this Article or by law to the Trustee or the Securityholders may be exercised from time to time, and as often as shall be deemed
expedient, by the Trustee or by the Securityholders. 
 Section 6.06 Control by Securityholders. 

The holders of a majority in aggregate principal amount of the Securities of any series at the time Outstanding, determined in accordance with
Section 8.04, shall have the right to direct 

  
 26 

 
the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee with respect to such series; provided,
however, that such direction shall not be in conflict with any rule of law or with this Indenture or subject the Trustee in its sole discretion to personal liability. Subject to the provisions of Section 7.01, the Trustee shall have the right
to decline to follow any such direction if the Trustee in good faith shall, by a Responsible Officer or officers of the Trustee, determine that the proceeding so directed, subject to the Trustee’s duties under the Trust Indenture Act, would
involve the Trustee in personal liability or might be unduly prejudicial to the Securityholders not involved in the proceeding. The holders of a majority in aggregate principal amount of the Securities of any series at the time Outstanding affected
thereby, determined in accordance with Section 8.04, may on behalf of the holders of all of the Securities of such series waive any past default in the performance of any of the covenants contained herein or established pursuant to
Section 2.01 with respect to such series and its consequences, except a default in the payment of the principal of, or premium, if any, or interest on, any of the Securities of that series as and when the same shall become due by the terms of
such Securities otherwise than by acceleration (unless such default has been cured and a sum sufficient to pay all matured installments of interest and principal and any premium has been deposited with the Trustee (in accordance with
Section 6.01(c)). Upon any such waiver, the default covered thereby shall be deemed to be cured for all purposes of this Indenture and the Company, the Trustee and the holders of the Securities of such series shall be restored to their former
positions and rights hereunder, respectively; but no such waiver shall extend to any subsequent or other default or impair any right consequent thereon. 

Section 6.07 Undertaking to Pay Costs. 
 All parties
to this Indenture agree, and each holder of any Securities by such holder’s acceptance thereof shall be deemed to have agreed, that any court may in its discretion require, in any suit for the enforcement of any right or remedy under this
Indenture, or in any suit against the Trustee for any action taken or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such suit, and that such court may in its discretion assess
reasonable costs, including reasonable attorneys’ fees and expenses, against any party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; but the provisions of this
Section shall not apply to any suit instituted by the Trustee, to any suit instituted by any Securityholder, or group of Securityholders, holding more than 10% in aggregate principal amount of the Outstanding Securities of any series, or to any suit
instituted by any Securityholder for the enforcement of the payment of the principal of (or premium, if any) or interest on any Security of such series, on or after the respective due dates expressed in such Security or established pursuant to this
Indenture. 

  
 27 

 ARTICLE 7 

CONCERNING THE TRUSTEE 

Section 7.01 Certain Duties and Responsibilities of Trustee. 

(a) The Trustee, prior to the occurrence of an Event of Default with respect to the Securities of a series and after the curing of all Events of Default
with respect to the Securities of that series that may have occurred, shall undertake to perform with respect to the Securities of such series such duties and only such duties as are specifically set forth in this Indenture, and no implied covenants
shall be read into this Indenture against the Trustee. In case an Event of Default with respect to the Securities of a series has occurred (that has not been cured or waived), the Trustee shall exercise with respect to Securities of that series such
of the rights and powers vested in it by this Indenture, and use the same degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances in the conduct of his or her own affairs. 

(b) No provision of this Indenture shall be construed to relieve the Trustee from liability for its own negligent action, its own negligent failure to
act, or its own willful misconduct, except that: 
 (i) prior to the occurrence of an Event of Default with respect to the Securities of a series and
after the curing or waiving of all such Events of Default with respect to that series that may have occurred: 
 (A) the duties and obligations of
the Trustee shall with respect to the Securities of such series be determined solely by the express provisions of this Indenture, and the Trustee shall not be liable with respect to the Securities of such series except for the performance of such
duties and obligations as are specifically set forth in this Indenture, and no implied covenants or obligations shall be read into this Indenture against the Trustee; and 

(B) in the absence of bad faith on the part of the Trustee, the Trustee may with respect to the Securities of such series conclusively rely, as to the
truth of the statements and the correctness of the opinions expressed therein, upon any certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture; but in the case of any such certificates or opinions that
by any provision hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirements of this Indenture; 

(ii) the Trustee shall not be liable to any Securityholder or to any other Person for any error of judgment made in good faith by a Responsible Officer
or Responsible Officers of the Trustee, unless it shall be proved that the Trustee was negligent in ascertaining the pertinent facts; 
 (iii) the
Trustee shall not be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction of the holders of not less than a majority in principal amount of the Securities of any series at the time
Outstanding relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee under this Indenture with respect to the Securities of that series;

  
 28 

 (iv) none of the provisions contained in this Indenture shall require the Trustee to expend or risk its
own funds or otherwise incur personal financial liability in the performance of any of its duties or in the exercise of any of its rights or powers if there is reasonable ground for believing that the repayment of such funds or liability is not
reasonably assured to it under the terms of this Indenture or adequate indemnity against such risk is not reasonably assured to it; 
 (v) The
Trustee shall not be required to give any bond or surety in respect of the performance of its powers or duties hereunder; 
 (vi) The permissive
right of the Trustee to do things enumerated in this Indenture shall not be construed as a duty of the Trustee; and 
 (vii) No Trustee shall have
any duty or responsibility for any act or omission of any other Trustee appointed with respect to a series of Securities hereunder. 
 Section 7.02
Certain Rights of Trustee. 
 Except as otherwise provided in Section 7.01: 

(a) The Trustee may conclusively rely and shall be protected in acting or refraining from acting upon any resolution, certificate, statement,
instrument, opinion, report, notice, request, consent, order, approval, bond, security or other paper or document believed by it to be genuine and to have been signed or presented by the proper party or parties; 

(b) Any request, direction, order or demand of the Company mentioned herein shall be sufficiently evidenced by a Board Resolution or an instrument
signed in the name of the Company by any authorized officer of the Company (unless other evidence in respect thereof is specifically prescribed herein); 

(c) The Trustee may consult with counsel and the opinion or written advice of such counsel or, if requested, any Opinion of Counsel shall be full and
complete authorization and protection in respect of any action taken or suffered or omitted hereunder in good faith and in reliance thereon; 
 (d)
The Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request, order or direction of any of the Securityholders pursuant to the provisions of this Indenture, unless such
Securityholders shall have offered to the Trustee security or indemnity reasonably acceptable to the Trustee against the costs, expenses and liabilities that may be incurred therein or thereby; nothing contained herein shall, however, relieve the
Trustee of the obligation, upon the occurrence of an Event of Default with respect to a series of the Securities (that has not been cured or waived), to exercise with respect to Securities of that series such of the rights and powers vested in it by
this Indenture, and to use the same degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances in the conduct of his or her own affairs; 

  
 29 

 (e) The Trustee shall not be liable for any action taken or omitted to be taken by it in good faith and
believed by it to be authorized or within the discretion or rights or powers conferred upon it by this Indenture; 
 (f) The Trustee shall not be
bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, consent, order, approval, bond, security, or other papers or documents or inquire as to the
performance by the Company of one of its covenants under this Indenture, unless requested in writing so to do by the holders of not less than a majority in principal amount of the Outstanding Securities of the particular series affected thereby
(determined as provided in Section 8.04); provided, however, that if the payment within a reasonable time to the Trustee of the costs, expenses or liabilities likely to be incurred by it in the making of such investigation is, in the opinion of
the Trustee, not reasonably assured to the Trustee by the security afforded to it by the terms of this Indenture, the Trustee may require security or indemnity reasonably acceptable to the Trustee against such costs, expenses or liabilities as a
condition to so proceeding. The reasonable expense of every such examination shall be paid by the Company or, if paid by the Trustee, shall be repaid by the Company upon demand; 

(g) The Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents or attorneys
and the Trustee shall not be responsible for any misconduct or negligence on the part of any agent or attorney appointed with due care by it hereunder; 

(h) In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or
caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and
interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services; it being understood that the Trustee shall use reasonable efforts which are consistent with accepted practices in the banking industry to
resume performance as soon as practicable under the circumstances; 
 (i) In no event shall the Trustee be responsible or liable for special,
indirect, punitive or consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit) irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of
action; and 
 (j) The Trustee agrees to accept and act upon instructions or directions pursuant to this Indenture sent by unsecured e-mail,
facsimile transmission or other similar unsecured electronic methods; provided, however, that (a) the party providing such written instructions, subsequent to such transmission of written instructions, shall provide the originally executed
instructions or directions to the Trustee in a timely manner, and (b) such originally executed instructions or directions shall be signed by an authorized representative of the party providing such instructions or directions. If the party
elects to give the Trustee e-mail or 

  
 30 

 facsimile instructions (or instructions by a similar electronic method) and the Trustee in its discretion elects
to act upon such instructions, the Trustee’s understanding of such instructions shall be deemed controlling. The Trustee shall not be liable for any losses, costs or expenses arising directly or indirectly from the Trustee’s reliance upon
and compliance with such instructions notwithstanding such instructions conflict or are inconsistent with a subsequent written instruction. The party providing electronic instructions agrees to assume all risks arising out of the use of such
electronic methods to submit instructions and directions to the Trustee, including without limitation the risk of the Trustee acting on unauthorized instructions, and the risk or interception and misuse by third parties. The Trustee may request that
the Company deliver an Officer’s Certificate setting forth the names of individuals and/or titles of officers authorized at such time to furnish the Trustee with Officer’s Certificates, Company Orders and any other matters or directions
pursuant to this Indenture. 
 (k) The rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation,
its right to be indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder. 
 (l) The Trustee shall
not be deemed to have knowledge of any Default or Event of Default (other than an Event of Default relating to the failure to pay the interest on, or the principal of, the Securities) until the Trustee shall have received written notification in the
manner set forth in this Indenture or a Responsible Officer of the Trustee shall have obtained actual knowledge. 
 Section 7.03 Trustee Not
Responsible for Recitals or Issuance or Securities. 
 (a) The recitals contained herein and in the Securities shall be taken as the statements of
the Company, and the Trustee assumes no responsibility for the correctness of the same. The Trustee shall not be responsible for any statement in any registration statement, prospectus, or any other document in connection with the sale of
Securities. The Trustee shall not be responsible for any rating on the Securities or any action or omission of any rating agency. 
 (b) The Trustee
makes no representations as to the validity or sufficiency of this Indenture or of the Securities. 
 (c) The Trustee shall not be accountable for
the use or application by the Company of any of the Securities or of the proceeds of such Securities, or for the use or application of any moneys paid over by the Trustee in accordance with any provision of this Indenture or established pursuant to
Section 2.01, or for the use or application of any moneys received by any paying agent other than the Trustee. 
 Section 7.04 May Hold
Securities. 
 The Trustee or any paying agent or Security Registrar, in its individual or any other capacity, may become the owner or pledgee of
Securities with the same rights it would have if it were not Trustee, paying agent or Security Registrar. 

  
 31 

 Section 7.05 Moneys Held in Trust. 

Subject to the provisions of Section 11.05, all moneys received by the Trustee shall, until used or applied as herein provided, be held in trust for the
purposes for which they were received, but need not be segregated from other funds except to the extent required by law. The Trustee shall be under no liability for interest on any moneys received by it hereunder except such as it may agree with the
Company to pay thereon. 
 Section 7.06 Compensation and Reimbursement. 

(a) The Company shall pay to the Trustee for each of its capacities hereunder from time to time compensation for its services as the Company and the
Trustee shall from time to time agree upon in writing. The Trustee’s compensation shall not be limited by any law on compensation of a trustee of an express trust. The Company shall reimburse the Trustee upon request for all reasonable
out-of-pocket expenses incurred by it. Such expenses shall include the reasonable compensation and expenses of the Trustee’s agents and counsel. 

(b) The Company shall indemnify each of the Trustee in each of its capacities hereunder against any loss, liability or expense (including the cost of
defending itself and including the reasonable compensation and expenses of the Trustee’s agents and counsel) incurred by it except as set forth in Section 7.06(c) in the exercise or performance of its powers, rights or duties under this
Indenture as Trustee or Agent. The Trustee shall notify the Company promptly of any claim for which it may seek indemnity. The Company shall defend the claim and the Trustee shall cooperate in the defense. The Trustee may have one separate counsel
and the Company shall pay the reasonable fees and expenses of such counsel. The Company need not pay for any settlement made without its consent, which consent shall not be unreasonably withheld. This indemnification shall apply to officers,
directors, employees, shareholders and agents of the Trustee. 
 (c) The Company need not reimburse any expense or indemnify against any loss or
liability incurred by the Trustee or by any officer, director, employee, shareholder or agent of the Trustee through negligence or bad faith. 
 (d)
To ensure the Company’s payment obligations in this Section, the Trustee shall have a lien prior to the Securities on all funds or property held or collected by the Trustee, except that held in trust to pay principal of or interest on
particular Securities. When the Trustee incurs expenses or renders services in connection with an Event of Default specified in Section 6.01(4) or (5), the expenses (including the reasonable fees and expenses of its counsel) and the
compensation for services in connection therewith are to constitute expenses of administration under any bankruptcy law. The provisions of this Section 7.06 shall survive the termination of this Indenture and the resignation or removal of the
Trustee. 

  
 32 

 Section 7.07 Reliance on Officer’s Certificate. 

Except as otherwise provided in Section 7.01, whenever in the administration of the provisions of this Indenture the Trustee shall deem it reasonably
necessary or desirable that a matter be proved or established prior to taking or suffering or omitting to take any action hereunder, such matter (unless other evidence in respect thereof be herein specifically prescribed) may, in the absence of
negligence or bad faith on the part of the Trustee, be deemed to be conclusively proved and established by an Officer’s Certificate delivered to the Trustee and such certificate, in the absence of negligence or bad faith on the part of the
Trustee, shall be full warrant to the Trustee for any action taken, suffered or omitted to be taken by it under the provisions of this Indenture upon the faith thereof. 

Section 7.08 Disqualification; Conflicting Interests. 

If the Trustee has or shall acquire any “conflicting interest” within the meaning of Section 310(b) of the Trust Indenture Act, the Trustee and
the Company shall in all respects comply with the provisions of Section 310(b) of the Trust Indenture Act. 
 Section 7.09 Corporate Trustee
Required; Eligibility. 
 There shall at all times be a Trustee with respect to the Securities issued hereunder which shall at all times be a corporation
organized and doing business under the laws of the United States of America or any state or territory thereof or of the District of Columbia, or a corporation or other Person permitted to act as trustee by the Commission, authorized under such laws
to exercise corporate trust powers, having a combined capital and surplus of at least fifty million U.S. dollars ($50,000,000), and subject to supervision or examination by federal, state, territorial, or District of Columbia authority. 

If such corporation or other Person publishes reports of condition at least annually, pursuant to law or to the requirements of the aforesaid supervising or
examining authority, then for the purposes of this Section, the combined capital and surplus of such corporation or other Person shall be deemed to be its combined capital and surplus as set forth in its most recent report of condition so published.
The Company may not, nor may any Person directly or indirectly controlling, controlled by, or under common control with the Company, serve as Trustee. In case at any time the Trustee shall cease to be eligible in accordance with the provisions of
this Section, the Trustee shall resign immediately in the manner and with the effect specified in Section 7.10. 
 Section 7.10 Resignation and
Removal; Appointment of Successor. 
 (a) The Trustee or any successor hereafter appointed may at any time resign with respect to the Securities
of one or more series by giving written notice thereof to the Company and by transmitting notice of resignation by mail, first class postage prepaid, to the Securityholders of such series, as their names and addresses appear upon the Security
Register. Upon receiving such notice of resignation, the Company shall promptly appoint a successor trustee with respect to Securities of such series by written instrument, in duplicate, executed by order of the Board of Directors, one copy of which
instrument shall be delivered to the resigning Trustee and one copy to the successor trustee. If no successor trustee shall have been so appointed and have accepted appointment within 30 days after the mailing of such notice of resignation, the
resigning Trustee may petition any court of competent jurisdiction for the appointment of a successor trustee with respect to Securities of such series, or any Securityholder of that series who has been a bona fide holder of a Security or Securities
for at least six months may on behalf of himself and all others similarly situated, petition any such court for the appointment of a successor trustee. Such court may thereupon after such notice, if any, as it may deem proper and prescribe, appoint
a successor trustee. 

  
 33 

 (b) In case at any time any one of the following shall occur: 

(i) the Trustee shall fail to comply with the provisions of Section 7.08 after written request therefor by the Company or by any Securityholder
who has been a bona fide holder of a Security or Securities for at least six months; or 
 (ii) the Trustee shall cease to be eligible in accordance
with the provisions of Section 7.09 and shall fail to resign after written request therefor by the Company or by any such Securityholder; or 

(iii) the Trustee shall become incapable of acting, or shall be adjudged a bankrupt or insolvent, or commence a voluntary bankruptcy proceeding, or a
receiver of the Trustee or of its property shall be appointed or consented to, or any public officer shall take charge or control of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation; 

then, in any such case, the Company may remove the Trustee with respect to all Securities and appoint a successor trustee by written instrument, in duplicate,
executed by order of the Board of Directors, one copy of which instrument shall be delivered to the Trustee so removed and one copy to the successor trustee, or any Securityholder who has been a bona fide holder of a Security or Securities for at
least six months may, on behalf of that holder and all others similarly situated, petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor trustee. Such court may thereupon after such notice, if
any, as it may deem proper and prescribe, remove the Trustee and appoint a successor trustee. 
 (c) The holders of a majority in aggregate principal
amount of the Securities of any series at the time Outstanding may at any time remove the Trustee with respect to such series by so notifying the Trustee and the Company and may appoint a successor Trustee for such series with the consent of the
Company. 
 (d) Any resignation or removal of the Trustee and appointment of a successor trustee with respect to the Securities of a series pursuant
to any of the provisions of this Section shall become effective upon acceptance of appointment by the successor trustee as provided in Section 7.11. 

(e) Any successor trustee appointed pursuant to this Section may be appointed with respect to the Securities of one or more series or all of such
series, and at any time there shall be only one Trustee with respect to the Securities of any particular series. 

  
 34 

 Section 7.11 Acceptance of Appointment By Successor. 

(a) In case of the appointment hereunder of a successor trustee with respect to all Securities, every such successor trustee so appointed shall execute,
acknowledge and deliver to the Company and to the retiring Trustee an instrument accepting such appointment, and thereupon the resignation or removal of the retiring Trustee shall become effective and such successor trustee, without any further act,
deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Trustee; but, on the request of the Company or the successor trustee, such retiring Trustee shall, upon payment of its charges, execute and
deliver an instrument transferring to such successor trustee all the rights, powers, and trusts of the retiring Trustee and shall duly assign, transfer and deliver to such successor trustee all property and money held by such retiring Trustee
hereunder. 
 (b) In case of the appointment hereunder of a successor trustee with respect to the Securities of one or more (but not all) series, the
Company, the retiring Trustee and each successor trustee with respect to the Securities of one or more series shall execute and deliver an indenture supplemental hereto wherein each successor trustee shall accept such appointment and which
(i) shall contain such provisions as shall be necessary or desirable to transfer and confirm to, and to vest in, each successor trustee all the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or
those series to which the appointment of such successor trustee relates, (ii) shall contain such provisions as shall be deemed necessary or desirable to confirm that all the rights, powers, trusts and duties of the retiring Trustee with respect
to the Securities of that or those series as to which the retiring Trustee is not retiring shall continue to be vested in the retiring Trustee, and (iii) shall add to or change any of the provisions of this Indenture as shall be necessary to
provide for or facilitate the administration of the trusts hereunder by more than one Trustee, it being understood that nothing herein or in such supplemental indenture shall constitute such Trustees co-trustees of the same trust, that each such
Trustee shall be trustee of a trust or trusts hereunder separate and apart from any trust or trusts hereunder administered by any other such Trustee and that no Trustee shall be responsible for any act or failure to act on the part of any other
Trustee hereunder; and upon the execution and delivery of such supplemental indenture the resignation or removal of the retiring Trustee shall become effective to the extent provided therein, such retiring Trustee shall with respect to the
Securities of that or those series to which the appointment of such successor trustee relates have no further responsibility for the exercise of rights and powers or for the performance of the duties and obligations vested in the Trustee under this
Indenture, and each such successor trustee, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or those series to which the
appointment of such successor trustee relates; but, on request of the Company or any successor trustee, such retiring Trustee shall duly assign, transfer and deliver to such successor trustee, to the extent contemplated by such supplemental
indenture, the property and money held by such retiring Trustee hereunder with respect to the Securities of that or those series to which the appointment of such successor trustee relates. 

(c) Upon request of any such successor trustee, the Company shall execute any and all instruments for more fully and certainly vesting in and
confirming to such successor trustee all such rights, powers and trusts referred to in paragraph (a) or (b) of this Section, as the case may be. 

(d) No successor trustee shall accept its appointment unless at the time of such acceptance such successor trustee shall be qualified and eligible
under this Article. 

  
 35 

 (e) Upon acceptance of appointment by a successor trustee as provided in this Section, the Company shall
transmit notice of the succession of such trustee hereunder by mail, first class postage prepaid, to the Securityholders, as their names and addresses appear upon the Security Register. If the Company fails to transmit such notice within ten days
after acceptance of appointment by the successor trustee, the successor trustee shall cause such notice to be transmitted at the expense of the Company. 

Section 7.12 Merger, Conversion, Consolidation or Succession to Business. 

Any corporation into which the Trustee may be merged or converted or with which it may be consolidated, or any corporation resulting from any merger,
conversion or consolidation to which the Trustee shall be a party, or any corporation succeeding to all or substantially all the corporate trust business of the Trustee, including the administration of the trust created by this Indenture, shall be
the successor of the Trustee hereunder, provided that such corporation shall be qualified under the provisions of Section 7.08 and eligible under the provisions of Section 7.09, without the execution or filing of any paper or any further
act on the part of any of the parties hereto, anything herein to the contrary notwithstanding. In case any Securities shall have been authenticated, but not delivered, by the Trustee then in office, any successor by merger, conversion or
consolidation to such authenticating Trustee may adopt such authentication and deliver the Securities so authenticated with the same effect as if such successor Trustee had itself authenticated such Securities. 

Section 7.13 Preferential Collection of Claims Against the Company. 

The Trustee shall comply with Section 311(a) of the Trust Indenture Act, excluding any creditor relationship described in Section 311(b) of the Trust
Indenture Act. A Trustee who has resigned or been removed shall be subject to Section 311(a) of the Trust Indenture Act to the extent included therein. 

Section 7.14 Notice of Default. 
 If any Event of
Default occurs and is continuing and if such Event of Default is known to a Responsible Officer of the Trustee, the Trustee shall mail to each Securityholder in the manner and to the extent provided in Section 313(c) of the Trust Indenture Act
notice of the Event of Default within the earlier of 90 days after it occurs and 30 days after it is known to a Responsible Officer of the Trustee or written notice of it is received by the Trustee, unless such Event of Default has been cured;
provided, however, that, except in the case of a default in the payment of the principal of (or premium, if any) or interest on any Security, the Trustee shall be protected in withholding such notice if and so long as the Responsible Officers
of the Trustee in good faith determine that the withholding of such notice is in the interest of the Securityholders. 

  
 36 

 ARTICLE 8 

CONCERNING THE SECURITYHOLDERS 

Section 8.01 Evidence of Action by Securityholders. 

Whenever in this Indenture it is provided that the holders of a majority or specified percentage in aggregate principal amount of the Securities of a
particular series may take any action (including the making of any demand or request, the giving of any notice, consent or waiver or the taking of any other action), the fact that at the time of taking any such action the holders of such majority or
specified percentage of that series have joined therein may be evidenced by any instrument or any number of instruments of similar tenor executed by such holders of Securities of that series in person or by agent or proxy appointed in writing. 

If the Company shall solicit from the Securityholders of any series any request, demand, authorization, direction, notice, consent, waiver or other action,
the Company may, at its option, as evidenced by an Officer’s Certificate, fix in advance a record date for such series for the determination of Securityholders entitled to give such request, demand, authorization, direction, notice, consent,
waiver or other action, but the Company shall have no obligation to do so. If such a record date is fixed, such request, demand, authorization, direction, notice, consent, waiver or other action may be given before or after the record date, but only
the Securityholders of record at the close of business on the record date shall be deemed to be Securityholders for the purposes of determining whether Securityholders of the requisite proportion of Outstanding Securities of that series have
authorized or agreed or consented to such request, demand, authorization, direction, notice, consent, waiver or other action, and for that purpose the Outstanding Securities of that series shall be computed as of the record date; provided, however,
that no such authorization, agreement or consent by such Securityholders on the record date shall be deemed effective unless it shall become effective pursuant to the provisions of this Indenture not later than six months after the record date. 

Section 8.02 Proof of Execution by Securityholders. 

Subject to the provisions of Section 7.01, proof of the execution of any instrument by a Securityholder (such proof will not require notarization) or his
or her agent or proxy and proof of the holding by any Person of any of the Securities shall be sufficient if made in the following manner: 
 (a) The
fact and date of the execution by any such Person of any instrument may be proved in any reasonable manner acceptable to the Trustee. 
 (b) The
ownership of Securities shall be proved by the Security Register of such Securities or by a certificate of the Security Registrar thereof. 
 The Trustee
may require such additional proof of any matter referred to in this Section as it shall deem necessary. 

  
 37 

 Section 8.03 Who May be Deemed Owners. 

Prior to the due presentment for registration of transfer of any Security, the Company, the Trustee, any paying agent and any Security Registrar may deem and
treat the Person in whose name such Security shall be registered upon the books of the Security Registrar as the absolute owner of such Security (whether or not such Security shall be overdue and notwithstanding any notice of ownership or writing
thereon made by anyone other than the Security Registrar) for the purpose of receiving payment of or on account of the principal of, premium, if any, and (subject to Section 2.03) interest on such Security and for all other purposes; and
neither the Company nor the Trustee nor any paying agent nor any Security Registrar shall be affected by any notice to the contrary. 
 Section 8.04
Certain Securities Owned by Company Disregarded. 
 In determining whether the holders of the requisite aggregate principal amount of Securities of a
particular series have concurred in any direction, consent or waiver under this Indenture, the Securities of that series that are owned by the Company or any other obligor on the Securities of that series or by any Person directly or indirectly
controlling or controlled by or under common control with the Company or any other obligor on the Securities of that series shall be disregarded and deemed not to be Outstanding for the purpose of any such determination, except that for the purpose
of determining whether the Trustee shall be protected in relying on any such direction, consent or waiver, only Securities of such series that the Trustee actually knows are so owned shall be so disregarded. The Securities so owned that have been
pledged in good faith may be regarded as Outstanding for the purposes of this Section, if the pledgee shall establish to the satisfaction of the Trustee the pledgee’s right so to act with respect to such Securities and that the pledgee is not a
Person directly or indirectly controlling or controlled by or under direct or indirect common control with the Company or any such other obligor. In case of a dispute as to such right, any decision by the Trustee taken upon the advice of counsel
shall be full protection to the Trustee. 
 Section 8.05 Actions Binding on Future Securityholders. 

At any time prior to (but not after) the evidencing to the Trustee, as provided in Section 8.01, of the taking of any action by the holders of the
majority or percentage in aggregate principal amount of the Securities of a particular series specified in this Indenture in connection with such action, any holder of a Security of that series that is shown by the evidence to be included in the
Securities the holders of which have consented to such action may, by filing written notice with the Trustee, and upon proof of holding as provided in Section 8.02, revoke such action so far as concerns such Security. Except as aforesaid any
such action taken by the holder of any Security shall be conclusive and binding upon such holder and upon all future holders and owners of such Security, and of any Security issued in exchange therefor, on registration of transfer thereof or in
place thereof, irrespective of whether or not any notation in regard thereto is made upon such Security. Any action taken by the holders of the majority or percentage in aggregate principal amount of the Securities of a particular series specified
in this Indenture in connection with such action shall be conclusively binding upon the Company, the Trustee and the holders of all the Securities of that series. 

  
 38 

 ARTICLE 9 

SUPPLEMENTAL INDENTURES 

Section 9.01 Supplemental Indentures Without the Consent of Securityholders. 

In addition to any supplemental indenture otherwise authorized by this Indenture, the Company and the Trustee may from time to time and at any time enter into
an indenture or indentures supplemental hereto (which shall conform to the provisions of the Trust Indenture Act as then in effect), without the consent of the Securityholders, for one or more of the following purposes: 

(a) to cure any ambiguity, defect, or inconsistency herein or in the Securities of any series; 

(b) to comply with Article Ten; 
 (c) to provide
for uncertificated Securities in addition to or in place of certificated Securities; 
 (d) to add to the covenants, restrictions, conditions or
provisions relating to the Company for the benefit of the holders of all or any series of Securities (and if such covenants, restrictions, conditions or provisions are to be for the benefit of less than all series of Securities, stating that such
covenants, restrictions, conditions or provisions are expressly being included solely for the benefit of such series), to make the occurrence, or the occurrence and the continuance, of a default in any such additional covenants, restrictions,
conditions or provisions an Event of Default, or to surrender any right or power herein conferred upon the Company; 
 (e) to add to, delete from, or
revise the conditions, limitations, and restrictions on the authorized amount, terms, or purposes of issue, authentication, and delivery of Securities, as herein set forth; 

(f) to make any change that does not adversely affect the rights of any Securityholder in any material respect; 

(g) to provide for the issuance of and establish the form and terms and conditions of the Securities of any series as provided in Section 2.01, to
establish the form of any certifications required to be furnished pursuant to the terms of this Indenture or any series of Securities, or to add to the rights of the holders of any series of Securities; 

(h) to evidence and provide for the acceptance of appointment hereunder by a successor trustee; or 

(i) to comply with any requirements of the Commission or any successor in connection with the qualification of this Indenture under the Trust Indenture
Act. 

  
 39 

 The Trustee is hereby authorized to join with the Company in the execution of any such supplemental indenture,
and to make any further appropriate agreements and stipulations that may be therein contained, but the Trustee shall not be obligated to enter into any such supplemental indenture that affects the Trustee’s own rights, duties or immunities
under this Indenture or otherwise. 
 Any supplemental indenture authorized by the provisions of this Section may be executed by the Company and the Trustee
without the consent of the holders of any of the Securities at the time Outstanding, notwithstanding any of the provisions of Section 9.02. 

Section 9.02 Supplemental Indentures With Consent of Securityholders. 

With the consent (evidenced as provided in Section 8.01) of the holders of not less than a majority in aggregate principal amount of the Securities of
each series affected by such supplemental indenture or indentures at the time Outstanding, the Company, when authorized by a Board Resolution, and the Trustee may from time to time and at any time enter into an indenture or indentures supplemental
hereto (which shall conform to the provisions of the Trust Indenture Act as then in effect) for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Indenture or of any supplemental indenture
or of modifying in any manner not covered by Section 9.01 the rights of the holders of the Securities of such series under this Indenture; provided, however, that no such supplemental indenture shall, without the consent of the holders of each
Security then Outstanding and affected thereby, (a) extend the fixed maturity of any Securities of any series, or reduce the principal amount thereof, or reduce the rate or extend the time of payment of interest thereon, or reduce any premium
payable upon the redemption thereof or (b) reduce the aforesaid percentage of Securities, the holders of which are required to consent to any such supplemental indenture. 

It shall not be necessary for the consent of the Securityholders of any series affected thereby under this Section to approve the particular form of any
proposed supplemental indenture, but it shall be sufficient if such consent shall approve the substance thereof. 
 Section 9.03 Effect of
Supplemental Indentures. 
 Upon the execution of any supplemental indenture pursuant to the provisions of this Article or of Section 10.01, this
Indenture shall, with respect to such series, be and be deemed to be modified and amended in accordance therewith and the respective rights, limitations of rights, obligations, duties and immunities under this Indenture of the Trustee, the Company
and the holders of Securities of the series affected thereby shall thereafter be determined, exercised and enforced hereunder subject in all respects to such modifications and amendments, and all the terms and conditions of any such supplemental
indenture shall be and be deemed to be part of the terms and conditions of this Indenture for any and all purposes. 
 Section 9.04 Securities
Affected by Supplemental Indentures. 
 Securities of any series affected by a supplemental indenture, authenticated and delivered after the execution of
such supplemental indenture pursuant to the provisions of this Article or of Section 10.01, may bear a notation in form approved by the Company, provided such form meets 

  
 40 

 the requirements of any securities exchange upon which such series may be listed, as to any matter provided for
in such supplemental indenture. If the Company shall so determine, new Securities of that series so modified as to conform, in the opinion of the Board of Directors, to any modification of this Indenture contained in any such supplemental indenture
may be prepared by the Company, authenticated by the Trustee and delivered in exchange for the Securities of that series then Outstanding. 

Section 9.05 Execution of Supplemental Indentures. 

Upon the request of the Company, accompanied by its Board Resolutions authorizing the execution of any such supplemental indenture, and upon the filing with
the Trustee of evidence of the consent of Securityholders required to consent thereto as aforesaid, the Trustee shall join with the Company in the execution of such supplemental indenture unless such supplemental indenture affects the Trustee’s
own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion but shall not be obligated to enter into such supplemental indenture. The Trustee, subject to the provisions of Section 7.01,
shall receive an Officer’s Certificate or an Opinion of Counsel as conclusive evidence that any supplemental indenture executed pursuant to this Article is authorized or permitted by the terms of this Article and that all conditions precedent
to the execution of the supplemental indenture have been complied with; provided, however, that such Officer’s Certificate or Opinion of Counsel need not be provided in connection with the execution of a supplemental indenture that establishes
the terms of a series of Securities pursuant to Section 2.01 hereof. 
 Promptly after the execution by the Company and the Trustee of any supplemental
indenture pursuant to the provisions of this Section, the Company shall (or shall direct the Trustee to) transmit by mail, first class postage prepaid, a notice, setting forth in general terms the substance of such supplemental indenture, to the
Securityholders of all series affected thereby .as their names and addresses appear upon the Security Register. Any failure of the Company to mail, or cause the mailing of, such notice, or any defect therein, shall not, however, in any way impair or
affect the validity of any such supplemental indenture. 
 ARTICLE 10 

SUCCESSOR ENTITY 
 Section 10.01
Company May Consolidate, Etc. 
 Nothing contained in this Indenture shall prevent any consolidation or merger of the Company with or into any other
Person (whether or not affiliated with the Company) or successive consolidations or mergers in which the Company or its successor or successors shall be a party or parties, or shall prevent any sale, conveyance, transfer or other disposition of the
property of the Company or its successor or successors as an entirety, or substantially as an entirety, to any other Person (whether or not affiliated with the Company or its successor or successors); provided, however, the Company hereby covenants
and agrees that, upon any such consolidation or merger (in each case, if the Company is not the survivor of such transaction) or any such sale, conveyance, transfer or other disposition (other than a sale, conveyance, transfer or other disposition
to a Subsidiary of the Company), the due and punctual payment of the 

  
 41 

 principal of (premium, if any) and interest on all of the Securities of all series in accordance with the terms
of each series, according to their tenor, and the due and punctual performance and observance of all the covenants and conditions of this Indenture with respect to each series or established with respect to such series pursuant to Section 2.01
to be kept or performed by the Company shall be expressly assumed, by supplemental indenture (which shall conform to the provisions of the Trust Indenture Act, as then in effect) reasonably satisfactory in form to the Trustee executed and delivered
to the Trustee by the entity formed by such consolidation, or into which the Company shall have been merged, or by the entity which shall have acquired such property. 

Section 10.02 Successor Entity Substituted. 

(a) In case of any such consolidation, merger, sale, conveyance, transfer or other disposition and upon the assumption by the successor entity by
supplemental indenture, executed and delivered to the Trustee and satisfactory in form to the Trustee, of the obligations set forth under Section 10.01 on all of the Securities of all series Outstanding, such successor entity shall succeed to
and be substituted for the Company with the same effect as if it had been named as the Company herein, and thereupon the predecessor corporation shall be relieved of all obligations and covenants under this Indenture and the Securities. 

(b) In case of any such consolidation, merger, sale, conveyance, transfer or other disposition, such changes in phraseology and form (but not in
substance) may be made in the Securities thereafter to be issued as may be appropriate. 
 (c) Nothing contained in this Article shall require any
action by the Company in the case of a consolidation or merger of any Person into the Company where the Company is the survivor of such transaction, or the acquisition by the Company, by purchase or otherwise, of all or any part of the property of
any other Person (whether or not affiliated with the Company). 
 ARTICLE 11 

SATISFACTION AND DISCHARGE 

Section 11.01 Satisfaction and Discharge of Indenture. 

If at any time: (a) the Company shall have delivered to the Trustee for cancellation all Securities of a series theretofore authenticated and not
delivered to the Trustee for cancellation (other than any Securities that shall have been destroyed, lost or stolen and that shall have been replaced or paid as provided in Section 2.07 and Securities for whose payment money or Governmental
Obligations have theretofore been deposited in trust or segregated and held in trust by the Company and thereupon repaid to the Company or discharged from such trust, as provided in Section 11.05); or (b) all such Securities of a
particular series not theretofore delivered to the Trustee for cancellation shall have become due and payable, or are by their terms to become due and payable within one year or are to be called for redemption within one year under arrangements
satisfactory to the Trustee for the giving of notice of redemption, and the Company shall deposit or cause to be deposited with the Trustee as trust funds the entire amount in moneys or Governmental Obligations or a combination thereof, sufficient
in the 

  
 42 

 opinion of a nationally recognized firm of independent public accountants expressed in a written certification
thereof delivered to the Trustee, to pay at maturity or upon redemption all Securities of that series not theretofore delivered to the Trustee for cancellation, including principal (and premium, if any) and interest due or to become due to such date
of maturity or date fixed for redemption, as the case may be, and if the Company shall also pay or cause to be paid all other sums payable hereunder with respect to such series by the Company then this Indenture shall thereupon cease to be of
further effect with respect to such series except for the provisions of Sections 2.03, 2.05, 2.07, 4.01, 4.02, 4.03 and 7.10, that shall survive until the date of maturity or redemption date, as the case may be, and Sections 7.06 and 11.05, that
shall survive to such date and thereafter, and the Trustee, on demand of the Company and at the cost and expense of the Company shall execute proper instruments acknowledging satisfaction of and discharging this Indenture with respect to such
series. 
 Section 11.02 Discharge of Obligations. 

If at any time all such Securities of a particular series not heretofore delivered to the Trustee for cancellation or that have not become due and payable as
described in Section 11.01 shall have been paid by the Company by depositing irrevocably with the Trustee as trust funds moneys or an amount of Governmental Obligations sufficient to pay at maturity or upon redemption all such Securities of
that series not theretofore delivered to the Trustee for cancellation, including principal (and premium, if any) and interest due or to become due to such date of maturity or date fixed for redemption, as the case may be, and if the Company shall
also pay or cause to be paid all other sums payable hereunder by the Company with respect to such series, then after the date such moneys or Governmental Obligations, as the case may be, are deposited with the Trustee the obligations of the Company
under this Indenture with respect to such series shall cease to be of further effect except for the provisions of Sections 2.03, 2.05, 2.07, 4,01, 4.02, 4,03, 7.06, 7.10 and 11.05 hereof that shall survive until such Securities shall mature and be
paid. 
 Thereafter, Sections 7.06 and 11.05 shall survive. 

Section 11.03 Deposited Moneys to be Held in Trust. 

All moneys or Governmental Obligations deposited with the Trustee pursuant to Sections 11.01 or 11.02 shall be held in trust and shall be available for payment
as due, either directly or through any paying agent (including the Company acting as its own paying agent), to the holders of the particular series of Securities for the payment or redemption of which such moneys or Governmental Obligations have
been deposited with the Trustee. 
 Section 11.04 Payment of Moneys Held by Paying Agents. 

In connection with the satisfaction and discharge of this Indenture all moneys or Governmental Obligations then held by any paying agent under the provisions
of this Indenture shall, upon demand of the Company, be paid to the Trustee and thereupon such paying agent shall be released from all further liability with respect to such moneys or Governmental Obligations. 

  
 43 

 Section 11.05 Repayment to Company. 

Any moneys or Governmental Obligations deposited with any paying agent or the Trustee, or then held by the Company, in trust for payment of principal of or
premium, if any, or interest on the Securities of a particular series that are not applied but remain unclaimed by the holders of such Securities for at least two years after the date upon which the principal of (and premium, if any) or interest on
such Securities shall have respectively become due and payable, or such other shorter period set forth in applicable escheat or abandoned or unclaimed property law, shall be repaid to the Company on May 31 of each year or upon the
Company’s request or (if then held by the Company) shall be discharged from such trust; and thereupon the paying agent and the Trustee shall be released from all further liability with respect to such moneys or Governmental Obligations, and the
holder of any of the Securities entitled to receive such payment shall thereafter, as a general creditor, look only to the Company for the payment thereof. 

ARTICLE 12 
 IMMUNITY OF
INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS 
 Section 12.01 No Recourse. 

No recourse under or upon any obligation, covenant or agreement of this Indenture, or of any Security, or for any claim based thereon or otherwise in respect
thereof, shall be had against any incorporator, stockholder, officer or director, past, present or future as such, of the Company or of any predecessor or successor corporation, either directly or through the Company or any such predecessor or
successor corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that this Indenture and the obligations issued hereunder are solely
corporate obligations, and that no such personal liability whatever shall attach to, or is or shall be incurred by, the incorporators, stockholders, officers or directors as such, of the Company or of any predecessor or successor corporation, or any
of them, because of the creation of the indebtedness hereby authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Securities or implied therefrom; and that any and all such
personal liability of every name and nature, either at common law or in equity or by constitution or statute, of, and any and all such rights and claims against, every such incorporator, stockholder, officer or director as such, because of the
creation of the indebtedness hereby authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Securities or implied therefrom, are hereby expressly waived and released as a condition
of, and as a consideration for, the execution of this Indenture and the issuance of such Securities. 

  
 44 

 ARTICLE 13 

MISCELLANEOUS PROVISIONS 

Section 13.01 Effect on Successors and Assigns. 
 All
the covenants, stipulations, promises and agreements in this Indenture made by or on behalf of the Company shall bind its successors and assigns, whether so expressed or not. 

Section 13.02 Actions by Successor. 
 Any act or
proceeding by any provision of this Indenture authorized or required to be done or performed by any board, committee or officer of the Company shall and may be done and performed with like force and effect by the corresponding board, committee or
officer of any corporation that shall at the time be the lawful successor of the Company. 
 Section 13.03 Surrender of Company Powers. 

The Company by instrument in writing executed by authority of its Board of Directors and delivered to the Trustee may surrender any of the powers reserved to
the Company, and thereupon such power so surrendered shall terminate both as to the Company and as to any successor corporation. 
 Section 13.04
Notices. 
 Except as otherwise expressly provided herein, any notice, request or demand that by any provision of this Indenture is required or permitted
to be given, made or served by the Trustee, the Security Registrar, any paying or other agent under this Indenture or by the holders of Securities or by any other Person pursuant to this Indenture to or on the Company may be given or served by being
deposited in first class mail, postage prepaid, addressed (until another address is filed in writing by the Company with the Trustee), as follows: . Any notice, election, request or demand by the Company or any Securityholder or by any other Person
pursuant to this Indenture to or upon the Trustee shall be deemed to have been sufficiently given or made, for all purposes, if given or made in writing at the Corporate Trust Office of the Trustee. 

Section 13.05 Governing Law; Jury Trial Waiver. 

This Indenture and each Security shall be governed by, and construed in accordance with, the internal laws of the State of New York, except to the extent that
the Trust Indenture Act is applicable. 
 EACH PARTY HERETO, AND EACH HOLDER OF A SECURITY BY ACCEPTANCE THEREOF, HEREBY WAIVES, TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS INDENTURE. 

  
 45 

 Section 13.06 Treatment of Securities as Debt. 

It is intended that the Securities will be treated as indebtedness and not as equity for federal income tax purposes. The provisions of this Indenture shall be
interpreted to further this intention. 
 Section 13.07 Certificates and Opinions as to Conditions Precedent. 

(a) Upon any application or demand by the Company to the Trustee to take any action under any of the provisions of this Indenture, the Company shall
furnish to the Trustee an Officer’s Certificate stating that all conditions precedent provided for in this Indenture (other than the certificate to be delivered pursuant to Section 13.12) relating to the proposed action have been complied
with and, if requested, an Opinion of Counsel stating that in the opinion of such counsel all such conditions precedent have been complied with, except that in the case of any such application or demand as to which the furnishing of such documents
is specifically required by any provision of this Indenture relating to such particular application or demand, no additional certificate or opinion need be furnished. 

(b) Each certificate or opinion provided for in this Indenture and delivered to the Trustee with respect to compliance with a condition or covenant in
this Indenture (other than the certificate to be delivered pursuant to Section 13.12 or Section 314(a)(1) of the Trust Indenture Act) shall include (i) a statement that the Person making such certificate or opinion has read such
covenant or condition; (ii) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based; (iii) a statement that, in the opinion
of such Person, he has made such examination or investigation as is reasonably necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been complied with; and (iv) a statement as to whether or
not, in the opinion of such Person, such condition or covenant has been complied with. 
 Section 13.08 Payments on Business Days. 

Except as provided pursuant to Section 2.01 pursuant to a Board Resolution, and set forth in an Officer’s Certificate, or established in one or more
indentures supplemental to this Indenture, in any case where the date of maturity of interest or principal of any Security or the date of redemption of any Security shall not be a Business Day, then payment of interest or principal (and premium, if
any) may be made on the next succeeding Business Day with the same force and effect as if made on the nominal date of maturity or redemption, and no interest shall accrue for the period after such nominal date. 

  
 46 

 Section 13.09 Conflict with Trust Indenture Act. 

If and to the extent that any provision of this Indenture limits, qualifies or conflicts with the duties imposed by Section 318(c) of the Trust Indenture
Act, such imposed duties shall control. 
 Section 13.10 Counterparts. 

This Indenture may be executed in any number of counterparts, each of which shall be an original, but such counterparts shall together constitute but one and
the same instrument. The exchange of copies of this Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Indenture as to the parties hereto and may be used in lieu of the
original Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes. 

Section 13.11 Separability. 
 In case any one or more
of the provisions contained in this Indenture or in the Securities of any series shall for any reason be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other
provisions of this Indenture or of such Securities, but this Indenture and such Securities shall be construed as if such invalid or illegal or unenforceable provision had never been contained herein or therein. 

Section 13.12 Compliance Certificates. 
 The Company
shall deliver to the Trustee, within 120 days after the end of each fiscal year during which any Securities of any series were outstanding, an officer’s certificate stating whether or not the signers know of any Event of Default that occurred
during such fiscal year. Such certificate shall contain a certification from the principal executive officer, principal financial officer or principal accounting officer of the Company that a review has been conducted of the activities of the
Company and the Company’s performance under this Indenture and that the Company has complied with all conditions and covenants under this Indenture. For purposes of this Section 13.12, such compliance shall be determined without regard to
any period of grace or requirement of notice provided under this Indenture. If the officer of the Company signing such certificate has knowledge of such an Event of Default, the certificate shall describe any such Event of Default and its status.

 Section 13.13 U.S.A Patriot Act. 
 The parties
hereto acknowledge that in accordance with Section 326 of the U.S.A. Patriot Act, the Trustee, like all financial institutions and in order to help fight the funding of terrorism and money laundering, is required to obtain, verify, and record
information that identifies each person or legal entity that establishes a relationship or opens an account with the Trustee. The parties to this Indenture agree that they will provide the Trustee with such information as it may request in order for
the Trustee to satisfy the requirements of the U.S.A. Patriot Act. 

  
 47 

 Section 13.14 Force Majeure. 

In no event shall the Trustee, the Security Registrar, any paying agent or any other agent under this Indenture be responsible or liable for any failure or
delay in the performance of its obligations hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military
disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions or utilities, communications or computer (software and hardware) services; it being understood that the Trustee, the Security Registrar, any paying
agent or any other agent under this Indenture shall use reasonable efforts which are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances. 

Section 13.15 Table of Contents; Headings. 
 The
table of contents and headings of the articles and sections of this Indenture have been inserted for convenience of reference only, are not intended to be considered a part hereof, and will not modify or restrict any of the terms or provisions
hereof. 

  
 48 

 IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed all as of the day
and year first above written. 
  

			
	ADURO BIOTECH, INC.
		
	By:	 	 
	Name:	 	 
	Title:	 	 

  

			
	[TRUSTEE], as Trustee
		
	By:	 	 
	Name:	 	 
	Title:	 	 

  
 49 

 CROSS-REFERENCE TABLE (1)
  

			
	 Section of Trust Indenture Act of 1939, as Amended
	  	Section of
Indenture
	 310(a)
	  	7.09
	 310(b)
	  	7.08
		  	7.10
	 310(c)
	  	Inapplicable
	 311(a)
	  	7.13
	 311(b)
	  	7.13
	 311(c)
	  	Inapplicable
	 312(a)
	  	5.01
		  	5.02(a)
	 312(b)
	  	5.02(c)
	 312(c)
	  	5.02(c)
	 313(a)
	  	5.04(a)
	 313(b)
	  	5.04(b)
	 313(c)
	  	5.04(a)
		  	5.04(b)
	 313(d)
	  	5.04(c)
	 314(a)
	  	5.03
		  	13.12
	 314(b)
	  	Inapplicable
	 314(c)
	  	13.07(a)
	 314(d)
	  	Inapplicable
	 314(e)
	  	13.07(b)
	 314(f)
	  	Inapplicable
	 315(a)
	  	7.01(a)
		  	7.01(b)
	 315(b)
	  	7.14
	 315(c)
	  	7.01
	 315(d)
	  	7.01(b)
	 315(e)
	  	6.07
	 316(a)
	  	6.06
		  	8.04
	 316(b)
	  	6.04
	 316(c)
	  	8.01
	 317(a)
	  	6.02
	 317(b)
	  	4.03
	 318(a)
	  	13.09

  
  

	(1)	This Cross-Reference Table does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of its terms or provisions. 

  
 50

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}]]